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Summary
Eukaryotic cells are characterized by having a subset of internal membrane 
compartments, each one with a speci c identity, structure and function. Proteins destined 
to be targeted to the exterior of the cell need to enter and progress through the secretory 
pathway. 
Transport of secretory proteins from the endoplasmic reticulum (ER) to the Golgi 
takes place by the selective packaging of proteins into COPII-coated vesicles at the ER 
membrane. Taking advantage of the extensive genetic tools available for S. cerevisiae 
we found that Hsp150, a yeast secretory glycoprotein, selectively exited the ER in the 
absence of any of the three Sec24p family members. Sec24p has been thought to be an 
essential component of the COPII coat and thus indispensable for exocytic membrane 
traf c.
Next we analyzed the ability of Hsp150 to be secreted in mutants, where post-Golgi 
transport is temperature sensitive. We found that Hsp150 could be selectively secreted 
under conditions where the exocyst component Sec15p is defective. Analysis of the 
secretory vesicles revealed that Hsp150 was packaged into a subset of known secretory 
vesicles as well as in a novel pool of secretory vesicles at the level of the Golgi. 
Secretion of Hsp150 in the absence of Sec15p function was dependent of Mso1p, a 
protein capable of interacting with vesicles intended to fuse with the plasma membrane, 
with the SNARE machinery and with Sec1p.
This work demonstrated that Hsp150 is capable of using alternative secretory pathways 
in ER-to-Golgi and Golgi-to-plasma membrane traf c. The sorting signals, used at both 
stages of the secretory pathway, for secretion of Hsp150 were different, revealing the 
highly dynamic nature and spatial organization of the secretory pathway.
Foreign proteins usually misfold in the yeast ER. We used Hsp150 as a carrier to assist 
folding and transport of heterologous proteins though the secretory pathway to the 
culture medium in both S. cerevisiae and P. pastoris. Using this technique we expressed 
Hsp150-HRP and developed a staining procedure, which allowed the visualization of 
the organelles of the secretory pathway of S. cerevisiae. 
1INTRODUCTION
1. Principles of intracellular 
membrane traf c
1.1 The exocytic pathway: an 
introduction
Eukaryotic cells contain membrane-
enclosed compartments, called organelles, 
which have specialized functions and 
contain a unique combination of proteins, 
lipids and cofactors. In order to conserve 
their identity, structure and functional 
dynamics, there has to be an organized 
intracellular traffic to and from these 
organelles. Only a few proteins can enter 
these organelles directly from the cytosol. 
Thus, most proteins have to be sorted and 
further distributed to their  nal destination 
(1, 2). They need to contain a signal peptide 
in order to accomplish the  rst step of the 
secretory pathway, this is, translocation 
into the endoplasmic reticulum (ER). 
From this point on they are transported 
in transport vesicles along the secretory 
pathway, while being modi ed, and  nally 
delivered to their destinations. In addition 
to maintaining the cell dynamics, the 
secretory pathway is used for the delivery 
of proteins, membrane and cell wall 
components to the growing bud area as the 
cell divides, and for secreting proteins to 
the exterior of the cell.
The intracellular route of secretory 
proteins was originally defined in 
mammalian cells (3), and was shown to be 
basically the same in S. cerevisiae by using 
genetic analysis (4). The yeast secretory 
pathway was initially defined using 
temperature-sensitive secretory mutants 
(sec) that reversibly accumulate exocytic 
proteins at the restrictive temperature 
of 37oC, whereas at the permissive 
temperature (25oC) intracellular transport 
is normal (5, 6). These conditional mutants 
have provided the tools for investigating 
Figure 1. A schematic illustration 
of the yeast secretory pathway 
and key proteins involved in 
each transport step. 
Protein translation from mRNA, is 
initiated on free ribosomes in the 
cytoplasm. Polypeptides are then 
translocated into the ER lumen, 
where they are modified and 
folded into an active conformation. 
For ER exit to occur proteins and 
packaged into vesicular transport 
carriers. Vesicles migrate to the 
Golgi and release their cargo after 
membrane fusion. In the Golgi 
proteins are further modi ed and 
sorted to their final destinations, 
which can be either to the growing 
bud (Plasma membrane, cell 
wall or culture medium) or to 
the vacuole. (PVC) prevacuolar 
complex.
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2the molecular mechanisms that regulate 
and allow traffic through the secretory 
pathway. Since then, the genes have been 
identified and divided into functional 
groups according to the transport step in 
which they are involved (see Figure 1).
1.2 Membrane-enclosed compartments 
with individual properties
Eukaryotic cells have membrane-
enclosed compartments. The existence 
of a membrane separating the lumen of 
the organelles from the cytosol permits 
the creation of unique and individual 
environments, which allow special 
reactions to occur that would not be capable 
of occurring in the cytosol. In Figure 2, 
transmission electron microscope pictures 
of a yeast cell can be found depicting the 
different organelles typically found within 
the cell.
Nucleus. The nucleus is the largest 
organelle in the eukaryotic cell and is 
easily visible with the light microscope. 
It is separated from the rest of the cell 
by an envelope consisting of an outer 
and inner nuclear membrane. The region 
between the two is the perinuclear space 
and is continuous with the lumen of the 
ER. Almost the entire DNA of the cell is 
located within the nucleus, which is the 
compartment for storage, replication and 
expression of genetic information. Nuclei 
often contain a nucleolus, or some times 
several, which are the sites of ribosome 
formation.
Mitochondria. Mitochondria are 
the energy power station of the cell. 
They are delimited by two membranes, 
a smooth outer membrane and a folded 
inner membrane that encloses the matrix. 
The folds are referred as cristae and the 
space between membranes is called the 
intermembrane space. Components of the 
respiratory chain and ATP synthesis reside 
within the inner mitochondrial membrane. 
The main function of the mitochondria is 
the oxidative degradation to CO2 and H20 
of energy-yielding substrates coupled with 
the synthesis of ATP, which is the major 
energy storage form used by the cell to 
drive reactions. Mitochondria probably 
evolved from aerobic prokaryotic bacteria 
living in symbiosis with anaerobic host 
cells (endosymbiotic theory) and hence 
have their own DNA (mtDNA), which 
is used to synthesize some of their own 
proteins.
Endoplasmic Reticulum (ER). The 
ER is a large intracellular compartment 
Figure 2. Electron micrographs depicting the different organelles within a yeast cell. 
Nucleus (N), endoplasmic reticulum (ER), Golgi complex (G), mitochondria (M), peroxisomes 
(P), vacuole (Vac), plasma membrane (PM) and cell wall (CW).
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3that extends throughout the cytoplasm. It 
can be subdivided into to two types, the 
rough ER (RER) and smooth ER (SER). 
The RER have many attached ribosomes, 
and is thus the site of protein biosynthesis. 
Most of the proteins synthesized at 
the SER undergo post-translational 
modi cations and are transported to their 
 nal destination by transport vesicles, or 
then remain within the ER.
Golgi Apparatus.  Like the ER, the 
Golgi is a complex network of membrane-
enclosed sub-compartments. There are cis, 
medial and trans-Golgi regions. The main 
function of the Golgi is protein maturation 
(phosphorylation, modi cation of glycans, 
and processing by proteolytic cleavages 
for example) and sorting of proteins to the 
various targets within the cell. 
Vacuole. The main function of the 
vacuole is the enzymatic degradation of 
various cellular components, as well as 
nutrients taken up from the surrounding 
environment via endocytosis. For this 
purpose vacuoles are  lled with different 
types of degradative enzymes, hydrolases 
with acidic pH optima. Vacuoles also act 
as storage compartments of amino acids 
and detoxi cation components. 
1.3 A model for vesicle-mediated 
transport
It often takes only seconds for a secretory 
vesicle to move between intracellular 
organelles. But this very rapid traf c is 
also very selective. Only a subset of the 
proteins and lipids in the donor membrane 
are allowed into the transport vesicle, 
thus permitting membraneous organelles 
to maintain their identity. During the 
formation of the vesicle, a specific set 
of proteins, including the coat proteins 
COPI, COPII and clathrin, carries out a 
sequential set of actions that lead to the 
budding of vesicles. Coat components 
are required to generate highly curved 
membrane and to select cargo into them. 
After vesicle  ssion, uncoating takes place 
and the naked vesicle is allowed to fuse 
with the target membrane. The budding 
reaction is generally regulated by the 
small G proteins of the ARF family, which 
in the GTP-activated state initiates coat 
assembly at the bud site. Coat disassembly 
then results when GTP is hydrolyzed to 
GDP (reviewed in (7, 8)) (Figure 3).
COPI and COPII coated vesicles are 
used in the anterograde and recycling 
pathways between the Golgi and the ER 
- COPI from the Golgi to the ER and intra-
Golgi cisternae, and COPII from ER to 
the Golgi. The clathrin-coated vesicles are 
used in two major routes, from the plasma 
membrane to the early endosome and from 
the Golgi to the endosome. It should be 
noticed that tubular transport containers 
also exist in traf c between organelles (9, 
10). Their formation should follow the 
same principles as explained above.
1.4 Rab GTPases as molecular switches
The Rab proteins constitute a family 
of GTPase proteins, that together with 
other proteins take part in the transport 
of vesicles, controlling the docking and 
fusion of vesicles to the target membranes. 
Many of the transport vesicles only form 
if speci c Rab and SNARE proteins are 
coupled on their membrane, thus allowing 
the vesicle to correctly fuse. Rab proteins 
play an important role in the speci city 
of vesicular transport. As with the 
soluble NSF attachment protein receptor 
(SNAREs), each Rab protein has a unique 
distribution at the cellular membranes and 
each organelle has at least one type of 
Rab on its cytosolic surface. Rab proteins 
are known for facilitating and regulating 
the tethering and fusion of the vesicles, 
cargo sorting and cytoskeleton-dependent 
transport.
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1. RabGTP activation and coat recruitment. The guanyl exchange factor (GEF) recruits 
and activates the Rab by exchange of the bound nucleotide. Activated Rab in the GTP form 
then recruits set of protens that function as a coat. 2. Coat polymerization. Additional coat 
component are recruited and cargo intended for exit are packaged into the forming vesicle at 
this stage. Transmembrane cargo directly interact with the coat proteins, while soluble cargo 
interact via adapter proteins. 3. Vesicle budding. Polymerization of the coat leads to membrane 
deformation and formation of a vesicle. Vesicles scission between the neck of the vesicle and the 
donor compartment is severed either by direct action of the coat or by accessory proteins. 4. Coat 
disassembly. After the vesicle has been released from the membrane, various events including 
inactivation of the small GTPase, phosphoinositide hydrolysis, and the action of uncoating 
enzymes lead to uncoating of the vesicle thus exposing proteins on the membrane, which are 
involved in subsequent membrane fusion reaction.
1.4.1 The Rab GTPase cycle
As with all the other GTPases, Rab 
proteins circulate between membrane and 
the cytosol. When in the GDP form, they 
are inactive and present in the cytosol. In 
the GTP form, they are active and coupled 
to membranes. An enzyme, guanine 
nucleotide exchange factor (GEF), 
catalyzes the change of GDP for GTP, 
which leads to a conformational change 
in the Rab (exposure of two isoprenoid 
lipids) that allows it to anchor itself to the 
membrane (Figure 4). Once in the GTP 
form it recruits a speci c subset of proteins, 
called effectors, to particular sites on the 
membrane and facilitate their assembly 
into larger complexes. These effectors 
carry out the downstream functions 
associated with the Rab protein. The 
GTP hydrolysis is facilitated by GTPase 
activating proteins (GAPs) and returns the 
Rab into the GDP form. A protein called 
Rab GDP dissociation inhibitor (GDI) 
removes the Rab GDP from the membrane 
and solubilizes it, restoring the cytosolic 
reservoir. Reattachment of the Rab to the 
membrane for a new cycle is facilitated 
by GDI displacement factors (GDF) 
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mechanism that leads to a downstream 
action triggered by the hydrolysis of GTP, 
Rab proteins are often seen as molecular 
switches, which regulate and synchronize 
the sequential steps required in all aspects 
of intracellular membrane traf c. 
1.5 Tethering factors
In addition to SNAREs, other proteins 
participate in the pairing of two opposing 
membranes. Tethering factors recognize 
two target membranes and help bring 
them into close proximity, thus allowing 
pairing of the t- and v-SNAREs. Their 
ability to interact with Rabs and SNAREs, 
together with their restricted subcellular 
localization, suggest that tethers help 
determine the specificity of membrane 
fusion (reviewed in (12, 13). As examples 
we can  nd the transport protein particle 
TRAPP I in ER to Golgi, TRAPP II in 
intra-Golgi, GARP in early endosome/
PVC to Golgi and the exocyst in Golgi to 
plasma membrane fusion events.
Tethering factors may be divided into 
two families: long coiled-coil proteins 
such as p115, or large multisubunit 
complexes such as the exocyst complex. 
Unlike the Rab and SNARE families 
where different members share a common 
mechanism of action, the different 
tethers may facilitate membrane traffic 
through distinct mechanisms.  Tethering 
factors have been implicated in different 
aspects of intracellular traffic such as 
bridging of membranes, SNARE complex 
assembly, cargo selection, coat dynamics, 
cytoskeleton-linking and signaling events.
1.5.1 Bridging of membranes
One feature associated to tethers is 
the physical association of transport 
intermediates to the target membranes, 
in a step that precedes SNARE paring 
and membrane fusion. As the vesicle 
approaches, tethering factors (exempli ed 
in Figure 5 by TRAPPI complex) can 
bridge two opposing membranes at 
distances more than 200 nm, where t- and 
v-SNAREs cannot physically interact yet. 
The tethering complex may then bring the 
vesicle into close proximity to the target 
membrane, where the SNARE pairs form 
a complex. The assembly of the SNARE 
complexes then leads to the fusion of 
the transport vesicle with the target 
membrane.
Figure 4. Model of the RabGTP cycle
RabGTPases cycle between the cytosol and the membrane where they recruit a subset of effector 
proteins, which carry downstream events. See text for details. Guanine nucleotide exchange 
factor (GEF), GTPase activating proteins (GAPs), Rab GDP dissociation inhibitor (GDI), GDI 
displacement factors (GDF). 
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1. Approach. The vesicle moves close to the target membrane compartment, possibly guided by 
the action of the cytoskeleton. 2. Tethering. The vesicle then becomes tethered to the acceptor 
compartment by the combination of a GTP bound Rab and a tethering factor. This step occurs at 
a distance where v- and t-SNAREs do not interact. 3. Pairing. The tether then brings donor and 
target membrane into close proximity where the SNAREs can assemble into a four-helix bundle. 
This “trans-SNARE complex” then promotes fusion of the vesicle and acceptor lipid bilayers. 
1.6 SNARE hypothesis and speci city 
of vesicular transport
SNARE (soluble N-ethylmaleimide-
sensitive factor attachment protein 
receptor) proteins are considered to be 
the key components that drive membrane 
fusion in all trafficking steps of the 
secretory pathway (reviewed in (14)). 
SNARE proteins form a superfamily 
of small proteins with a characteristic 
SNARE motif (stretch of 60-70 amino 
acids arranged in heptad repeats). At the 
C-terminus, most SNAREs have a single 
transmembrane domain, or then are subject 
to post-translational modifications that 
lead to their insertion into the membrane. 
Variations in the N-terminal region lead 
to the classi cation of the SNAREs into 
different subgroups. 
SNAREs mediate membrane fusion 
by forming a helical complex of elongated 
coiled-coils of four parallel -helices, each 
Figure 6. Membrane fusion is mediated by the formation of SNARE complexes between 
donor and acceptor compartments.
A general model for the regulation of SNARE assembly in membrane fusion events is shown. 
Prior to membrane docking, donor and acceptor bilayers undergo a tethering process, mediated 
by Rab GTPases and tethering complexes (see Figure 5), thus bringing trans-SNARE complexes 
on apposed membranes within close proximity. At this stage members of the Sec1/Munc18 family 
are recruited, which might promote the formation of a trans-SNARE complex between the two 
membranes or maintain the primed complexes in a metastable intermediate (represented as a 
plus or minus signals respectively). After input by some fusogenic signal, the SNARE regulators 
are released, which allows for the full zippering of the trans complexes from their membrane-
distal to membrane proximal ends, this bringing the two membranes into close proximity. Bilayer 
fusion between the two membranes then occurs (depicted here according to the stalk hypothesis). 
Subsequently the four-helix cis-SNARE bundle is disassembled by NSF (Sec18p in yeast) and its 
partner -SNAP (Sec17p in yeast) and the v-SNARE is recycled back to the donor compartment. 
See text for further details concerning the regulatory mechanisms. SNAREs (v-SNARE = yellow; 
SNAP-25-like t-SNARE = green and blue; syntaxin-like t-SNARE = purple). 
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between two opposing membranes. At 
the central layer of this complex, the “0” 
layer, there are 4 conserved residues, 
3 glutamines (Q) and one arginine (R). 
The contributing SNARE motifs are 
thus classified as Qa-, Qb, Qc- and R-
SNAREs.
SNAREs are broadly distributed 
throughout the secretory pathway and 
at the membrane they target for. NSF 
(N-ethylmaleimide-sensitive factor, or 
Sec18p in yeast) guarantees that a free 
pool of SNAREs is always present. 
Before a SNARE complex between donor 
and acceptor can form, the SNAREs on 
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helical Qabc intermediate (see Figure 
6). The formation of this intermediate is 
rate limiting, but highly reactive after 
formed. Factors such as Sec1p/Munc18 
(SM) family members may bind to 
these intermediates and stabilize them 
until a R-SNARE is incorporated into 
them. SNAREs are thought to drive 
membrane fusion through the formation 
of the 4 helical bundle, starting at the 
N-terminus and proceeding to the C-
terminus, and hence the term Zippering. 
Central to this zipper-like assembly 
model, is the formation of the SNARE in 
trans-con guration; i.e. where SNAREs 
participating in the SNARE complex 
reside in two opposing membranes. As 
the SNARE complex assembles in the 
N to C terminus direction, “zippering 
up”, they exert mechanical forces on the 
membranes bringing them into close 
proximity while deforming there normal 
curvature, thus facilitating the formation 
of the stalks required for fusion. After 
fusion, the SNARE complexes are now in 
the cis-orientation, i.e. they reside on the 
same membrane. These complexes remain 
biologically inactive until they dissociate. 
The disassembly requires energy (ATP), 
NSF and SNAPs (soluble NSF attachment 
proteins or Sec17p in yeast) that together 
dissociate the complex. After disassembly, 
some of the SNAREs are returned to their 
original compartment by intracellular 
membrane traffic. As a consequence, 
SNAREs exist not only on the organelle 
for which they mediate membrane fusion, 
but also on the organelles involved in 
their recycling. Thus, there needs to be 
a temporal and spatial regulation of the 
events leading to membrane fusion, to 
avoid incorrect membrane fusion events.
1.6.1 SNARE regulation
SNAREs are considered to be the elements 
that drive membrane fusion, and hence the 
names fusogens or engines for membrane 
fusion. Thus, while being a central element 
to the fusion of two membranes, they 
alone are insuf cient. Additional proteins 
are required to mediate membrane fusion 
in vivo. Many of these factors, which can 
be called SNARE regulators, play a role 
in the assembly and ability of SNAREs to 
form such complexes (reviewed in (15)). 
Regulation of SNARE activity is crucial 
for the maintenance of the organelle 
identity. In this sense, regulators may 
bind to SNAREs early in the secretory 
pathway to avoid cognate SNAREs from 
forming until they reach their appropriate 
destination. SNAREs tend to be broadly 
distributed, but on the other hand fusion 
events tend to occur in localized regions, 
for example in polarized delivery to the 
bud tip of the yeast. In this sense only 
SNAREs in the fusion region need to be 
activated. Thus some factors may promote 
the formation of these trans-complexes 
in these regions while others may restrict 
the activation of SNAREs in regions 
distant to the site of fusion. When SNARE 
complexes form, they exist in a metastable 
state (loose trans-complex). SNARE 
regulators may bind at this stage and either 
promote the zippering up or then stabilize 
this state until certain stimulus occurs (e.g. 
regulated exocytosis). Thus, SNAREs may 
be seen as switches that favour (match-
makers) or inhibit (match-breakers) the 
assembly of SNARE complexes (15).
Sec1/Munc18 (SM) family. SM 
family members bind to the syntaxin 
(Qa-) class of t-SNAREs in both yeast 
and mammalian cells. A feature of the 
syntaxin class is that they have a N-
terminal regulatory domain (Habc) folded 
as a three helice bundle that may fold back 
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terminus, and form an intra-molecular 
four-helix bundle, called the “closed” 
conformation (16). In yeast, SM family 
members (Sec1p for example) may bind 
to preassembled SNARE complexes 
activating them, and prevent the folding 
back of the Habc domain. In cases where 
the syntaxin N-terminus does not form a 
closed conformation (Sed5p or Tlg2p), 
SM family members (Sly1p or Vps45p) 
may bind to the N-terminal peptide of 
the regulatory domain (17, 18). Yeast 
SM family members favour the transition 
of inactive to active t-SNARE and thus 
promote the assembly of the SNARE 
complex. In contrast, in mammalian cells, 
SM family members (Munc18a) bind to 
the closed conformation of syntaxin and 
were therefore initially thought to prevent 
SNARE assembly. Although SM family 
members appear to play opposing roles 
in yeast and mammalian cells, recent 
evidence suggest a positive role for them, 
by preventing for example oligomerization 
between syntaxins, or by inhibiting their 
association with other SNAREs while 
traf cking to their  nal destination (19). 
Synaptotagmins and Munc13/Unc-
13. These regulators are found exclusively 
in higher eukaryotes and mediate stimulus-
coupled exocytosis. 
Synaptotagmins have a C2 domain 
that works as a calcium sensor and 
hence mediates st imulus-coupled 
secretion. Binding of synaptotagmins 
to the metastable SNARE complexes 
inhibits complete zippering up until the 
influx of calcium. Upon calcium influx 
synaptotagmins facilitate assembly of the 
SNARE complex leading to fusion of the 
docked vesicles (15).
Munc13/Unc-13 contains a C1 domain 
that is sensitive to diacylglycerol and 
binds to the N-terminal regulatory domain 
of syntaxins. Munc13/Unc-13 may favour 
SNARE complex assembly by promoting 
the change from closed to the open state of 
syntaxin (15).  
LMA1. Lma1p binds to the t-
SNARE (Vam3p) involved in vacuolar 
fusion in yeast that is normally found 
in cis-complexes. After disassembly of 
the cis-SNARE complexes by Sec18p, 
Lma1p is transferred from Sec18p to the 
t-SNARE Vam3p, and prevents Vam3p 
from reentering into a cis-complex. 
Vam3p- Lma1p thus enters a fusion cycle, 
when the SNAREs form a tight trans-
complex. The concerted action of calcium, 
calmodulin and phosphatase activity lead 
to the release of Lma1p from Vam3p, and 
the bilayers fuse (20).
Phosphorylation as a mechanism of 
regulation. Internal and external signals 
in the cell lead to signaling cascades that 
culminate in the activation or repression 
of kinases and phosphatases. Regulation 
of intracellular transport by protein 
phosphorylation allows the cell to couple 
vesicular traffic with the prevailing 
conditions. Recently many of the elements 
involved in the fusion event, such as 
Rabs, tethering factors, SNAREs and their 
regulators are subject to phosphorylation. 
In general phosphorylation seems to 
favour the binding of the SNARE 
regulator at the expense of their binding 
SNARE, thus disrupting the formation of 
acceptor complexes, and hence inhibiting 
the fusion of two membranes. For example 
phosphorylation of the NH2-domain of 
syntaxin (Sso1/2) inhibits the binding of 
its partner t-SNARE SNAP-25 (Sec9) and 
thus prevents the formation of acceptor 
complexes (21).
Vsm1. Vsm1p is capable of binding 
to the yeast t-SNARE syntaxin Sso1/2p, 
after the latter has been phosphorylated 
(22). The binding of Vsm1p to Sso1/2p 
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prevents binding of the t-SNARE partner 
Sec9p, thus preventing the formation of 
acceptor complexes for posterior fusions 
events to occur (23). 
2. Endoplasmic Reticulum 
2.1 Entry into the exocytic pathway
Proteins destined to enter the ER can be 
divided into two groups: a) soluble proteins 
that are secreted to the exterior of the cell 
or remain in the lumen of an organelle 
such as the ER, Golgi or vacuole and b) 
membrane proteins, such as those present 
in the plasma membrane and those on the 
membranes of the secretory organelles. 
The synthesis of most exocytic proteins 
begins on free ribosomes in the cytosol. 
The presence of a 15 to 50 residue signal 
peptide at the N-terminus of the nascent 
polypeptide chain directs the ribosome to 
the ER membrane and initiates transfer 
of the growing polypeptide across the ER 
membrane (24). The newly synthesized 
polypeptide thus enters the exocytic 
pathway. Translocation of the polypeptide 
into the ER lumen can occur either 
cotranslationally or posttranslationally. 
In mammalian cells, translocation of 
proteins into the ER occurs primarily 
cotranslationally, i.e. simultaneously with 
protein synthesis, whereas yeast is capable 
of using both pathways (25). The reason 
for this may be that in fast growing cells 
translocation may not always keep pace 
with translation (26). 
2.1.1 Signal peptides
The decision on the translocation mode is 
determined by the hydrophobicity of the 
signal peptide. The signal peptide (from 
15 up to more than 50 amino acids) is 
composed by an essential hydrophobic 
central region, called the h-region of 6 to 
15 amino acids. The h-region is  anked 
by two polar regions, the n-region located 
N-terminally and the c-region located 
to the C-terminus. Within the c-region, 
a cleavage site for the ER-located signal 
peptidase is present, resulting in removal 
of the signal peptide (27).
The more hydrophobic the signal 
peptide, more likely the polypeptide will 
be translocated cotranslationally. This 
is mainly due to the signal recognition 
par t ic le  (SRP),  which mediates 
cotranslational translocation, associates 
with the h-region within the signal peptide. 
Less hydrophobic cores do not bind SRP, 
and thus these polypeptides use the post-
translational route (28). Both translocation 
pathways require speci c targeting of the 
polypeptide to the site of translocation
2.1.2 Co-translational translocation
In  cotranslat ional  t ranslocat ion, 
synthesis of the polypeptide is coupled 
to translocation or insertion into the 
ER membrane.  Essential to this type of 
translocation is the presence of the signal 
recognition particle (SRP) and its ER 
membrane-bound receptor (SR). 
When a protein is being synthesized, 
the SRP recognizes the signal peptide that 
emerges from the ribosome and directs 
the polypeptide with the ribosome to 
the ER membrane (for review see (29)). 
Two domains, the S domain and the Alu 
domain constitute the SRP (Figure 7). 
The S domain mediates signal peptide 
binding and docking to the SR, while the 
Alu domain is responsible for a transient 
delay in translation, i.e. elongation arrest 
(30, 31). The SRP of higher eukaryotes is 
composed of six proteins SRP9, SRP14, 
SRP19, SRP54, SRP68 and SRP72 
assembled on the SRP RNA 7SL (25). The 
yeast SRP homolog is also composed of 6 
proteins (Srp14p, Srp21p, Srp54p, Srp65p, 
Srp68p and Srp72p) assembled on scR1 
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Figure 7. SRP-mediated co-translational translocation. 
In cotranslational translocation, the ribosome is bound to the translocon (Sec61 complex; Sec61p, 
Ss1p and Sbh1p), and translocation and translation occur simultanously. The N-terminal signal 
peptide (yellow box) is recognized by the signal recognition particle (SRP) as soon as it emerges 
from the ribosomal polypeptide exit tunnel. In eukaryotes peptide elongation is temporarily 
arrested upon the formation of the SRP-RNC complex (RNC, ribosome nascent chain complex). 
This complex is then targeted to the ER membrane by binding to its receptor SR. The nascent 
polypeptide is then transferred to the Sec61 complex and translocated into the ER lumen as 
translation of the remaining mRNA (green) proceeds. The ER chaperone Kar2p/BiP, in the ADP 
from, binds to the emerging polypeptide. Thereafter the polypeptide looses its signal peptide.
Structures: Schematic overview of the mammalian SRP bound to the signal sequence carrying 
80S ribosome (RNC) based on a cryo-EM structure (Wild et al., 2004). The S and Alu domains 
of SRP are illustrated. The 40S and 60S ribosomal subunits are yellow and grey respectively. 
Reprinted, with permission, from Nature Structural & Molecular Biology, Volume 11, Number 
11 (c) 2004.
The Methanococcus jannaschii SecY complex viewed from the cytoplasm. (Osborne et al., 2005). 
The N-terminal domain of SecY (TMD1–5) is shown in dark blue with TMD2b in bright blue. 
The C-terminal domain (TMD6–10) is shown in red, with TMD7 shown in yellow. The plug that 
blocks the pore of the closed channel (TMD2a) is shown in green. The SecE and Sec subunits 
are shown in white.
Cytosolic view of E. coli SecY channel, with the plug modeled in its open position (Osborne et 
al., 2005). The asterisk indicates the region where introduced cysteines resulted in cross-links 
between the plug and the TM segment of SecE.
Reprinted, with permission, from the Annual Review of Cell and Developmental Biology, Volume 
21 (c) 2005 by Annual Reviews
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RNA, except that there is no SRP9 and 
there are two copies of Srp14p in yeast 
(31). SRP54 constitutes the universally 
conserved region of the S domain and 
is responsible for the signal sequence 
binding (32, 33) and the GTP-dependent 
SR interaction (34, 35). The SRP9, SRP14 
and the SRP RNA 7SL form the Alu 
domain (36, 37). 
The SRP binds to the signal peptide 
as it emerges from the ribosome and then 
targets the ribosome-nascent chain (RNC)-
SRP complex to the ER by interacting 
with ER-membrane bound SR. At this 
stage the elongation arrest induced by 
the Alu domain provides a longer time 
frame for the interaction to take place. 
The elongation arrest is not essential 
for translocation to occur but increases 
translocation ef ciency (38).
The ER membrane-bound receptor 
SR is a heterodimeric complex composed 
of SR and SR in mammals (39, 40) and 
its homologues Src101p and Src102p in 
yeasts (41, 42). SR/Src101p is a GTPase 
and SR/Src102p is responsible for 
anchorage to the ER.
Binding of GTP by SRP54 and 
SR helps stabilize the complex formed 
between SRP and SR and initiates the 
transfer of the signal peptide from the 
SRP54 subunit to the Sec61 component 
of the Sec61 complex at the translocation 
site. Hydrolysis of GTP by both SRP54 
and SR is required to dissociate the SRP-
SR complex and to resume polypeptide 
synthesis (43).
The Sec61 complex is composed 
of three subunits, Sec61, Sec61 and 
Sec61 in mammals. The yeast homolog 
counterparts are called Sec61p, Sbh1p and 
Sss1p in S. cerevisiae (44). Ss1p in yeast is 
also present in a second trimeric complex, 
called the Ssh1p complex together with 
Ssh1p and Ssh2p, homologues of Sec61p 
and Sbh1p, respectively. Ssh1p has been 
proposed to function in the cotranslational 
pathway since it interacts with membrane-
bound ribosomes but not with components 
involved with the posttranslational 
pathway (45). 
The largest subunit of the Sec61 
complex is the Sec61 subunit and 
spans the membrane ten times (44). The 
protein-conducting channel formed by the 
Sec61 complex is a passive pore, i.e. the 
polypeptide can slide in either direction, 
and therefore the channel requires 
accessory proteins to provide the driving 
force to ensure that the polypeptide slides 
into the ER. In the case of cotranslational 
translocation the force is provided by GTP 
hydrolysis that occurs during translation 
(46). Although the channel is passive, a 
tight seal ensures that no ions or proteins 
traverse freely the pore. There is a short 
helix in the Sec61-subunit (TM2) that 
functions as a plug. It slides back upon 
binding of a ribosome and the signal 
peptide to the -subunit, opening the pore 
for translocation (47). Once the signal 
peptide is connected to the Sec61 channel 
walls, the peptide region distant to the 
signal sequence is pushed through the 
pore and prevents the plug from returning 
to the closed state. Although translocation 
occurs through one pore of the Sec61 
complex, the actual translocation complex 
is composed of four Sec61 complexes. 
Two of them are associated side by 
side, with each dimer being packed 
in a back-to-back fashion (48). The 
oligomerization of the translocation 
channel may recruit additional factors 
such as TRAM (membrane chaperone) 
and TRAP (unknown function), that 
may play important roles for example in 
translocation of transmembrane proteins, 
or increase the surface area available to 
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bind the ribosome, increasing the stability 
of the connection (48, 49). 
The polypeptide chain then elongates 
into the ER lumen where the signal 
peptide is cleaved off by the signal 
peptidase and is rapidly degraded. The 
polypeptide continues to elongate through 
the translocon into the ER lumen. 
After the translation is completed, the 
ribosomes are released, the C-terminus 
of the protein is drawn into the ER 
lumen, the short -helix that constitutes 
the plug slides black closing the pore, 
and the translocated protein assumes its 
conformation.
Transmembrane proteins may be 
orientated differently depending on 
the flanking amino acids of the first 
transmembrane region (for a more detailed 
explanation see (50)). The transmembrane 
region is composed of hydrophobic 
amino acids usually arranged as -
helical regions of 20 to 25 residues. This 
sequence, called stop-transfer sequence, 
blocks further translocation of the 
polypeptide into the ER, the ribosome is 
released from the translocation apparatus 
and  nishes its job in the cytosol. In the 
case of a multispanning protein, the  rst 
transmembrane region often determines 
the orientation of the subsequent ones, 
which alternate correspondingly. During 
the synthesis of a membrane protein, the 
transmembrane segments move from 
the aqueous interior of the Sec61channel 
through a lateral gate into the lipid phase 
of the ER membrane (47). Proteins can 
also be anchored in the ER membrane by 
internal signal peptides that are not cleaved 
by signal peptidase. Proteins that span 
the membrane multiple times may result 
from alternating series of internal signal 
peptides and stop-transfer sequences.
Cleavage of the signal peptide, N-
linked glycosylation and folding of the 
polypeptide are essential cotranslational 
events. Since folding of many protein 
precursors occurs simultaneously with 
cotranslational translocation, the activity of 
luminal proteins such as protein disul de 
isomerase (PDI) and the chaperone BiP/
Kar2p may be added to the list of functions 
required for successful translocation (51).
2.1.3 Post-translational translocation
Eukaryotes have the capacity of 
translocating proteins post-translationally, 
i.e. after they have been fully synthesized 
in the cytosol and released from the 
ribosome. These proteins have a less 
hydrophobic signal peptide, and may 
therefore not interact with the SRP during 
their synthesis (28). Posttranslational 
translocation was determined in S. 
cerevisiae (52, 53) and requires a seven-
component Sec complex constituted by 
the Sec61 complex (the same used in 
cotranslational-translocation), and the 
Sec62/63 complexes together with the 
luminal BiP/Kar2p, a member of the Hsp70 
family of ATPases (54, 55). The Sec62/63 
complex is composed of Sec62p and 
Sec63p, and the nonessential components 
Sec71p and Sec72p. The yeast Sec61 
complex components are Sec61p, Sbh1p 
and Sss1p, and those of the Sec62/63 
subcomplex are Sec62p, Sec63p, Sec71p 
and Sec72p. The mammalian homologue 
of Sec62/63 subcomplex lacks Sec71p and 
Sec72p homologs (56, 57). Presumably, the 
completed polypeptide chain is presented 
to the ER membrane in a complex with 
cytosolic chaperones that cycle on and off, 
and like in cotranslational translocation, 
the Sec61 complex serves as the channel. 
The signal peptide binds initially to 
the Sec61p component of the Sec61 
complex and directs the polypeptide to the 
translocation channel (58). While bound to 
Sec61p, the signal peptide simultaneously 
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Figure 8. Post-translational translocation. 
After it is synthesized in the cytosol, the polypeptide is released from the ribosome. The 
polypeptide is kept in solution in a loosely folded state by cytosolic chaperones of the Hsp70 
family. The signal peptide targets it to the translocation channel, which is formed by the Sec61 
complex and the Sec62/63 complex. Polypeptide binding to Sec62/63 induces conformational 
changes that lead to the transfer of the signal peptide to the Sec61 complex and the polypeptide 
is initially translocated through the channel. The J-domain of Sec63 stimulates ATP hydrolysis 
by the ER chaperone Kar2p, which binds to the translocating polypeptide in the ADP bound form 
and prevents it from slipping back into the cytosol. When the polypeptide has moved a suf cient 
distance into the ER lumen, another Kar2p molecule can bind to it. This process is repeated until 
the polypeptide chain has passed through the channel. Kar2p is released from the polypeptide 
upon exchange of ADP for ATP, which opens the peptide-binding pocket.
contacts Sec62p of the Sec62/63 complex 
(59) (Figure 8). When the signal peptide is 
bound to the posttranslational translocation 
complex, the cytosolic chaperones are 
released, thus helping the passive forward 
movement of the polypeptide (60). Since 
the polypeptide in the channel can slide 
in either direction, the driving force to 
ensure the correct direction is provided 
by BiP/Kar2p. Binding of BiP/Kar2p to 
the polypeptide prevents its sliding back, 
and hence posttranslational translocation 
is thought to occur through a ratcheting 
mechanism (53). BiP/Kar2p has a peptide-
binding pocket that is open in the ATP 
form and closed in the ADP form. BiP-
ATP binds to a lumenal region of Sec63p 
called the J domain that is close to the 
incoming peptide. The interaction of BiP 
with the J domain activates ATP hydrolysis 
and the peptide pocket closes, capturing 
a region of the incoming polypeptide. 
The peptide-binding pocket shows no 
sequence speci city when activated by the 
J domain and the location of the J domain 
guarantees that BiP/Kar2p activation only 
occurs in close proximity to the incoming 
polypeptide (61, 62), ensuring that no 
backsliding occurs. The polypeptide 
moves forward by Brownian motion, 
other molecules of BiP/Kar2p bind to it 
and this process continues until the whole 
polypeptide has been translocated. After 
the polypeptide has moved away from 
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the channel, exchange of ADP for ATP 
on BiP/Kar2p releases it for a new cycle 
and rebinding to the polypeptide does not 
occur (61).
2.2 Protein maturation in the ER
After translocation of the polypeptide 
into the ER, the protein needs to adopt 
the correct final conformation to be 
fully functional. For this purpose the 
polypeptide undergoes a series of post-
translocation modifications that are 
initiated in the ER, such as signal peptide 
cleavage, glycosylation and formation of 
disulfide bonds. All of these processes 
are required for the protein to fold into 
its correct and active three-dimensional 
conformation. 
2.2.1 Signal peptide cleavage
Maturation in the ER begins by the removal 
of the signal peptides while the protein is 
being translocated or then shortly after. In 
the case where the signal peptide serves as 
the membrane anchoring transmembrane 
domain it remains uncleaved. The signal 
peptidase is a complex called the signal 
peptidase complex (SPC). The mammalian 
SPC is composed of five components 
SPC18, SPC21, SPC22/23, SPC25 and 
SPC12 (63). The yeast SPC consists of four 
components, Sec11p, Spc1p, Spc2p and 
Spc3p (64, 65), where the core catalytical 
domain is constituted by the essential 
Spc3p and Sec11p components (66, 67). 
Spc1p and Spc2p are non-catalytical and 
are not essential for the overall function. 
They are tightly associated in the SPC 
and their role may be in assisting the 
interaction with the translocation channel 
and in enhancing the overall activity of the 
SPC (68, 69).
When a protein is being translocated, 
the SPC is recruited to the translocation 
channel and interacts with members of 
the Sec61 complex. In mammalian cells, 
SPC21 interacts with the Sec61-subunit 
(70), whereas in yeast the interaction 
with Sbh1p and Sbh2p (homologues of 
Sec61-subunit) is mediated by the Spc2p 
component (69). 
2.2.2 Core-glycosylation
The most common modification of 
proteins that enter the ER is glycosylation. 
The addition of glycans has been shown 
to be important for a variety of functions. 
The glycans are important in the folding of 
the protein and serve as signals for quality 
control. They play a role in conferring 
stability to proteins, by protecting them 
from pH-in icted denaturation and from 
proteases. They can also be involved in 
targeting and signaling events. Addition 
of different glycan chains may also help 
creat different isoforms of the same 
protein, which would allow an increase in 
their speci city. From yeast to mammalian 
cells, glycans are generally added to amino 
(N-glycosylation) or hydroxyl groups 
(O-glycosylation) of speci c amino acid 
residues (reviewed by (71-73).
2.2.2.1 N-linked glycosylation 
In general, N-glycosylated proteins 
are secretory proteins that are either 
exported to the plasma membrane, or 
to the extracellular matrix, or then to 
the cell wall (72). N-linked core glycans 
are added from a lipid carrier (dolichol-
pyrophosphate) to the protein en bloc 
in the lumen of the ER. In Figure 9 the 
biosynthesis of the core oligosaccharide 
Dol-PP-GlcNAc2Man9Glc3 is shown. 
The core glycan, which has a defined 
structure in virtually all eukaryotes, 
results from the sequential addition of 
monosaccharides in a reaction catalyzed 
by monosaccharyltransferases in the 
ER membrane (74-76). Synthesis starts 
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in the cytosol by the transfer of N-
acetylglucosamine phosphate from UDP-
GlcNAc to the carrier Dol-P, creating 
GlcNAc-PP-Dol, in a step that is inhibited 
by tunicamycin. After addition of 6 more 
monosaccharides (one GLcNAc and  ve 
mannose residues) donated by UDP-
GLcNAc or GDP-Man, the glycan chain 
moiety is  ipped across the ER membrane 
to its luminal side, by an ATP-independent 
bi-directional flipase. In yeast Rft1p is 
responsible for this event (73). In the 
lumen, four additional mannoses and 
three glucoses are added sequentially and 
specifically creating the final branched 
glycan core. In the ER lumen, the lipid-
activated sugars Dol-P-Man and Dol-P-
Glc serve as donors. The addition of the 
terminal -1,2 linked glucose residue is of 
special importance, since it is required for 
ef cient recognition by the ER-resident 
oligosaccharyl transferase (OST) (71, 
77). OST is responsible for the transfer 
of the oligosaccharide core to the amino 
group of the asparagine residue of the 
consensus sequence Asp-X-Ser/Thr, where 
X may be any amino acid except proline. 
OST is composed of 8 proteins, Wbp1p, 
Swp1p, Ost2p, Ost1p, Ost5p, Stt3p, 
Ost3p/Ost6p and Ost4p arranged in 3 sub-
complexes. Wbp1p, Swp1p, Stt3p, Ost1p 
and Ost2p are essential, but cells lacking 
the other three genes exhibit defects in 
N-glycosylation and growth (reviewed 
by (78)). All yeast OST components, 
except Ost4p and Ost5p, have mammalian 
homologues (79). The yeast Stt3p has 
two homologues in mammalian cells, 
STT3-A and STT3-B, and the Ost3p/
Ost6p are homologous to the mammalian 
N33 and IAP. The formation of the OST 
complex with these different proteins 
creates different isoforms that differ in 
activity, composition and tissue speci city 
(80). Similarly in yeast the presence of 
either Ost3 or Ost6 subunits in the OST 
complex modi es the transfer speci city 
towards proteins to be glycosylated and 
they specify the interaction with different 
translocation complexes (81). The Stt3p 
subunit appears to compose the active 
site of the OST (82) and Wbp1p interacts 
directly with the Sss1p component of 
the Sec61 translocation complex (83), 
which results in close positioning of the 
OST to the translocon complex where 
N-glycosylation occurs as the nascent 
polypeptide emerges. The potential N-
glycosylation site is approximately 65 
amino acids away from the ribosomal 
peptidyl–tRNA binding site and hence 
interacts with the polypeptide chain 
shortly after it has entered the ER lumen 
(84). After the oligosaccharide core is 
transferred to the polypeptide, in yeast and 
in mammalian cells, some initial trimming 
occurs where the terminal 1,2-glucose 
and the remaining two 1,3-glucoses 
residues are removed by -glucosidase 
I (CWH41 in yeast) and -glucosidase II 
(ROT2 in yeast), respectively (reviewed 
by (85)). Further trimming may occur later 
in the Golgi or in the ER (86). In Figure 
9 examples of possible trimming events is 
depicted on the core of the oligosaccharide 
as well as the enzymes involved.
2.2.2.2 O-linked glycosylation
Unlike its higher eukaryotic partners, 
yeast only possess one type of O-
glycosylation, which is typically known 
as O-mannosylation, since it refers to 
the addition of mannoses (Man) to the 
hydroxyl groups of certain serine or 
threonine residues of the polypeptide. 
For approximately 30 years since 
their discovery, protein mannosylation 
was thought to be a fungal specific 
modi cation. However In the late 90s -
dystroglycan was isolated from muscle 
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Figure 9. Glycan biosynthesis in the ER. 
The yeast proteins known to be involved in each step are indicated. Adapted from Helenius 
and Aebi, 2004. In the lower panel the cleavage sites on the N-glycan core by the ER-resident 
trimming glycosidases are indicated.
and nerve cells and showed to have 
mannose residues (87).The biosynthesis 
of O-glycans starts in the yeast ER lumen 
during translocation. The first mannose 
residue is linked to a serine or threonine in 
a reaction catalyzed by protein O-mannosyl 
transferases (PMTs). The activated sugar 
is supplied by Dol-P-Man, resulting in 
-D-mannosyl linkage (reviewed by 
(88)). The PMT family can be subdivided 
into three subfamilies PMT1, PMT2 and 
PMT4 (88, 89), each one with different 
substrate speci city (90). Depletion of any 
one of the PMT genes is viable, although 
cells lacking multiple PMT genes exhibit 
severe defects (91). In yeast the active 
enzyme consists actually of a dimer of 
different members of the PMT family, 
which is responsible for different substrate 
speci cities even within the same protein 
(92, 93). The seven potential protein O-
mannosyl transferases (Pmt1 to Pmt7) 
have 50-80% homology (88). Addition of 
mannose residues continues in the Golgi 
apparatus. Higher eukaryotes on the other 
hand, have the ability of O-glycosylating 
other residues such as hydroxylysine 
(Hyl), hydroxyproline (Hyp) and tyrosine 
(Tyr) with a variety of sugars such as 
N-acetylglucosamine (GlcNAc), N-
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acetylgalactosamine (GalNAc), glucose 
(Glu), galactose (Gal), rhamnose (Rha), 
xylose (Xyl), arabinose (Ara) and fucose 
(Fuc) (71). 
It has been proposed that O- and 
N- glycosylation compete for the 
same substrate in the ER and that O-
glycosylation precedes N-glycosylation 
(94). In this study they show that cell 
wall protein 5 (Ccw5) could only be N-
glycosylated when O-glycosylation of 
certain sites was abolished. For proper 
N-glycosylation to occur, the region 
recognized by the OST, the sequon (N-
X-S/T, where X can be any amino acid 
except proline) has to have a hydroxy 
group donated by serine or threonine, to 
mechanistically allow N-linkage between 
the oligosaccharide and the peptide (95). 
In this sense by modifying the hydroxy 
group in the sequon it is possible to 
regulate N-glycosylation. 
2.2.3 Protein folding and quality control 
in the ER
The ER provides an opt imized 
environment for folding, oxidation and 
assembly of oligomeric proteins. The 
composition of the ER lumen, as well 
as its redox conditions favors the fold of 
proteins to native conformations. A set of 
proteins such as chaperones and folding 
enzymes stabilize the partially folded 
protein during the process of folding and 
assembly.  If the protein fails to achieve 
its correct folded state, it is detected by the 
ER quality control machinery and is either 
refolded or then targeted to ER-associated 
degradation (ERAD).
2.2.3.1 Chaperones and folding enzymes
The formation of disulphide bonds 
between the correct cystein residues plays 
an important role in the stability of the 
 nal protein structure. In average a protein 
has a disulphide bond for every 500 amino 
acids, and the formation of such a bond 
is spontaneous. Acquisition of correct 
disulphide bonds is crucial for the protein. 
In eukaryotic cells oxidoreductin 1 
(Ero1p) and protein disulphide isomerase 
(PDI) enzymes ensure correct formation 
of disulphide bonds (for review see (96)).
Ero1p is an ER membrane-associated 
protein that has seven conserved cysteine 
residues that are thought to be involved 
in catalyzing the electron transfer. In 
agreement with its function in assisting 
the folding of the protein in the ER, 
expression of both yeast Ero1p and human 
hERO1-L are induced by the unfolded 
protein response (UPR) (97). PDI is an 
abundant soluble ER protein and contains 
two thioredoxin-like Cys-Gly-His-Cys 
(CGHC) active sites. Depending on the 
reduction state of PDI, it may aid in the 
formation, removal or isomerization of 
the disulphide bond (98). Formation of 
the disulphide bond is thought to occur 
through a relay mechanism with the 
transfer of oxidizing equivalents. In this 
mechanism flavin adenine dinucleotide 
(FAD)-bound Ero1p oxidizes PDI directly 
though disulfide exchange, PDI then 
catalyzes the formation of disulfides in 
folding proteins. The ability of FAD-bound 
Ero1p to rapidly pass electrons directly 
to the terminal acceptor O2 provides the 
driving force for disul de formation (99, 
100). Formation of disulphide bonds 
requires that the oxidizing conditions be 
maintained in the ER. Glutathione is the 
major redox buffer in eukaryotic cells, 
and exists in two states reduced (GSH) 
and oxidized (GSSG) (101). The ratio 
of GSH/GSSG in the ER is much more 
oxidizing than the ratio in the cytosol (3:1 
vs. 100:1) and hence for a long time it was 
thought that glutathione was the source 
of oxidizing equivalents for disulphide 
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bond formation, but the Ero1p-PDI 
mechanism is independent of glutathione 
(99). The function of glutathione appears 
to provide the net reducing equivalents to 
the ER that buffer the ER against transient 
hyperoxidizing conditions (102). PDI has 
four homologues in yeast (EUG1, MPD1, 
MPD2 and EPS1) and Ero1p speci cally 
oxidizes only PDI (96). PDI and its 
homologues are required to rearrange/
isomerase the disulphide bonds since 
many of them occur simultaneously in 
the protein. But to ful ll this function PDI 
and its homologues have to exist in the 
reduced state. Thus the redox-exchange 
between cytosol and ER ensures that some 
PDI can exist in the reduced state for 
proper isomerization of the polypeptides 
(96, 103).
The ER has additional proteins in the 
lumen that assist the folding of the protein, 
like BiP (Kar2p in S. cerevisiae), an Hsp70 
family molecular chaperone. BiP like 
other HSP70 proteins is composed of two 
domains, an N-terminal ATPase domain 
and a C-terminal substrate domain, 
whose af nity is regulated by nucleotide 
binding to the ATPase domain. (ATP 
low af nity, rapid and ADP high af nity 
and slow) (104). BAP (Sil1p in yeast) is 
the nucleotide exchange factor of BiP 
mediating the exchange of ADP for ATP 
(105, 106). The difference of exchange 
rate is the basis of the posttranslational 
mechanism, where ADP-BiP remains 
attached to the incoming polypeptide 
preventing its sliding back (discussed 
above). BiP does not bind to proteins 
in their native state but instead binds 
temporarily to newly synthesized proteins 
and more permanently to misfolded, under-
glycosylated or unassembled proteins that 
are captured by the ER quality control 
machinery and hence cannot exit the 
ER (107). BiP performs its action by 
recognizing unfolded polypeptides and 
inhibiting molecular aggregation, thus 
maintaining them in a form capable for 
correct folding and oligomerization (104). 
BiP is an essential protein with multiple 
functions that is conserved in eukaryotes. It 
has a role in translocation of polypeptides, 
in their folding and assembly (104), in ER 
quality control (108), in ER-associated 
protein degradation (109), in sensing ER 
stress (110) and is also required for fusion 
of nuclear membranes (karyogamy) during 
cell mating in yeast (111).
The ER has another Hsp70 family 
molecular chaperone called GRP170 
(Lhs1p in yeast) that shares some 
overlapping functions with BiP. Lhs1p 
does not interact signi cantly with the J-
domain of Sec63 but is required for correct 
folding of polypeptides translocated into 
the ER as well as in the refolding and 
processing of misfolded proteins (105, 
112, 113). Lhs1p and BiP are thought to 
interact with each other coordinating their 
ATP cycles (114) where Lhs1p stimulates 
the nucleotide exchange phase of BiP, 
while BiP favors the ATP hydrolysis of 
Lhs1p. This mutual mechanism may allow 
coordinated binding and release of Kar2p 
and Lhs1p to and from different regions 
of the unfolded polypeptide. This might 
enhance native folding of the released 
region while minimizing the possibility 
of aggregation with other non-native 
sequences.
2.2.3.2 Quality control and ER-
associated degradation
Before a protein can exit the ER, it has 
to be correctly assembled in its native 
conformation. If the protein fails to 
achieve its correct conformation the 
ER quality control machinery (ERQC) 
detects the protein and targets it either for 
degradation or then attempts to refold it 
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Figure 10. ER quality control. 
Calnexin and calreticulin assist in the folding of glycoproteins in the ER. After the N-glycan core is 
transferred to the nascent chain of the protein two glucose residues (red) are removed by glucosidase 
I and II. The protein in the monoglucosylated form can then interact with calnexin and callreticulin. 
Correct disulphide-bond formation is promoted by the thiol-disulphide oxidoreductase ERp57. 
In addition, the enzymes oxidoreductin 1 (Ero1p) and protein disulphide isomerase (PDI) ensure 
that the correct disulphide bonds are formed. Cleavage of the remaining glucose by glucosidase 
II terminates the interaction of the polypeptide with either calnexin or calreticulin. If the protein 
is correctly folded it is allowed to exit the ER. GRP170 (Lhs1p) and BiP coordinately bind to and 
are released from different regions the folding polypeptide, which is thought to enhance native 
folding while preventing aggregation. However in the scenario the protein is not in the native 
state it is a substrate for the UDP-glucose:glycoprotein glucosyltransferase, which adds a single 
glucose and the polypeptide may enter a new folding cycle attempt. If the polypeptide remains 
too long in the unfolded state, the ER 1,2-mannosidase I removes one mannose residue. This 
leads to recognition by the ER degradation-enhancing 1,2-mannosidase-like protein (EDEM), 
which targets these proteins for the ER-associated degradation (ERAD) pathway. The unfolded 
protein is retro-translocated back into the cytosol, where it is ubiquitinated and degraded by the 
proteasome.
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(Figure 10). In general the other organelles 
to which exocytic proteins are destined do 
not support proper folding. The ERQC 
guarantees that unfolded proteins are not 
targeted to their terminal destinations 
where they might potentially damage the 
cell (108). The cell uses two mechanisms 
to distinguish between the native and 
incorrect conformation, one is the use 
of a variety of sensor molecules, such as 
chaperones, and the second is by tagging 
them with ubiquitin or glucose. The tags 
are added to the protein when hydrophobic 
residues, unpaired cysteine residues and 
aggregates are detected. In the majority 
of the cases, there are no speci c signals 
or motifs that surrender the protein to the 
ERQC, so all proteins that pass through 
the ER are subjected to it (108).
In mammalian cells one of the best-
characterized ERQC systems is the 
calnexin/calreticulin cycle. Calnexin and 
calreticulin are members of the legume 
lectin family and are homologous to 
each other. They bind to the N-glycan 
core. Calnexin is a type I transmembrane 
protein, while calreticulin is soluble (115). 
Although a functional calnexin/calreticulin 
cycle has not been characterized fully in 
yeast, some homologues can be found 
in the yeast ER, for example CWH41/
glucosidase I and GLS2/glucosidase 
II (116, 117), KRE5/UGGT (118)  and 
Cne1p/Calnexin (119).  Imperfect 
polypeptides must be eliminated to avoid 
injury to the cell. For this purpose the cell 
has developed a subset of mechanisms 
that correctly recognize a protein, which 
should be destroyed. Such a system has 
to be capable of distinguishing between a 
protein to be destroyed from a protein that 
is in the process of acquiring the correct 
form. The mechanism adopted appears 
to be the residence time in the ER, thus 
giving the glycopeptide sufficient time 
to fold and assemble before it is targeted 
for degradation (73). The cycle starts 
when the N-glycan core is added to the 
nascent polypeptide by the OST (reviewed 
in (73, 108)). Two glucose residues are 
removed by the action of glucosidase I 
and glucosidase II, respectively (Figure 
10). The presence of a monoglucosylated 
core serves as a ligand and is recognized 
by calnexin or calreticulin. The binding of 
calnexin/calreticulin prevents aggregation, 
degradation and export of the non-native 
polypeptide. The binding of calnexin 
and calreticulin recruits ERp57, a thiol-
disulphide oxido-reductase with homology 
to PDI. Release of the glycopeptide from 
the complex is provided by the action 
of glucosidase II. The glycopeptide 
is now free in the lumen and does not 
bind to lectins. If the protein is correctly 
folded, it is allowed to be exported 
out of the ER. If the glycoprotein has 
hydrophobic residues exposed, it is 
recognized by UDP-Glc::glycoprotein 
glucosyltransferase (UGGT), and the 
glycoprotein reglucosylates. UGGT only 
reglucosylates improperly folded proteins 
and hence serves as a folding sensor in the 
cycle. The glycoprotein can reenter a new 
cycle in an attempt to be properly folded. 
If the glycoprotein remains too long in 
the ER, which is a signal that the protein 
is improperly folded, the ER manosidase 
I removes a mannose residue. The ER 
manosidase I has a very low activity, 
thus giving a chance to the polypeptide to 
adopt its native conformation. After the 
ER mannosidase I has removed a mannose 
residue, the membrane bound ER protein 
called EDEM (ER degradation-enhancing-
mannosidase-like protein, Htm1p/Mnl1p 
in yeast) binds to it. Once the mannose 
residue has been removed, the af nity of 
both UGGT and glucosidase II is reduced, 
thus preventing the entry of the unfolded 
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protein into a new folding cycle. EDEM 
and calnexin can associate with each other 
forming a complex. Presumably EDEM 
then targets misfolded Man8GlcNAc2-
glycoproteins for degradation. The non-
native glycoprotein is removed from the 
ER by retrotranslocation into the cytosol 
and is subsequently targeted to ubiquitin-
dependent degradation by the proteasome, 
in a process called ER-associated 
degradation (ERAD). The ERAD system 
involves three steps: recognition of 
misfolded proteins, retrograde transport 
or dislocation back to the cytoplasm, and 
ubiquitin-dependent degradation involving 
the proteasome (reviewed in (73, 120).
The sequential trimming of N-linked 
glycans is not the only mechanism that 
targets misfolded proteins for degradation. 
The ER chaperones associate with 
hydrophobic surfaces of unfolded proteins, 
whereas oxido-reductases bind to them 
and control the formation/isomerization 
of disulphide bonds. Eps1p, a homolog 
of PDI, for example targets misfolded 
membrane protein for degradation (121). 
In the second step these unfolded proteins 
are dislocated back to the cytosol through 
a putative channel like the heterotrimeric 
Sec61 complex, or then possibly through 
a channel formed by Der1p (Derlin-1 in 
mammalian cells) (122). The driving force 
for the retrotranslocation seems to be 
provided by the sequential ubiquitination 
of the cytoplasmic exposed lysine residues 
by ubiquitin ligases and the binding of 
ubiquitin binding factors. An example of 
such ubiquitin ligases is Ubc6p, Ubc7p 
and Cue1p. Ubc6p is and ER membrane 
protein, while Ubc7p relies on Cue1p for 
ER membrane recruitment (120). Another 
ubiquitin ligase complex present on the ER 
is composed of Hrd1p/Der3p ligase that is 
localized to the ER through Hrd3p, Ubc7p 
and the ubiquitin conjugating enzyme 
Ubc1p and is responsible for the regulated 
degradation of HMG reductase and CPY 
(123, 124). A third ubiquitin ligase present 
at the ER membrane is Doa10p that works 
together with Ubc6p and Cue1p/Ubc7p to 
remove integral membrane proteins and is 
capable of targeting soluble proteins also 
(125). Therefore it seems that different 
substrates use different degradation 
targeting mechanisms and may use 
different ERAD (126). In the third step, 
targeting to the ubiquitin-dependent 
degradation involving the proteasome 
starts with binding of Cdc48p–Npl4p–
Ufd1p to monoubiquitinated proteins. 
Then Rad23p and Dsk2p bind to 
polyubiquitinated proteins through a UBA 
domain, and deliver the protein to the 
proteasome system due to the presence of a 
UBL (ubiquitin-like) region that mediates 
its interaction with the 26S proteasome.
2.3 Exiting the ER: COPII vesicles
Transport vesicle-mediated traffic 
provides a versatile and dynamic 
connection between two organelles, and 
allows speci c cargo to be selected from 
the donor compartment and delivered to 
the target compartment. The formation 
of these transport vesicles depends on 
molecular coats that cover the cytosolic 
face of the vesicles. In this section we will 
discuss the features of the coat proteins 
involved in exit of cargo proteins from the 
ER.
2.3.1 Molecular features of COPII 
proteins
Three protein components are required 
to form COPII-coated vesicles. These 
include Sar1p in its GTP-bound state, and 
the heterodimers Sec23p/24p and Sec13p/
31p (127). These proteins are suf cient to 
reconstitute the physical characteristics 
of the COPII coated vesicles in vitro. 
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Given that more than one third of the 
proteome is targeted to the ER, probably 
additional components assist the core 
COPII components in functions related to 
specialized cargo sorting (128).  Recent 
studies carried out on each of these 
components have revealed the molecular 
features that allow these proteins to ful ll 
their functions.   
2.3.1.1 Sar1p, Sec12p and Sec16p
Formation of the coat starts with the 
recruitment of cargo proteins to ER exit 
site. Recruitment of coat proteins starts by 
change of the secretion associated and Ras-
related protein-1 (Sar1p) from the inactive 
GDP-bound state to the activated GTP-
bound state. The GEF of Sar1p, Sec12p, 
is a 70 kDa type II transmembrane protein 
localized to the ER membrane, with a 
large cytosolic domain that catalyzes 
the exchange of nucleotide on Sar1p 
(129). Upon activation, Sar1p becomes 
localized to the ER membrane due to 
a conformation change, where a 20-23 
amino acid amphipathic helix is exposed. 
A hydrophobic patch at the N-terminus 
of the helix contains a STAR (Sar1 N-
terminal activation recruitment) motif 
that mediates its partitioning into the ER 
membrane (130, 131). Sar1p is a GTPase 
belonging to the Ras superfamily (132). 
The Sar1p GTP hydrolysis is activated 
by binding of Sec23p, which contributes 
a key arginine to the active site of Sar1p, 
accelerating the slow intrinsic GTPase 
activity of Sar1p (133). Further binding 
of the Sec13p/31p complex accelerates 
the GTPase activity of Sec24p-Sec23p-
Sar1p (134).  GTP hydrolysis is required 
for cargo sorting (135) and for COPII 
vesicle disassembly.  Generation of 
COPII vesicles occurs at subdomains of 
the ER membrane called ER exit sites or 
transitional ER sites, which are ribosome-
free subdomains. These specialized 
domains have been shown to be stable, but 
very dynamic structures in mammalian 
cells (136) and in the yeast P. pastoris 
(137).  The components responsible for 
the formation of these subdomains are not 
known, but may involve scaffold proteins 
on the cytoplasmic side of the ER that 
would recruit the components required 
for formation of COPII vesicles. One 
such possible scaffold protein and COPII 
interacting protein is Sec16p. SEC16 is 
an essential gene in S. cerevisiae that 
encodes a 240 kDa hydrophilic protein 
that associates peripherally, yet tightly 
with the ER membrane. Sec16p is capable 
of interacting with Sec23p (138) and with 
Sec31p (139). The function of Sec16p 
appears to involve the nucleation and 
stabilization of the COPII vesicle coat at 
the ER membrane. The ability of Sec16p 
to localize to the ER and to interact with 
both of the COPII heterodimers, together 
with the ability of Sec23p/24p and Sec13p/
31p to polymerize, could create such a 
specialized domain at the ER membrane 
(140).  Although Sec16p has been 
proposed to play a role in scaffolding, the 
presence of such ER domains remains to 
be veri ed. 
2.3.1.2 Sec23p/24p complex
Sec23p (84 kDa) and Sec24p (104 KDa) 
come together to form a heterodimer of 195 
kDa. Sec23p is structurally homologous 
to Sec24p, each one is composed of an 
-helical region, a -barrel region, a zinc-
 nger domain, a gelsolin-like domain and 
a trunk domain (141). The 3D structure 
of Sec23p/Sec24p in complex with Sar1p 
has been solved (133, 142)(Figure 11). 
The ER membrane interface region of the 
assembled Sec23p/24p/Sar1p complex 
forms, a concave and positively charged 
surface that  ts to the shape and charge 
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of a standard COPII vesicle. Although 
structurally related, Sec23p and Sec24p 
have speci c roles. Sec23p is the speci c 
GAP of Sar1p (143), contributing a 
specific arginine residue to the active 
site of Sar1p, while Sec24p is the cargo 
adaptor subunit. The GTPase activity of 
Sec23p is independent of Sec24p, and 
the cargo selection capacity of Sec24p is 
independent of Sec23p (140, 144). 
Detailed analysis of the Sec23p/
Sec24p complex interaction with cargo 
molecules, have revealed the presence of at 
least three binding pockets in Sec24p (A, B 
and C sites) that allow the accommodation 
of both cargo and SNARE (145, 146). 
Binding of proteins to the COPII coat 
takes place though sorting motifs. These 
sorting motifs are present in the cytosolic 
SNAREs and in the cytoplasmic tails of 
transmembrane cargo proteins. In the case 
of soluble cargo proteins, the sorting motifs 
are apparently located in the cytosolic tails 
of their putative transmembrane receptors 
(146, 147) These motifs can be subdivided 
into 4 general categories: Di-acidic motifs 
such as [DE]X[DE], di-basic motifs such 
as RR, di-hydrophobic motifs such as 
FF,FY,LL or VV and then other motifs 
(146-148). 
An interesting feature of the COPII 
coat can been observed in reference to 
SNARE selectivity. The binding pocket 
A can recognize an YNNSNPF sequence 
present in the N-terminal regulatory 
domain of the SNARE protein syntaxin 
Sed5p, the B site can recognize Lxx-
L/M-E on the N-terminus of Bet1p and 
Sed5p, and the C site recognizes Sec22p 
(146). Since a fusion event between two 
membranes can only occur if the SNAREs 
are pre-disposed, this is if they are in 
the acceptor complex form, the COPII 
coat recognizes the assembly state of 
Figure 11. COPII coat vesicle formation.
1. Coat recruitment. At the endoplasmic reticulum Sec12p recruits and activates Sar1p, which 
results in the insertion of the N-terminal helix of Sar1p–GTP into the membrane bilayers. This 
stabilizes Sar1p on the ER membrane which in turn recruits the Sec23p/24p complex through 
Sar1p–GTP binding to the Sec23 subunit. Cargo is packaged at this stage. Transmembrane cargo 
directly interacts with the COPII coat, meanwhile soluble cargo interact via adapter proteins. 
Finally, the Sec13p/31p complex binds to the forming coat resulting in completion of the coat 
at the ER membrane. 2. Coat propagation and vesicle budding. The Sar1p–Sec23p/24p 
cargo complex becomes concentrated in local scaffolds such as in increased regions of Sar1p, 
Sec16p and also by binding to the self-assembled Sec13p/31p cage. These properties result 
in the construction of a cuboctahedral cage. Sar1p displacement is accelerated by both cargo- 
and Sec31p-mediated stimulation of the GAP activity of Sec23p. Insertion of Sar1p into the 
membrane together with its interaction with the concave face of Sec23p/24p help curve the 
membrane. Recruitment of an active ring of newly recruited Sar1p-GTP to the vesicle neck may 
help membrane curvature and formation of the  ssion pore. 3. COPII coat structures. The 
molecular structures of the core components involved in COPII-coated-vesicle budding from 
the ER are shown. Left panel: structures of Sar1p represented by ribbon diagrams, showing the 
transition from the GDP- to GTP-bound states. Structural prediction of Sec12p modeled as a 
-propeller WD40 domain. Middle panel: Structure of the Sar1p–Sec23p/24p complex showing 
the multivalent cargo adaptor platform sites. Right panel: model of the Sec13p/31p complex. It 
is composed of -propeller WD40 domains and -solenoid motifs. In green the self-assembled 
Sec13p/31p heterotetramers are shown without Sec23–Sec24, revealing that Sec13p/31p is 
necessary and suf cient to generate the COPII cage. Structures reprinted, with permission, from 
the Nature Reviews in Molecular Cell Biology, Volume 7 (c) 2006 by Nature publishing group. 
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the SNAREs and binds preferentially 
to fusogenic SNAREs. Thus the B-site 
preferentially binds to the free v-SNARE 
Bet1p and the A-site to Sed5 within the t-
SNARE acceptor complex composed of 
Sec22p, Sed5p and Bos1p.
In mammalian cells there are two 
isoforms of Sec23p, called hSec23Ap 
and hSec23Bp, which are 85% identical 
to each other and 48% to yeast Sec23p. 
The expression pro le varies between cell 
types, with hSec23Ap being the functional 
counterpart of yeast Sec23p (149). Sec24p 
has four isoforms in mammalian cells 
(Sec24A to Sec24D), each one with tissue-
speci c expression (150). In addition to 
Sec24p, yeast has two homologous proteins 
Sfb2p/Iss1p and Sfb3p/Ist1p that are 56% 
and 23% identical to Sec24p, respectively. 
Both homologues can form a complex with 
Sec23p and appear to be involved in cargo 
packaging (151-155). The Sec23p/Sfb3p 
complex is capable of driving COPII coat 
formation and generate vesicles, but is 
unable to package the v-SNARE Bet1p 
and hence these vesicles are not capable 
of fusing to the target membrane (155). 
Thus it seems that the function of Sfb3, 
is to confer cargo-sorting diversity, since 
the COPII coats formed exclusively of 
Sec23p/Sec24p are not capable of sorting 
the plasma membrane ATPase Pma1p into 
vesicles (154). In a similar way, COPII 
coats formed of Sec23p/Sfb2p are capable 
of driving vesicle formation and promote 
the recruitment of pro--factor (153, 156). 
Unlike the complex formed with Sfb3p, 
Sec23p/Sfb2p is capable of packaging 
the correct pair of SNAREs, and further 
more  overexpression of Sfb2p is able to 
suppress the lethality of sec24 deletion 
(151). Thus, COPII-coated vesicles may be 
formed by all of these combinations, this 
is, Sec23p with Sec24p, Sfb2p or Sfb3p, 
thus maximizing the sorting capacity of 
the budding vesicle (140). 
2.3.1.3 Sec13p/31p complex
The Sec13p/31p complex is composed 
of two copies of Sec13p and two copies 
of Sec31p that come together to form a 
stable asymmetric heterotetramer. Similar 
to S. cerevisiae, there are two mammalian 
Sec13 isoforms called SEC13-like-1 
protein or SEC13R and SEC13-like, or 
SEH1 (157). Sec13p is composed of a 
WD40 domain, a structural arrangement 
of several blades arranged radially around 
a central axis. Each blade consists of four-
stranded anti-parallel -sheet formed by 
WD40 repeats.  The WD40 repeats are 40 
amino acid motifs that often terminate with 
the conserved Trp-Asp dipeptide (158). 
Like for Sec13p, there are also two 
mammalian SEC31 isoforms, called A 
and B (159).  Structure prediction of 
Sec31p suggests a WD40 domain in its 
N-terminus, two regions of -solenoid 
structure separated by a region with low 
complexity (158). Previous studies have 
suggested that the heterotetramer arranges 
itself in an elongated globular domain with 
two-fold symmetry with the following 
organization Sec31p-Sec13p-Sec13p-
Sec31p (160), and that formation of the 
COPII cage requires both Sec23p/24p 
and Sec13p/31p (161). But recent studies 
suggest that Sec13p/31p can self-assemble 
into a cage with a novel cuboctahedral 
structure with the subunits arranged in 
the Sec13p-Sec31p-Sec31p-Sec13p order 
(162). This self-assembling cytosolic cage 
would act as a scaffold agent recruiting 
the Sec23p/24p-cargo to the emerging 
vesicle. Sec13p and Sec31p interact 
through the common WD40 domains and 
the Sec31p-Sec31p interaction results 
from the dimerization of the C-terminal 
-solenoid domains, with each vertices 
of the cage being formed by four Sec13p 
molecules. The same type of interactions, 
i.e. the -propeller--solenoid scaffold, 
are found in the clathrin cage, re ecting 
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an evolutionarily conserved feature of coat 
protein complexes (144). The arrangement 
of the cage in a cuboctahedral design, 
instead of the icosahedral symmetry in 
clathrin-coated cages, results in a less 
rigid structure of the COPII cage.  This 
would allow the cage to be more  exible 
for the incorporation of a wide variety 
of cargo, some of which do not  t in the 
typical COPII cage, like procollagen and 
chylomicrons (144).
2.3.1.4 Accessory proteins
Even though the puri ed coat components 
and guanine nucleotides are suf cient to 
drive vesicle formation in vitro, additional 
proteins may be involved in the budding 
event to ensure appropriate spatial-
temporal regulation. There is a subset 
of proteins such as Shr3p, Chs7p and 
Vma22p that are capable of interacting 
with secretory cargo proteins and 
facilitate their incorporation into COPII 
vesicles (128). They may either assist the 
formation of a secretion-competent form 
or by sorting the cargo proteins into the 
vesicles. ER exit of GPI-anchored proteins 
is dependent of Uso1p, the tethering factor 
required to fuse COPII vesicles with the 
Golgi membrane. Sec34p and Sec35p are 
members of the conserved oligomeric 
Golgi (COG) complex, required for 
tethering functions in retrograde traffic 
within the Golgi. Incorporation of GPI-
anchored proteins into COPII vesicles is 
also dependent on the Rab GTPase Ypt1p 
as well as the SNAREs Bos1p, Bet1p 
and Sec22p (163-165). Although these 
proteins play a crucial role in the sorting 
of GPI-anchored proteins, they are not 
required for the uptake of other types of 
cargo molecules.
Another protein required to for the 
biogenesis of COPII vesicle is the Ypt1p-
interacting protein, Yip1p, which is an 
integral membrane protein that cycles 
between the ER and the Golgi (166). 
Yip1p together with Yif1p, another Ypt1p-
interacting protein, form a heteromeric 
complex (167). Ypt1p and Yip1p may 
work as a diffusion barrier and increase 
the possibility of forming a vesicle at 
a certain region of the ER membrane. 
Mechanistically, Uso1p and Ypt1p may 
bind to sorting motifs of specific cargo 
molecules, whereafter Yip1p and Yif1p 
may cluster the secretory cargo together, 
until the coat proteins initiate their 
polymerization at these sites (168).
2.3.2 Formation of COPII transport 
vesicles
In previous models of COPII cage vesicle 
assembly, the  rst step is the activation of 
Sar1p by its GEF, Sec12p present on the 
ER membrane, allowing Sar1p to become 
ER membrane-attached due to exposure 
and membrane insertion of an N-terminal 
-helix. In a second step, Sar1p recruits the 
heterodimeric complex Sec23p/24p, which 
captures cargo destined from the ER to 
the Golgi. In a third step, the Sec13p/31p 
heterotetramer together with Sec23p/24p 
drive cage assembly, leading to vesicle 
budding and formation of a COPII-coated 
transport vesicle (169). But recent studies 
suggest a novel model for formation of 
COPII-coated vesicles. This model is in 
agreement with models of clathrin-coated 
vesicle formation, and suggest a common 
mechanism for formation of coated 
transport vesicles (144). In the subsequent 
section we will address these new features 
and their implications. 
In addition to the function of Sar1p-
GTP in recruiting the Sec23p/24p 
complex to the ER membrane, Sar1p may 
also facilitate generation of membrane 
curvature and vesicle  ssion (131, 170). 
Sar1p-GTP, in the absence of Sec23p/24p 
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and Sec13p/31p appears to be capable of 
inducing membrane curvature, resulting 
in the formation of tubules at ER exit 
sites. Additionally, Sar1p-GTP seems to 
be recruited to the  ssion pore to form a 
ring of activated molecules. Fission of the 
vesicle requires GTP hydrolysis.
 The GEF activity of Sec12p is 
10-fold faster than the GAP activity of 
Sec23p, and thus continuous charging of 
the growing bud with Sar1p-GTP would 
help propagate coat assembly, stabilizing 
the coat at sites where GTP hydrolysis 
has occurred (171) by the cross-linking 
functions of Sec13p/31p (162). Formation 
of a ring of activated Sar1p is essential 
to control the balance between positive 
and negative curvature of the membrane 
prior to vesicle  ssion (131, 170, 172). 
Novel and important information came 
from the fact that Sec13p/31p can self-
assemble into a cuboctahedral cage, thus 
providing a potential local scaffold where 
COPII components can assemble (162). In 
addition to the pre-assembled Sec13p/31p 
cage, additional scaffold agents may 
be involved such as Sec16p (144). The 
intrinsic GAP activity of the Sec23p/24p/
Sar1p was elicited approximately 30 
seconds after the addition of Sar1p-GTP 
to Sec23p/Sec24p. This complex may 
diffuse along the ER membrane capturing 
cargo. When Sec24/24/Sar1p come into 
contact with the preassembled Sec13p/31p 
cage, they become stably associated to it, 
forming the  nal COPII cage. 
Structural analysis has revealed that 
the cargo sorting Sec24p subunit associated 
to the middle domain of Sec31p, closer to 
the vertices formed by Sec13p whereas 
Sec23p associates to the C-terminal domain 
of Sec31p, which is relatively accessible 
and in the center of the cage (162). This 
would allow independent control of the 
release of Sar1p by the GAP activity of 
Sec23p, which is further stimulated by the 
binding of Sec31p from the cargo related 
packaging activity of Sec24p (144). The 
formation of multivalent interaction 
between the different coat components 
as well with the transmembrane cargo or 
receptors would help stabilize the coat 
until vesicle budding has occurred (144). 
The COPII Sec13p/31p cage is formed by 
the four vertices at each intersection, this 
arrangement would allow the cage to be 
relatively flexible and assume different 
sizes depending on the angles formed 
between the four vertices (144, 162). 
Interestingly the Sec24p subunit of the 
Sec23p/24p complex, the one responsible 
for cargo sorting is localized in the region 
proximal to the vertices formed by Sec13p 
and hence may influence the geometry 
and the size of the cage accordingly to 
the cargo incorporated. In Figure 11 the 
interactions and a schematic overview of 
the molecules that drive COPII-coated-
transport carriers can be seen.  
2.3.3 Fusion of vesicles with the Golgi 
membrane
After budding of the COPII transport 
vesicle from the ER membrane, GTP 
hydrolysis leads to the uncoating of the 
vesicle, preparing it for fusion with the 
Golgi membrane. Although in yeast 
little evidence supports a role for the 
cytoskeleton in delivery of transport 
vesicles to the Golgi membrane, in 
mammalian cells the ER to Golgi 
transport is dependent on the microtubule 
cytoskeleton and the motor protein dynein/
dynactin (173-175). In mammalian cells, 
an ER to Golgi intermediate compartment 
(ERGIC) exists between the ER and the 
Golgi. This compartment is defined by 
the presence of the lectin ERGIC-53 
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(176). Analysis of the ERGIC dynamics in 
mammalian cells revealed that uncoated 
vesicles migrate forward to the Golgi 
complex and COPI-coated vesicles 
derived from the Golgi are directed to 
the ER (See chapter in molecular features 
of COPI coats). ERGIC may represent 
the  rst compartment that discriminates 
between anterograde and retrograde 
transport (177). The existence of ERGIC 
in mammalian cells could be due to the 
fact that vesicles have to be transported 
across long distances from dispersed ER 
exit sites to the central peri-nuclear Golgi 
(169). Since yeast cells are small compared 
to mammalian cells, traf c between the 
ER and Golgi may occur in the absence 
of an ERGIC-like compartment by simple 
diffusion (178). 
After the vesicle is relatively close to 
the membrane of the Golgi, two separate 
processes ensure that only the correct 
vesicles fuse. Vesicle tethering and 
SNARE assembly, ensure the speci city 
of vesicle traffic. The first interaction 
between the transport vesicle and the 
Golgi membrane is provided by tethering 
factors, these include Uso1p and the 
TRAPP I complex (179-181).  TRAPP 
I  (transport protein particle I) is a large 
oligomeric complex composed of seven 
subunits (Bet5p, Bet3p, Trs20p, Trs23p, 
Trs31p, Trs33p, Trs85p) that helps bridge 
the distance between the Golgi membrane 
and the vesicle (182). Besides functioning 
in tethering TRAPPI also functions as a 
GEF for the RabGTPase Ypt1p (183), a 
yeast Rab1 homolog that is present on ER-
to-Golgi transport vesicles. Once these 
vesicles arrive at the Golgi membrane 
Ypt1p recruits Uso1p to the membrane 
(180). Uso1p is the yeast homolog of 
mammalian p115 and is a large coiled-
coil protein that helps bridge the target 
membrane and the vesicle, and possibly 
also facilitates SNARE complex assembly 
(184). 
When the vesicle is suf ciently close 
to the Golgi membrane to allow SNARE 
assembly, fusion of the two membranes 
is initiated. The SNAREs involved in this 
fusion reaction are Bet1p (Qc) present 
on the vesicle and Sed5p (Qa), Bos1p 
(Qb) and Sec22 (R) present on the target 
Golgi membrane (185). The yeast Sly1p 
belongs to the Sec1p/Munc18p family 
that is involved in modulating SNARE 
activity. The yeast Sly1p interacts with 
the N-terminal regulatory domain of the 
syntaxin Sed5p and helps promote the 
assembly state of the SNARE-complex 
and consequently fusion (17, 186). After 
fusion of the two membranes, soluble 
and transmembrane cargo proteins are 
delivered to the Golgi, and the cis-
SNAREs are disassembled by the action 
of Sec18p and Sec17p.
3. Golgi: The major sorting 
station of the cell
The next compartment of the secretory 
pathway is the Golgi complex. In this 
compartment exocytic proteins are 
subjected to modi cations of their glycans 
and to proteolytic processing of precursor 
proteins. In addition to these functions, 
the Golgi is involved in sorting of 
proteins to proceed through the secretory 
pathway or to be retrieved to the ER or to 
remain in the Golgi. Thus the Golgi is a 
highly specialized sorting organelle that 
is capable of maintaining its structural 
organization while sorting proteins to the 
cell surface or the endosome/vacuole. In 
this section we will address briefly the 
features and characteristics that allow the 
Golgi to perform these functions.
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3.1 Structure and function
3.1.1 Topology of the Golgi
The general image of a Golgi is a stack 
of flat cisternae that can be subdivided 
into different sub-compartments like cis-, 
medial- and trans-Golgi. The number of 
cisternae within an individual stack varies, 
but in animal cells it is approximately 
seven (187). In a typical mammalian 
cell the Golgi occurs normally in the 
perinuclear region. In contrast, in the 
yeast S. cerevisiae the Golgi is scattered 
throughout the cytoplasm, and usually 
occurs as single cisternae (178). On the 
other hand, the yeast P. pastoris appears to 
have Golgi structures organized as stacks 
(see Figure 2) (137).  
3.1.2 Modi cation of protein-bound 
glycans
In the ER a universal glycan core was 
added to the polypeptide and further 
trimmed. It functioned as a sensor for 
folding state of the polypeptide. This core-
N-glycan is further modi ed in the Golgi 
by glycosidases and glycosyltransferases 
that generate the diversity of protein-bound 
N-glycans.  Although the core structure 
is universally conserved from yeast to 
human, the modi cations that occur in the 
Golgi are very different. Mammalian cells 
have a wide variety of structures where a 
core consisting of N-acetylglucosamine 
and mannose is decorated with more N-
acetylglucosamine, galactose, sialic acid 
and fucose. In contrast, the yeast N-glycans 
are extended with only mannose residues 
(188). Extension may give rise to a smaller 
(hex<15) core or to a larger (Hex>15) outer 
chain (188). Many of the glycoproteins 
incorporated into the cell wall and 
periplasmic space contain a large mannose 
backbone composed of approximately 50 
mannose residues. Meanwhile proteins that 
remain intracellularly, like for example 
CPY, have smaller glycan chains where 
only a small amount of mannose residues 
are added (189).  
Elongation of the N-glycan core 
starts with the cis-Golgi resident 1,6-
mannosyltransferase, Och1p, that extends 
Man8GlcNAc2 by one single mannose 
residue (190) (See Figure 12). Further 
elongation occurs by sequential addition 
of mannose residues by two enzyme 
complexes called mannan polymerase 
(M-Pol) I and II, creating the backbone 
of 1,6-linked mannose residues. M-Pol I 
is responsible for addition of the  rst 10 
mannose residues (191), where after, M-Pol 
II elongates the chain by approximately 40 
more mannose residues. This backbone is 
then branched by the sequential addition of 
more mannose residues by Mnn2p, Mnn5 
and Mnn1p. Some of the branches may 
acquire a phosphomannose in a reaction 
catalyzed by Mnn4p and Mnn6p (192, 
193). The N-glycan core of intracellular 
proteins is extended by only three mannose 
residues. The  rst is added by Och1p, then 
an unidenti ed 1,2-mannosyltransferase 
adds the second mannose and the third is 
added by Mnn1p (188). 
All of the mannosyl transferases 
are putative type II membrane proteins 
with a short cytoplasmic N-terminus, a 
short membrane-spanning region and 
a conserved catalytic lumenal domain. 
This type II orientation is relatively 
uncommon in membrane proteins of other 
compartments than the Golgi, and their 
transmembrane domain is significantly 
shorter than that of other membrane 
proteins (188). These features seem to 
be involved in retention of the glycan-
modifying enzymes in the Golgi, as well 
as in targeting them to speci c cisternae.
In the Golgi the single O-linked 
mannose residue attached in the ER is 
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Figure 12. Golgi post-translational modi cations. 
In the cis- and medial-Golgi O- and N-glycosylation proceeds. These are carried out by Golgi 
cisternae resident enzymes, which catalyze different steps of the glycan elongation process. In 
the trans-Golgi for example proproteins may be processed into the  nal mature form by action of 
cleaving enzymes such as Kex2p. 
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extended by up to  ve mannose residues. 
Like in N-glycosylation, the donor 
is GDP-mannose, and the mannosyl 
transferases are type II transmembrane 
proteins. The transfer of the second 1,2-
linked mannosyl residue is catalyzed by 
either Ktr1p, Ktr3p or Mnt1p/Kre2p (194). 
Mnt1p/Kre2p adds the third mannose 
residue. The fourth and fifth mannose 
residues are added by Mnn1p resulting in 
1,3-linked mannose (88). Interestingly 
only proteins, transported to the exterior 
of the cell are O-mannosylated. When 
mannosylation of externalized proteins is 
disturbed, detection of these proteins in 
the extracellular space is greatly reduced. 
Since no intracellular accumulation 
of these proteins is detected in 
O-mannosylation mutants, it is not certain 
if O-mannosylation is a prerequisite for 
secretion or if these proteins are just more 
susceptible to protease degradation, (88). 
Almost all of the cell wall proteins show 
this type of modi cation, hence mutations 
disturbing O-glycosylation disturb cell 
wall stability by either reducing their 
secretion or then the glycan side chain 
residues are important for conferring 
structural stability (88). One possibility 
that could explain their reduced secretion 
and the lack of intracellular accumulation 
is if reduced O-mannosylation functions 
as a signal for vacuole sorting (the 
main proteolytic compartment) and 
consequently their degradation. Yeast cells 
with mutations in the O-glycosylation 
pathway show decreased cell wall stability 
as well as cell growth and multiplication 
vulnerability (91).
3.1.3 Precursor processing
Some proteins are synthesized as larger 
precursors that are proteolytically 
cleaved to a mature protein by specific 
endoprotease in late compartments of 
the secretory proteins, such as the trans-
Golgi. Examples of such proteins include 
the yeast pheromone -factor, killer 
toxin K1, Hsp150/Pir2p, proinsulin and 
digestive enzymes. The yeast trans-
Golgi harbors three enzymes responsible 
for proteolytic precursor cleavage of 
these proproteins, carboxypeptidase 
Kex1p, the serine protease Kex2p and 
the dipeptidyl aminopeptidase Ste13p 
(195). The first and best-characterized 
proprotein processing protease is the Kex2 
protease, so we will address this one as an 
example. Kex2p itself is synthesized as 
a zymogen (proenzyme), which itself is 
autocatalytically processed after its role 
in folding (196). Kex2p is composed of 
an N-terminal signal sequence, followed 
by the pro-domain, a catalytic domain 
belonging to the subtilase superfamily 
of Ca2+-dependent proteases, a unique P 
domain, a transmembrane domain and 
a C-terminal cytosolic tail (197). The C-
terminal extensions are required for proper 
cycling among late compartments of the 
secretory pathway (TGN and endosomes) 
(198). The unique P domain is responsible 
for stabilization and activity. Swapping 
this domain within the different members 
of the family of serine proteases results 
in differences in substrate recognition, 
stability and pH optimum (199). Kex2p 
uses the serine protease mechanism, 
where the catalytic triad composed of 
serine, histidine and aspartate are involved 
(198). The same catalytic triad is present 
in the enzymes of the trypsin superfamily 
(200), so it is essential to the processing 
protease to be capable of discriminating 
the correct substrates. It is also important 
that they are very ef cient since they are 
only exposed to their substrates briefly 
during their passage through the secretory 
pathway. Enzymes such as Kex2p have 
a high catalysis rate with high speci city 
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and do not show rate-limiting acylation 
(197). In contrast, the related subtilisins, 
which are digestive enzymes, have low 
catalysis rates with broad speci city, since 
they are exposed to the substrate for long 
periods of time and their role is to degrade 
the whole protein. One well known 
substrate of Kex2p is the pheromone 
precursor pro--factor, which contains 
2 to 4 copies of the -factor pheromone 
separated by Kex2 cleavage sites (201). 
This structural organization is similar 
to that of the mammalian neuropeptide 
precursor proopiomelanocortin (POMC), 
which is processed by the yeast Kex2p, 
when expressed in yeast cells (202). An 
other substrate of yeast Kex2p is pro-
killer-toxin. Similar to proinsulin it is a 
folded precursor with multiple chains 
connected by disulphide bonds (203). 
Studies on different potential substrates 
showed that Kex2p prefers dibasic sites 
like (K/R)-R with Arg (R) at the P1 site 
(198). Shortly after the discovery of the 
yeast Kex2 protease, several mammalian 
homologues were found, including human 
furin, the related prohormone convertases 
(PC) PC1/3, PC2, PC4, PC6A, PC6B and 
PC7, and the paired base amino acid-
cleaving enzyme (PACE) 4 (197). All 
of these proteins have the same overall 
structure and features of the yeast Kex2p, 
with the exception of enzymes like PC2 
that are soluble proteases.
3.2 Golgi maintenance and ER 
retrieval
The Golgi is organized in three regions, the 
cis-, medial- and trans-Golgi. Currently 
there are two models that explain how 
protein trafficking occurs through the 
Golgi apparatus in the cis to trans direction 
(204, 205). The vesicular transport model 
predicts that the Golgi cisternae are 
stable and distinct compartments that 
are connected by means of vesicular 
traffic (206). The cisternal progression 
and maturation model suggests that the 
cisternae are transient structures that form 
de novo and progress in the cis to trans 
direction while maturing, and then dissipate 
at the trans-Golgi (207). Both models 
have their limitations and are not mutually 
exclusive, since the cisternal progression 
and maturation model cannot explain the 
presence of anterograde cargo detected 
in the COPI vesicles, or the different 
transport rates of anterograde cargo. On 
the other hand, the vesicular transport 
model cannot explain the transport of large 
molecules that would not  t in the typical 
COPI vesicle (208). Recent imaging data 
support the maturation model for yeast 
cells, where individual cis-Golgi cisternae 
maturate in a very dynamic way to form 
trans-Golgi cisternae (209, 210). While 
the cisternal maturation model can explain 
rapid protein secretion in yeast, it cannot 
explain the transport rate of proteins in 
higher eukaryotes. In higher eukaryotes 
the Golgi cisternae are tightly stacked to 
each other, hence maturation of individual 
cisternae occurs at a relatively slow rate. 
The discussion of the biogenesis and 
maintenance of the Golgi compartment 
is beyond the scope of this study but a 
comprehensive discussion of the models 
can be found in two excellent reviews 
(205, 211), where a revision of the 
models is proposed in order to include 
the novel  ndings found in the structural 
organization and traf c of cargo within 
this organelle. These recent findings 
include the presence of inter-cisternal 
connections that connect adjacent cisternae 
(212, 213), which would be responsible 
for the transport within the different Golgi 
cisternae, and hence lead to the formation 
of the continuity-based models (211). In 
addition, they refer to the possible presence 
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of peri-Golgi vesicles that emerge at the 
tips of the different cisternae and traf c 
cargo in a bidirectional fashion. In order 
to maintain the dynamics and functionality 
of the cisternae, resident cisternae proteins 
that mature to later cisternae have to be 
returned to the new forming cis-cisternae. 
This is postulated to occur by retrograde 
transport by means of vesicles that capture 
components from later cisternae and then 
transport them back to earlier ones (214, 
215). Similar to the vesicles that form at 
the ER membrane, these Golgi-derived 
vesicles are also formed by cytosolic coat 
proteins that capture cargo and deform 
the membrane. In this case, speci c coat 
proteins form the so called COPI coat. 
Due to membrane traf c from the ER to 
the Golgi performed by COPII vesicles, 
the ER membrane is gradually consumed 
and some ER-resident proteins may escape 
to the Golgi. This retrograde traf c also 
requires COPI-coated vesicles, which are 
responsible for returning from the Golgi 
to the ER SNAREs, cargo adaptor proteins 
and membrane components. 
3.2.1 Molecular features of COPI 
proteins
The minimal components required to 
form COPI-coated vesicles in vitro are the 
COPI coatomer proteins, the small Rab 
family GTPase ADP-ribosylation factor 1 
(ARF1) and nucleotides (216). The COPI 
coatomer is a complex composed of seven 
different subunits , , ’, , , 	 and 
 
subunits in mammalian cells, and Ret1p, 
Sec26p, Sec27p, Sec21p, Ret2p, Sec28p 
and Ret3p, respectively, in yeast (169). 
Even though under certain conditions 
the coatomer may exist as two separate 
complexes, the F-COPI subcomplex (’

) and the B-COPI subcomplex (
	), in vivo it appears to exist solely as a 
completely formed complex (217). Similar 
to COPII coats, the COPI coatomer has 
N-terminal -propeller WD40 domains 
and -solenoid motifs (158). Some of the 
COPI subunits are structurally related to 
those of the clathrin coat and appear to 
ful ll the same functions (218-220). The 
B-COPI subunit may function as the outer 
surface layer of the coat, similar to the 
role played by the polymerized clathrin 
triskelions. Meanwhile, the F-COPI 
subunit may form the surface of the coat 
proximal to the membrane, similar to the 
adaptins of the clathrin coat. 
The function of the GTPase ARF1, 
or yARF1/2/3 in yeast, is similar to that 
of Sar1p in COPII cage assembly. ARF1 
in its GDP-bound form is inactive and 
soluble, and upon binding of GTP, a 
conformational change in the N-terminus 
leads to exposure of a myristoylated group, 
which allows its membrane association, 
and activates ARF (221).  Two additional 
factors, like in the case of COPII assembly, 
modulate the activity of ARF1 and assist 
in the assembly/disassembly of the COPI 
coat. These are the GTP exchange factor 
ARFGEF (in yeast Gea1p and Gea2p) and 
the GTPase-activating protein ARFGAP 
(in yeast Glo3p, Gcs1p) (222, 223). The 
ARFGEFs share a conserved 200 amino 
acid catalytic Sec7 domain (221). Unlike 
Sec12p (GEF in COPII assembly), 
ARFGEFs are soluble proteins that localize 
transiently to the Golgi membrane by an 
unidenti ed receptor. ARFGAPs contain 
a conserved zinc finger motif catalytic 
domain with a conserved arginine residue 
that is involved in GTPase activation 
(223). Initially, ARFGAP was thought not 
to structurally make part of the coat, and 
the primarily function of ARFGAP was 
thought to be to induce vesicle uncoating 
by stimulating GTP hydrolysis (224, 225). 
Recent results suggest an involvement of 
ARFGAP as a component of the coat due 
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to its requirement in cargo sorting and 
vesicle formation (226-228). 
3.2.2 Formation of COPI transport 
vesicles
The formation of the COPI transport 
carrier is initiated by recruitment of 
ARF1 to the Golgi membrane (see Figure 
13). This involves both the recruitment 
of ARFGEF (soluble) to an unknown 
receptor and ARF-GDP to the Golgi 
membranes. Targeting of ARF1-GDP to 
the Golgi membrane may be assisted by 
its interaction with the cytoplasmic region 
of p23, a member of the abundant p24 type 
I transmembrane Golgi-cargo receptors 
(229, 230). In addition, ARF1 may also 
be targeted to the Golgi membrane though 
its interactions with SNAREs that are 
normally present in COPI vesicles (231, 
232). Following nucleotide exchange on 
ARF1 by its GEF, ARF-GTP is released 
from p23/p24 and becomes associated to 
the Golgi membrane though membrane 
insertion of the myristoylated group. 
At this stage recruitment of the COPI 
coatomer takes place and coat assembly 
and cargo packaging is initiated (233). 
Simultaneously, ARFGAP1 is initially 
recruited to the Golgi membrane though 
its interaction with KDEL transmembrane 
receptors (Erd2p in yeast) (234, 235), with 
transmembrane proteins with dilysine 
motifs (228), through the cytoplasmic 
tail of p23/p24 (222) and its interactions 
with v-SNAREs involved in Golgi to 
ER traf c (236). The complex of ARF1, 
ARFGAP and coatomer together with 
cargo, start assembling on the Golgi 
membrane. At this stage GAP activity on 
ARF1 is still low and the coat assembly 
and cargo sorting still goes on. As the coat 
assembles and the COPI lattice is formed, 
the GAP activity increases at regions 
distal to the forming bud by a membrane 
curvature-dependent mechanism (224, 
237). In these studies, GAP activity of 
ArfGap1 was shown to be sensitive to 
membrane curvature. ArfGAP1 has a 
lipid-packaging sensor that recognizes 
when the membrane is positively curved, 
as is the case in the outermost region of 
the budding membrane vesicle (238). An 
increase in GAP activity was detected 
when the arti cial used liposomes where 
similar in size to that of an authentic 
COPI vesicle (60 nm), suggesting that 
coat formation should be stable at the 
bud neck, where the membrane curvature 
is negative, allowing formation of the 
COPI coated vesicle. In support of these 
observations, a ring of ARF-GTP forms 
at the vesicle neck. As the GAP activity 
on ARF1 increases at regions distal to the 
vesicle neck, GTP hydrolysis takes place 
and ARF1-GDP is released from the coat 
lattice. These dynamics between ARF1 
and ARFGAP1 activation allows speci c 
and accurate spatiotemporal regulation of 
the initiation of GTP hydrolysis (239).The 
polymerized coatomer may be maintained 
by multiple lateral interactions between its 
subunits that occur within the lattice even 
in the absence of Arf1-GTP (238). 
3.2.3 Sorting signals in COPI-mediated 
traf c
In order to proper sort proteins within 
the COPI vesicles that are destined to be 
transported back to the ER, or from later 
Golgi cisternae to previous ones, the 
cell uses a mechanism that relies on the 
presence of sorting signals on the cargo 
proteins. These sorting signals specify the 
intracellular localization of the protein 
and bind directly to the coat subunits, 
or to adaptor proteins. One such sorting 
signal that mediates ER retrieval of 
transmembrane proteins is the cytosolic 
canonical KKXX motif signature (where K 
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is lysine and X is any amino acid), which 
binds to the - and ’-COP subunits of the 
coat using two distinct but overlapping 
binding sites (240-242). As mentioned 
previously, the p24 protein family can bind 
to the -COP coatomer (243). For this they 
use mainly the di-phenylalanine motif but 
may also use two basic residues KK(X)n 
or KR(X)n where n2 (217). Luminal ER 
resident proteins that escape the ER must 
be distinguished and ef ciently retrieved 
from Golgi proteins and newly synthesized 
proteins on their way beyond the Golgi. 
For this purpose the cell uses a KDEL 
sequence (HDEL in yeast) that is typically 
found in the C-terminal end of luminal 
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Figure 13. COPI coat vesicle formation.
1. Coat recruitment. Arf1 is recruited to the Golgi membranes by its interaction with members 
of the p23/p24 family and with Golgi SNAREs involved in intra-Golgi and Golgi to ER transport. 
At the same time its GEF, ARFGEF is recruited to the ARFGEF receptor. Nucleotide exchange on 
ARF is mediated by the Sec7 domain of the GEF, which results in change of the bound nucleotide 
and insertion of an -helix into the membrane bilayers. When ARF is in the activated GTP form, 
it recruits the COPI coatomer. 2. Coat propagation and vesicle budding. At this stage, cargo 
is packaged into the forming vesicle. Transmembrane cargo are capable of interacting directly 
with the COPI coat, meanwhile soluble cargo interact via adapter proteins, such as the HDEL 
receptor. In the initial phase of the budding, the GAP activity is relatively low, insuring that the 
coat remains suf cient time to stabilize membrane deformation and cargo recruitment. As the bud 
grows, GAP activity increases at the distal sites of the forming vesicle by a membrane curvature 
dependent mechanism.
ER-resident proteins. The presence of 
this sequence allows recycling from early 
Golgi back to the ER (244). This sorting 
sequence binds in the Golgi to the KDEL 
receptor (Erd2p in yeast) (245-247), a 
transmembrane protein that spans the 
membrane 7 times (248) and is transported 
from the Golgi to the ER by means of the 
COPI pathway (249, 250). The binding of 
the ER proteins to the KDEL receptor is 
pH-dependent, which ensures the capture 
of the ligand in the Golgi and release 
in the ER (251). Additionally, ligand 
binding by the KDEL receptor induces 
oligomerization of the receptor, which may 
have an important role in its recruitment 
to COPI vesicles (235). The presence of 
a double lysine signal sequence together 
with a phosphorylated serine residue (in 
mammalian cells) is responsible for the 
recruitment of the KDEL receptor to the 
COPI-pathway (252).
Another ER retrieval signal present 
in the cytoplasmic tail of transmembrane 
proteins, such as Sec71p, is the L 
motif (WXXW/Y/F). This sorting motif 
allows its association to -COP (253). 
One interesting ER retrieval-sorting 
signal is the RXR sequence, which can 
be found in the cytoplasmic loops or C-
terminal tails of the subunits of the ATP-
sensitive K+ channel (254). These subunits 
assemble in the ER to a fully functional 
receptor. The binding of COPI coatomer 
to the individual subunits ensure that they 
remain in the ER until fully assembled. 
Upon assembly, multiple RXR motifs 
are exposed, and as a consequence it can 
bind to the 14-3-3 dimer proteins, which 
successfully mask the retention sequence 
and successfully compete for binding 
instead of COPI coatomer proteins, thus 
allowing transport of the fully assembled 
receptor to the plasma membrane (255). 
3.3 Station for sorting of proteins
The transport of newly synthesized 
proteins through the ER and Golgi 
cisternae occurs in a vectorial manner 
with virtually no diversion to alternative 
routes. However once proteins reach 
the trans-Golgi they may be directed to 
various destinations. They may be targeted 
to the extracellular space, to the plasma 
membrane and to the vacuole. Therefore 
the Golgi must be capable of sorting 
secretory proteins and cell surface proteins 
from proteins destined for endosomes or 
vacuoles (256, 257). The trans-Golgi also 
receives extracellular content and recycled 
proteins//lipids from the endosomal/
vacuolar compartments. The late Golgi 
compartment is for this reason regarded 
as the major protein sorting station and 
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is responsible for the correct targeting of 
newly synthesized proteins to their  nal 
destinations. To correctly ful ll this role, 
the Golgi must be capable of successfully 
discriminating between different sorts of 
proteins and be capable of segregating 
them into speci c sets of vesicles.  Two 
different populations of secretory vesicles 
may deliver secretory and cell wall cargo 
proteins to the cell surface (258). One 
population originates directly from the 
trans-Golgi membrane and delivers its 
cargo to the plasma membrane, while 
the other, appears to transit through an 
endosomal intermediate compartment 
“en route” to the plasma membrane (259, 
260). In the following sections we will 
address how these pathways function and 
are organized.
4. The endosomal/vacuolar 
system: a second sorting station
The vacuole is responsible for enzymatic 
degradation of cellular components, as 
well as breakdown of nutrients taken up 
from the surrounding environment. The 
endosomal/vacuolar system is subdivided 
into biochemically distinct compartments 
such as the early endosome, late 
endosome and vacuole (261, 262). Yeast 
genetic studies have helped elucidate the 
molecular details underlying the traf c to 
these compartments. Instrumental for this 
understanding were large-scale screens 
that identi ed several mutants defective 
in different steps of this pathway. This 
lead to the classi cation of the mutants 
according to the observed phenotype. For 
example, vps (vacuolar protein sorting) 
mutants typically secrete the vacuolar 
carboxypeptidase Y (CPY), pep mutants 
are defective in vacuolar protease activity, 
vam mutants have unusual vacuole 
morphology, end mutants are defective in 
endocytosis, and vac mutants are defective 
in vacuolar segregation (263). 
Cargo intended for delivery to the 
vacuole may follow two distinct pathways. 
They may be targeted directly to the 
vacuole (ALP pathway) or they may transit 
through endosomes from where they are 
then further sorted and  nally delivered to 
the vacuole (CPY pathway) (263-265).
4.1 The CPY Pathway
R e s e a r c h  o n  t h e  d e l i v e r y  o f 
carboxypeptidase Y (CPY) to the vacuole 
elucidated the first pathway that cells 
employ to deliver proteins to the vacuole 
and hence the name of this pathway (266-
269). CPY is synthesized as a prepro form 
and translocated across the ER membrane. 
After signal peptide cleavage by signal 
peptidase in the ER, the precursor form 
(p1, 67kDa) is glycosylated and delivered 
to the Golgi. Here it acquires sugar 
modi cations and becomes the Golgi (p2, 
69kDa) form. Exit of CPY from the Golgi 
occurs by its receptor, Vps10p/PEP1(270). 
The crucial residues required for proper 
sorting of proCPY to the vacuole are 
the residues QRPL (271). The receptor 
and its bound cargo, the Vps10-CPY 
complex, are transported from the trans-
Golgi to the late endosome (also known 
as pre-vacuolar/endosomal compartment, 
PVC) by vesicular traffic mediated by 
clathrin-coated vesicles and involves the 
dynamin related GTPase Vps1p (272). In 
the endosome, CPY dissociates from its 
receptor and is transported to the vacuole 
where it is proteolytically cleaved to the 
active mature form (mCPY, 61kDa). 
Meanwhile the receptor Vps10p is recycled 
back to the Golgi through the retrograde 
transport pathway and is available for a 
new sorting cycle (273). Vps10p is a type 
I transmembrane protein that is localized 
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predominantly to late Golgi membranes. 
The signal that mediates and controls the 
cellular localization of Vps10p is found 
in the cytosolic domain of the protein, 
where two aromatic-based signals, 
YSSL and FYVF, enable the protein to 
cycle between the trans-Golgi and the 
endosome (274, 275). The luminal portion 
of the receptor recognizes cargo, where 
binding occurs between the cystein-rich 
domain and the transmembrane domain 
of the receptor (276). When Vps10p is 
absent, CPY is secreted to a large extent 
to the culture medium. In addition, other 
vacuolar hydrolases of the proteinase A 
family (PrA, Pep4p) and aminopeptidase 
Y (APY) are also secreted, although to a 
lower extent, and are thus believed to be 
ligands for the receptor Vps10p (263, 275, 
277).
Two other proteins that cycle 
between the late Golgi and the endosomal 
compartments are Kex2p, and the 
dipeptidyl aminopeptidase A (DPAP A or 
more commonly known as Ste13p)(263). 
Recycling is achieved by aromatic-based 
amino acid motifs that associate with the 
retromer complex (278, 279). However, 
in contrast to Vps10p, these proteins 
have trans-Golgi retention signals that 
increase their local concentration in the 
late compartments of the Golgi (280).
4.1.1 Adaptor proteins: AP-1 complex 
and GGAs
Transport of cargo between the endosome 
and the late-Golgi requires clathrin and 
clathrin-adaptor proteins. The function of 
clathrin is to provide a scaffold for vesicle 
budding, similar to the function of the 
COPI and COPII coats. Meanwhile, the 
adaptor proteins link vesicle formation 
with protein sorting due to the ability to 
bind both to cargo and clathrin (281). 
Transport along the CPY pathway 
involves three such adaptor proteins, the 
heterotetrameric adaptor-protein (AP)-1 
complex and the Golgi-localized, -ear 
containing, Arf-binding family of proteins, 
commonly referred as GGAs, (Gga1p and 
Gga2p). 
In addition to the AP-1 complex 
(TGN to late endosome sorting) (282), 
three additional AP complex exist 
that participate in the sorting events 
along different pathways, namely AP-2 
(endocytosis) (283, 284), AP-3 (endosome/
TGN sorting to the vacuole) (285) and 
AP-4 which is present only in mammals 
and plants (TGN sorting to vacuole and 
basolateral sorting to plasma membrane) 
(286, 287). Besides these ubiquitous AP 
complexes, two additional complexes 
exist in higher eukaryotes that are cell-
type speci c. These are AP-1B (polarized 
epithelial cells, used in basolateral sorting) 
(288) and AP-3B (neurons, used for 
synaptic vesicle biogenesis) (281, 283).
The AP-1complex similar to the 
other AP complexes consists of two 
large subunits, Apl2p (a homologue of 
the mammalian 1 adaptin) and Apl4p 
(a  adaptin homologue), one medium 
subunit Apm1p (a 1 chain homologue) 
and one small subunit Aps1p (a 1 
chain homologue). The AP-1 complex 
is organized into three domains (289). 
The core domain is responsible for 
the recruitment of the complex to 
membranes by binding to Arf-GTP, 
to phosphoinositides and to sorting 
signals present on the cytoplasmic side 
of transmembrane cargo proteins. The 
hinge segments contain clathrin-box 
sequences that mediate the binding of 
clathrin. The third domain of the AP-1 
complex is organized into two ear or 
appendage domains that are responsible 
for the recruitment of accessory proteins. 
AP complexes selectively recognize and 
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bind to sorting signal(s) usually present in 
the cytoplasmic region of transmembrane 
proteins (290). Such signals include 
the tyrosine signal such as the NPXY 
sequence present on proteins destined 
for endocytosis, which is recognized by 
the AP-2 complex and the YXX motif 
(where Y is tyrosine and  is a bulky 
hydrophobic residue) (290, 291). Another 
type of sorting signal to which AP 
complexes attach is the dileucine signal 
D/EXXXLL (where D/E is aspartate or 
glutamate and L is leucine) (290).
The other group of adaptor protein that 
are recruited to the late-Golgi membranes 
by Arf-GTP are the GGA proteins (292). 
The GGA proteins are organized into three 
folded domains and are arranged in a fold 
that is similar to the overall structure of 
the AP-1 complex (289, 293). The VHS 
(Vps27, Hrs, Stam) domain functions as a 
recognition module for sorting signals that 
are exposed on the cytoplasmic tails of 
transmembrane cargo (294-297). Several 
of the transmembrane protein that traf c 
between the late Golgi and endosomes 
have a DXXLL signal that interact with 
the VHS domain of GGAs. The key D 
(aspartate) and LL (leucine) of the signal 
bind to an electropositive pocket and two 
shallow hydrophobic pockets, respectively 
on the surface of the VHS domain of 
GGAs (298, 299). In contrast, yeast GGAs 
do not have the speci c residues in the 
VHS domain that recognize the canonical 
DXXLL signal of the transmembrane 
cargo. Thus, the sorting determinant 
of yeast GGAs appears to be different. 
The GAT (GGA and TOM) domain is 
responsible for the ability of GGAs to 
bind speci cally to the GTP-bound form 
of Arf1 (300, 301). The GAT domain 
is subdivided into two subdomains, an 
amino-terminal hook that interacts with 
speci c regions of Arf and is capable of 
discriminating between the GTP and GDP 
forms (302), and a carboxy-terminal triple 
helix bundle that possibly may interact 
with SNAREs and with Rabaptin-5 that 
together with Rabex-5 participate in 
endosomal tethering and fusion events 
(303-305). The GAE (-adaptin ear) 
domain shares structural similarities with 
the ear domains of the 1- and 2 adaptin-
subunit isoforms (Apl4p in yeast) of AP-1. 
These domains interact with a specific 
set of accessory proteins all of which 
share a canonical peptide motif DFGX 
(where  is a bulky hydrophobic residue) 
(306). Differences in the peptide motifs 
and in their overall shape may account 
for the distinct binding preferences of a 
subset of speci c accessory proteins for 
either GGAs or -adaptins (289). Another 
significant different between yeast and 
mammalian GGAs is that yeast GGAs 
are less dependent on Arf and clathrin 
to fulfill their function, as compared to 
their mammalian homologues. Deletion 
of the genes encoding Gga1p or Gga2p 
individually result in minor phenotypic 
changes but deletion of both genes, 
similar to the sorting defects observed 
in vps10 mutants cells, result in 
inappropriate processing of the inactive 
precursors of vacuolar hydrolases such 
as CPY, PrA and the transmembrane 
carboxypeptidase S (CPS) (307). Pro-CPY 
and pro-PrA are sorted to the endosome by 
binding to the transmembrane receptor 
Vps10p. Meanwhile, sorting of pro-CPS 
(transmembrane protein) is Vps10p-
independent and correct sorting to the 
vacuole is dependent upon ubiquitination 
of the pro-CPS tail that occurs in the 
late-endosome/PVC (308). A Pro-CPS 
sorting defect is more severe than the 
sorting defects of pro-CPY and pro-PrA in 
gga1gga2 cells (307). Taken together, 
pro-CPS appears to be more dependent on 
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GGAs for proper sorting, and for example 
the late endosomal SNARE Pep12p, the 
transmembrane endopeptidase Kex2p and 
the transmembrane receptor Vps10p are 
missorted in gga1gga2 cells. Thus, it 
appears that GGA proteins are involved 
in proper sorting of transmembrane 
proteins to the late endosome (307, 309, 
310). The differences in sorting defects 
observed between the distinct cargo 
proteins may be due to the recruitment 
of a diverse subset of accessory proteins, 
by either AP-1 complex or GGAs, that 
recognize a speci c set of cargo proteins/
transmembrane receptors. 
4.1.2 Formation of functional transport 
vesicles 
So how does a transport vesicle carrying 
cargo destined to the vacuole through the 
CPY pathway form at the trans-Golgi 
membrane? As in the case of COPI and 
COPII coats, the first step in vesicle 
formation is membrane recruitment of 
the individual coat components. This 
involves localized activation of Arf by 
Arf-GEF, which converts Arf-GDP to Arf-
GTP. This change of nucleotide induces 
a structural rearrangement with exposure 
of a myristoylated amino-terminal -helix 
and a change of the spatial rearrangement 
of the “switch 1” and “switch 2” regions 
of Arf. Exposure of the myristoylated 
helix allows tethering of the Arf-GTP to 
the membranes of the late-Golgi, while 
the spatial rearrangement of the switch 
regions allows the recruitment of Arf 
effectors (301, 311, 312). The insertion of 
Arf-GTP to the membrane thus allows the 
recruitments of either GGAs or/and AP-1 
complex to the membrane. The precise 
mechanism of action of GGA and AP-1 
binding to Arf-GTP and cargo molecules 
is not fully elucidated and it is not known 
if binding of GGA is a prerequisite for 
binding of AP-1 complex or if these 
adaptors mediate transport in different 
directions, act in parallel pathways, or 
cooperate in the same transport steps (282, 
293, 313). Given that Arf-GTP is also found 
associated with the cis-Golgi membranes, 
the speci city of binding of the adaptor 
proteins to the late-Golgi membranes may 
be accomplished by either Arf-GEFs, Arf-
GAPs or in particular the local enrichment 
of phosphoinositide in the late-Golgi 
membranes. For instance, in yeast Laa1p 
is required for correct localization of AP-1 
to the late Golgi membranes, while no 
signi cant effect is seen in GGA protein 
distribution (314). The subsequent binding 
of GGAs through their GAT domain to 
Arf-GTP may stabilize this complex 
and hinder the activation action of the 
Arf-GAP on Arf-GTP, thus allowing the 
subsequent assembly steps (315). The 
binding of the adaptor proteins to Arf-
GTP present on the late-Golgi membrane 
places them in close proximity to the 
membrane, where they can interact with 
speci c signals exposed on the cytosolic 
side of transmembrane cargo/receptor 
proteins. The membrane-bound adaptors 
then initiate recruitment of clathrin to the 
TGN through interactions between the 
clathrin heavy chain and clathrin-box-like 
sequences present in the hinge segments 
of GGA and AP-1 complex (300, 316). At 
this stage the ear domain of the -adaptin 
subunit of AP-1 complex and the GAE 
domain of GGAs initiate the recruitment 
of a subset of accessory proteins that 
mediate or regulate, and are required for 
the formation of a functional clathrin-
coated vesicle. Such accessory proteins are 
for example the phosphoinositide-binding 
epsin-like proteins Ent3p and Ent5p that 
might help curve the membrane to allow 
vesicle budding and sort cargo (317, 318). 
These proteins, in addition to assisting 
Introduction
42
the function of GGA and AP-1 complex, 
may also be classi ed as adaptor proteins 
themselves, due to the ability to interact 
with clathrin and cargo proteins. Besides 
the above functions, accessory proteins are 
involved in vesicle budding, disassembly 
of the coat, vesicle targeting/fusion by 
establishing functional links to tethers 
and SNAREs on the target membrane, 
and may also provide interactions with 
the cell cytoskeleton (289). One such 
example of the involvement of accessory 
proteins in vacuolar protein sorting is 
the Vps15p/Vps34p complex. Vps15p is 
a myristoylated serine/threonine protein 
kinase that interacts with the GDP-
bound form of Gpa1p and recruits the 
phosphatidylinositol 3-kinase, Vps34p, 
to Golgi membranes (319, 320). This 
membrane-associated complex, which 
is activated by the GTP-bound form of 
Gpa1p, regulates vacuolar protein sorting. 
4.1.3 SNAREs involved in late-Golgi to 
PVC vesicle fusion
After the vesicle pinches off from the late-
Golgi it has to fuse with the appropriate 
target membrane. This specificity is 
achieved due to the presence of a speci c 
subset of SNAREs on the target and 
donor membranes that help dock and 
fuse the vesicle with the endosomal target 
membrane. Mutant cells that lack these 
proteins accumulate a large number of 40-
60 nm vesicles in the cytoplasm and display 
a single large round and poorly acidi ed 
vacuole that is incapable of forming 
the segregation structures required for 
vacuolar inheritance (264). These mutant 
genes are commonly referred as members 
of the class D VPS genes. Characterization 
of these genes revealed that many of their 
products are components of the SNARE 
complex machinery (267). These include 
the SNAREs Pep12p/Vps6p (t-SNARE, 
QA) and Vti1p (v-SNARE) that functions 
in both retrograde transport within the 
Golgi and transport to the PVC) (321, 322). 
SNARE complex formation is regulated 
by Vps45p (Sec1p like function) and the 
Rab GTPase Vps21p/Ypt51 p (a Rab5 
homologue that functions in endosome 
fusion in mammalian cells) and by  Sec17p 
(yeast -SNAP) and Sec18p (NSF) (323, 
324). An additional Sec1p/Munc18 family 
protein, Vps33p, is required for fusion of 
late Golgi-derived vesicles with the late 
endosome (325). Vps33p is part of the large 
class C Vps protein complex (addressed 
in the following sections) and is required 
for fusion of transport intermediates 
from early endosomes to late endosomes, 
as well as of late endosome-derived 
membranes with the vacuole through 
interactions with the vacuolar t-SNARE 
Vam3p (326, 327). Both Vps33p and 
Vps45 interact with the t-SNARE present 
on early endosome membranes Pep12p 
(325, 328). Similar to Vps33p, Vps45 is 
capable of interacting with another QA-
SNARE, Tlg2p, where this (QA) t-SNARE 
appears to be responsible for membrane 
association of Vps45p during the cycle of 
membrane fusion. Vps45p is thought to 
act as a molecular switch for the formation 
of the SNARE complex between Tlg2p/
Tlg1p/Snc2p and Vti1p, since prior to 
membrane fusion Vps45p dissociates 
from Tlg2p and only reassociates with 
the cis-SNARE complex after membrane 
fusion (329-331). Additional accessory/
regulatory proteins include Vps9p, Vps8p 
and Vps19p/Pep7p/Vac1p (263, 264, 
332, 333). Vps9p functions as a GEF 
for Vps21p (Rab5 homologue), and is 
homologous to the mammalian Rab5 
regulator, rabex-5 (332). Vps8p belongs 
to the class D VPS genes and is conserved 
across species. It is essential for sorting 
proteins to the endosome but dispensable 
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fo r delivery of proteins through the AP-3 
pathway to the vacuole (333-335). Vps8p 
is possibly a functional homologue to 
the mammalian rabaptin-5, and hence 
in analogy to the functional Rabex-5/
rabaptin-5 pair may work together with 
Vps9p in intra-endosomal membrane 
traffic. It is also a component of the 
CORVET complex. Vps19p/Pep7p/Vac1p 
is the effector molecule of the RabGTPase 
Vps21p and hence facilitates/regulates 
vesicle-mediated vacuolar protein sorting 
(336).Tethering of transport intermediates 
to the endosomal membranes is provided 
by the class C Vps complex proteins, 
which bind to Vps8p instead of the 
vacuolar membrane partners Vps41p and 
Vam6 (13, 325, 337).
4.2 The ALP Pathway 
Studies on the secretion of another 
membrane vacuolar protein, alkaline 
phosphatase (ALP) revealed that this 
protein is correctly localized to the vacuole 
when transport into or out of the PVC is 
defective, such as in class D and class E 
vps mutants (338, 339). In these studies the 
vacuolar maturation of ALP was followed 
and compared with the maturation of the 
vacuolar ATPase subunit (Vbh1p) and with 
the maturation of the vacuolar membrane 
protein carboxypeptidase S (CPS) under 
conditions where transport through the 
PVC is blocked, such as in vps27, vps45 
and pep12 mutants. Under these conditions 
transport of ALP is unaffected, while 
transport of other cargo along the CPY 
pathway was blocked. Correct delivery 
of ALP to the vacuole was not due to 
bypass to the cell surface and subsequent 
endocytosis, since additional late secretory 
mutants did not effect the correct sorting of 
ALP (338, 339). Due to the ability of ALP 
to follow an alternative transport pathway 
to the vacuole that completely bypasses the 
PVC, this pathway is commonly referred 
as the ALP pathway. 
4.2.1 The AP-3 adaptor complex 
provides sorting into the ALP pathway
Since ALP is not found in Golgi-derived 
40-60 nm vesicles that accumulate in 
vps45 mutant cells, it appears that ALP 
and other proteins that follow this pathway 
such as Vam3p and the vacuolar t-SNARE 
are sorted into a different class of transport 
vesicles that emerge from the late-Golgi 
(339). The vacuolar-sorting signal was 
identi ed in the cytoplasmic domain of 
ALP (13 to 16 amino acid sequence, rich 
in lysine and arginine residues). Domain 
swapping experiments showed that this 
region is sufficient to provide VPS27-
independent sorting of the hybrid Dap2p 
and CPS to the vacuole (264, 338, 339). 
The correct sorting of ALP to the vacuole 
is mediated by the binding of the AP-3 
adaptor complex to the cytosolic sorting 
sequence (285, 340, 341). Similar to the 
other family of AP complexes, the AP-3 
complex consists of two large subunits, 
Apl6p (a homologue of the mammalian 
3 adaptin) and Apl5p (a  adaptin 
homologue), one medium subunit Apm3p 
(a 3 chain homologue) and one small 
subunit Aps3p (a 3 chain homologue) 
(281, 282, 342, 343). However, unlike 
the related AP-1 and AP-2 clathrin 
adaptor complexes that recognize sorting 
sequences exposed on the cytosolic tail of 
transmembrane proteins and recruit them 
into clathrin-coated pits, the AP-3 complex 
is not associated with clathrin. Deletion of 
any one subunit of the AP-3 complex delays 
transport of ALP to the vacuole through 
the ALP pathway. Under these conditions 
ALP is transported by default through 
the CPY pathway, which is unaffected by 
mutations in the AP-3 complex (340, 341). 
The precise mechanism and place of action 
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of the AP-3 complex is still not clear. One 
model suggests that the AP-3 complex 
recognizes the sorting sequence present 
in the cytoplasmic tail of transmembrane 
cargo protein in membranes of the trans-
Golgi, and selectively recruits them into 
a distinct class of non-clathrin-coated 
vesicles (340). This model is based on the 
observations that GFP-ALP accumulates 
in the Golgi and cofractionates with Golgi 
markers. Due to the increased residence 
time in the Golgi and hence exposure to 
Golgi-localized glycosyltransferases, 
proALP is hyperglycosylated in AP-3 
mutants. A second model suggests that 
instead of the AP-3 complex working at 
the trans-Golgi level, it may be working in 
a post-Golgi compartment, where it would 
recycle certain ALP pathway proteins back 
to the Golgi (341). This model is based 
on the observations that ALP is found 
in a distinct population of small vesicle-
like structures that appear to be incapable 
of fusing with their target membrane. In 
AP-3 mutant cells, due to the inability 
of recycling the corresponding SNAREs 
back to the Golgi, the transport vesicles 
lack the SNARE machinery required for 
fusion, preventing their subsequent fusion. 
This block on the pathway could indirectly 
lead to missorting at the trans-Golgi, and 
subsequent accumulation in the Golgi and 
leakage to the CPY pathway.
Unlike the AP-1 complex, the AP-
3 complex is not associated to clathrin, 
since in yeast AP-3-dependent transport 
of ALP to the vacuole, is not impaired in 
clathrin mutant cells (344). However the 
3A subunit (Apl6p in yeast) is capable 
of interacting with clathrin through 
the clathrin-binding domain, and AP-3 
colocalizes with endosomal membranes in 
HeLa cells (345). Although it is possible 
that AP-3 is capable of functionally 
associating with clathrin to form clathrin-
coated vesicles in vivo, the only protein 
reported to be preferentially involved in 
the ALP pathway is Vam2/Vps41p (338, 
346), which contains a highly conserved 
sequence related to the linker region of 
the clathrin heavy chain. Interestingly, 
Vps41p can be cross-linked to Vam6/
Vps39p, and these two proteins appear 
to be involved in the same role, and part 
of a subcomplex that functions in vivo. 
Although these proteins would be good 
candidates for alternative proteins that 
could ful ll the role of clathrin, they are 
localized to one or two distinct patches 
on the vacuole membrane, and hence in 
principle should not mediate sorting at the 
Golgi (264, 347).
4.3 Sorting into the CPY vs. ALP 
pathway
As was discussed in the previous 
sections, two pathways target proteins to 
the vacuole. So how does the cell know 
which proteins are to be sorted into these 
pathways? The list of proteins to be 
transported to the vacuole through the 
CPY pathway includes a large number of 
proteins, while the ALP pathway includes 
mainly two reported proteins. Studies 
carried out on the sorting signals of these 
two pathways lead to the suggestion that 
entry to the ALP pathway is a signal-
mediated sorting event and hence saturable, 
since overexpression of ALP or in the 
absence of AP-3, ALP is delivered to the 
vacuole through the CPY pathway (338). 
Vacuolar delivery of Dap2p (dipeptidyl 
aminopeptidase B, DPAP B) through the 
CPY pathway is unaffected by removal 
or replacement of either the cytoplasmic, 
transmembrane or lumenal domains (348). 
Moreover, when the localization signals of 
resident ER or Golgi membrane proteins 
are mutated, these are directly transported 
to the vacuole (349). These data suggest 
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that transport of membrane proteins 
through the CPY pathway in yeast occurs 
by default. However recent data suggest 
that entry into the CPY pathway may be 
mediated by certain signals that selectively 
target these proteins to the different 
pathways. One such example includes 
the general amino acid permease Gap1p. 
The  nal destination of Gap1p, changes 
according to physiological clues, namely 
the available nitrogen source (350). In 
cells grown under rich nitrogen conditions, 
such as glutamate medium, Gap1p is 
transported directly from the Golgi to the 
vacuole. Change to suboptimal nitrogen 
concentrations, such as urea, causes 
Gap1p to be transported to the plasma 
membrane (351). Proper sorting of Gap1p 
to the plasma membrane is dependent on 
the COPII complex component Sec13p, 
the ER-resident membrane protein Shr3p, 
the GSE complex, as well as of Npr1p, 
which is involved in stability and retention 
of Gap1p at the plasma membrane (351-
354). Transport of Gap1p to the vacuole is 
dependent on the ubiquitination of Gap1p 
by the Rsp5p E3-ubiquitin ligase complex 
together with Bul1p/Bul2p (355), and 
occurs through the CPY pathway since it 
is dependent on Pep12p and facilitated by 
Gga1p and Gga2p (351, 356). The second 
example includes the selective transport 
of a mutant form of plasma membrane 
H+-ATPase (Pma1p). In wild type cells 
Pma1p is transported from the trans-Golgi 
to the plasma membrane through selective 
packaging into a speci c subset of secretory 
vesicles (258). When a mutant form of 
this protein is used, pma1-7, the normal 
delivery to the cell surface is inhibited and 
the protein is rerouted to the endosomal/
vacuolar compartment for degradation 
(357-359). Transport to the vacuole occurs 
through the CPY pathway, since mutations 
that affect the transport between Golgi 
and the PVC, such as vps1, vps8, pep12, 
gga1 and gga2 mutant cells, block the 
transport of pma1-7p for degradation 
and instead pma1-7p is rerouted to the 
cell surface (357, 358, 360). Similar to 
Gap1p, transport of mutant pma1-7 for 
degradation is dependent of Rsp5p-Bul1p-
Bul2p ubiquitin ligase protein complex 
(360). Thus it appears that ubiquitination 
is one regulatory mechanism that serves 
to target proteins to different pathways, 
and understanding how these proteins 
speci cally recognize and control the fate 
of exocytic proteins is object for further 
investigation (361). 
4.3.1 Separate pathways with common 
principles: The dynamin-like protein 
Vps1p
If indeed proteins that follow these 
pathways are separated into distinct 
vesicles, how are these regulated and how 
does the cell distinguish these vesicles 
from the secretory vesicles targeted to 
the cell surface? Functional studies on 
the formation of vesicles at the Golgi 
implicated one VPS gene encoding the 
dynamin-like GTPase Vps1p, in the 
budding of vesicles transporting vacuolar 
cargo from the Golgi apparatus (362, 363). 
In addition to VPS1, clathrin has also 
been implicated in such vesicle formation 
events, since a sudden loss of clathrin 
function results in mislocalization of 
vacuolar proteins to the cell surface (364). 
Even though clathrin plays a fundamental 
role in sorting into the CPY pathway, the 
ALP pathway is relatively unaffected by 
clathrin mutations, so the role of clathrin 
will not be addressed in this section (364). 
Thus, we will focus on Vps1p, due to its 
importance in both pathways. Mutations 
that lead to the inactivation of Vps1p result 
in missorting of proteins destined to the 
vacuole into secretory vesicles destined 
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for the cell surface. Vps1p is an 80-kDa 
protein with homology to the mammalian 
GTPase dynamin, which is required for 
endocytosis and appears to be involved in 
the pinching off of vesicles from the plasma 
membrane (362, 365-367). Mammalian 
dynamin is thought to act as a regulatory 
GTPase and as a mechanochemical  ssion 
factor, by accumulating at the emerging 
bud necks, where it initiates tubulation 
and vesiculation of membranes (368, 369). 
Dynamin and its homologues share three 
common domains, an amino-terminal 
GTPase domain, a middle domain and a 
GTPase effector domain (370). Dynamin 
itself contains two additional domains, 
the pleckstrin homology domain, 
which is responsible for the binding to 
phosphoinositides, and a proline-rich 
domain. Yeast cells lacking Vps1p do 
not display any defect in endocytosis but 
instead secrete the Golgi form of CPY 
(p2 form). In vps1 mutants, Golgi and 
vacuolar membrane proteins are delivered 
to the vacuole via the plasma membrane 
(363, 371). Vps1p is required in yeast for 
the transport of proteins through both the 
CPY and ALP pathway. This observation 
and the homology to dynamin suggest a 
similar role for Vps1p in the pinching off 
of vesicles (vesicle scission) that divert 
proteins intended for the vacuole from 
the secretory pathway in wild type cells. 
Vps1p is also required for maintenance 
and stability of Golgi-localized proteins, 
since in vps1 cells Kex2p and Vps10p 
are also delivered to the vacuole via 
the plasma membrane (272, 363, 371). 
Moreover, Vps1p appears to be involved 
in vesicle  ssion at vacuolar membranes. 
The yeast vacuole is a highly dynamic 
organelle that undergoes constant 
cycles of  ssion and fusion during both 
vacuole inheritance, and due to changes 
in osmolarity of the environment. When 
a yeast cell is exposed to hyperosmotic 
stress the vacuoles fragment, and when 
Vps1p is mutated the vacuoles lose the 
ability to fragment and enlarge (372, 373). 
Surprisingly, Vps1p also appears to be 
involved in regulating vacuolar membrane 
fusion since antibodies against Vps1p and 
temperature-sensitive mutations in Vps1p 
block vacuole fusion (373). Studies carried 
out on the localization of Vps1p revealed 
that the protein localizes to vacuoles, 
and to be exact, to vacuole membrane 
constrictions, and to a number of spots on 
vacuole membranes (373). The presence 
of Vps1p to membrane constrictions is 
in agreement with the role of Vps1p in 
vesicle fission. The presence of Vps1p 
in discrete spots appears to be linked to 
formation of complexes of Vps1p and 
the vacuolar SNARE Vam3p (373). The 
release of Vps1p from the Vps1p-Vam3p 
complex required the yeast NSF Sec18p, 
but did not its co-factor Sec17p (the yeast 
-SNAP) (373). So how does Vps1p 
coordinate vacuole fusion? Vps1p may 
trap Vam3p on the vacuole membrane 
making it a rate-limiting factor for fusion, 
thus favoring  ssion events. Alternatively, 
it may be involved as a sorting factor by 
separating v- and t-SNAREs or it may 
support the enrichment of Vam3p at 
docking sites (374, 375). The release of 
Vps1p at the onset of vacuole membrane 
fusion by the SNARE-activating ATPase 
Sec18p releases the t-SNAREs that may 
now initiate fusion events, bringing to an 
end the intrinsic  ssion activity of Vps1p. 
Alternatively, it is known that actin plays 
an active role in vacuolar fusion (376, 
377) and dynamins as well as dynamin-
like proteins, such as Vps1p, control actin 
dynamics. Consequently, it is possible that 
release of Vps1p from the Vps1p–Vam3p 
complex allows Vps1p to interact with 
actin or actin-regulating proteins, such as 
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Sla1p (378), and thus regulate a later step 
in vacuole membrane fusion.
In contrast to the mammalian 
homologue dynamin, the yeast Vps1p 
does not appear to be required for 
endocytosis, as in vps1 cells proteins are 
delivered to the vacuole via the plasma 
membrane (371). When a temperature-
sensitive mutant allele of END4, which 
specifically blocks the internalization 
step of endocytosis (379), is combined 
with vps1 cells, vacuolar proteins are 
no longer delivered to the vacuole but 
accumulate at the plasma membrane (371). 
In support of the idea that Vps1p does not 
play an essential role in endocytosis at 
the plasma membrane, the internalization 
kinetics of uracil permease Fur4p in 
vps1 cells (at 30oC) is similar to that of 
wild type cells (378). Fur4p is localized 
at the plasma membrane and mediates 
the speci c uptake of uracil. Similar to 
Gap1p, its expression and localization 
are tightly regulated by the uracil levels 
and environmental clues. Under normal 
conditions Fur4p is delivered directly to 
the cell surface via the secretory pathway. 
However in the presence of excess uracil, 
newly synthesized Fur4p can be directed 
to the degradative vacuolar pathway 
without ever passing through the plasma 
membrane (380). Normal degradation of 
plasma membrane Fur4p occurs through 
phosphorylation, which in turn facilitates 
ubiquitination of Fur4p, a process that is 
dependent on the Npi1p/Rsp5p ubiquitin-
protein ligase (381, 382). Fur4p is then 
internalized, and following endocytosis it 
is targeted to the vacuole for proteolysis 
(383). Three possible explanations for the 
observation that Vps1p is not required 
for endocytosis include that a dynamin-
like GTPase is not required for the 
endocytosis step, or then other dynamin 
related proteins might be involved in 
the scission of endocytic vesicles (263). 
These may include for example Mgm1p or 
Dnm1p, which coordinate mitochondrial 
 ssion and fusion (384). In addition to the 
above functions, Dnm1p is involved in 
the endocytic system although at a post-
internalization step, namely before fusion 
to the late endosome (385). Alternatively, 
Vps1p may be required under normal 
conditions, whereas under conditions 
where Vps1p is nonfunctional, other 
pathways, perhaps clathrin-independent, 
may compensate.
4.3.2 The CPY and ALP pathways 
converge at the vacuole 
The CPY and ALP transport pathways, 
which start diverging at the level of the 
late Golgi and follow two separate and 
distinct pathways to the vacuole, intersect 
only at a late stage, namely at the fusion 
with the vacuole. Class B and C vps 
mutants generally have a fragmented 
vacuole with more than 20 small vacuole-
like compartments, or lack any identi able 
vacuoles, respectively. Many of these 
genes encode components of the SNARE 
machinery, or components of a very large 
vacuole-associated complex that appears 
to be required for vacuolar membrane 
fusion events. These mutants typically 
show defects in ALP maturation and 
CPY processing. Delivery of CPY and 
ALP occurs by two parallel pathways, 
which meet at the vacuole. One such 
class B VPS gene encodes Vam3p, which 
is a vacuole-localized t-SNARE (QA) 
that is delivered to the vacuole through 
the ALP pathway and is required for the 
fusion of multiple transport intermediates 
with the vacuole (339, 386). In vam3 
mutants correct processing of both CPY 
and ALP is blocked. Although mature 
CPY is formed over time, this is due to 
aberrant intermediate processing of p2-
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CPY that occurs outside of the vacuole, 
since proALP processing does not occur 
in these cells, suggesting that ALP is 
trapped in a intracellular compartment 
distinct form the one which contains CPY 
(326, 387). In addition to Vam3p, the 
other proteins involved in the formation 
of the SNARE complex are Vti1p (QB) 
and Vam7p/Vps43p (QC) exposed on the 
vacuole membrane, and Ykt6p (R) present 
on the transport intermediate membrane 
(386, 388-391). Membrane fusion to 
the vacuole is regulated by the Rab-
GTPase Ypt7p and by Sec17p, Sec18p 
(392, 393). Other mutants such as the 
members of the class C VPS genes encode 
components of a large detergent-insoluble 
complex that is partially associated with 
vacuolar membranes known as the class 
C Vps complex. The class C Vps complex 
functions at two distinct protein traf cking 
steps. It has been reported to be required 
for fusion of late Golgi vesicles with the 
late endosome, and to be involved in 
fusion events at the vacuole (325, 337). 
In the latter case the class C Vps complex 
is also known as the homotypic fusion 
and vacuole protein sorting (HOPS) 
complex (327, 337). The HOPS/class C 
Vps complex is composed of six different 
subunits, the class B proteins Vps41p 
(Vam2p) and Vam6p (Vps39p) and the 
class C subunits Vps11p (Pep5p), Vps16p, 
Vps18p (Pep3p) and Vps33p (327, 347, 
394, 395). This complex is thought to 
mediate the transition from tethering to 
trans-SNARE pairing at the membrane 
due to its ability to interact with the GTP 
form of Ypt7 (the yeast Rab7) and to the 
SNAREs Vam3p/Vam7p (396-398). Each 
of the subunits of the HOPS/Class C 
Vps Complex appear to have specialized 
domains that contribute to the correct 
tethering function of this complex. Vps33p 
is homologous to the Sec1/Munc18 (SM) 
family proteins (325, 399). Vps11p and 
Vps18p have essential RING  nger zinc 
binding domains at their C-terminus 
(327). Vam6p (Vps39p) acts as a GEF on 
the Rab GTPase Ypt7p thus stimulating 
the nucleotide exchange on Ypt7p (395). 
Finally Vps41p appears to be specialized 
in two functions one is in tethering as a 
component of the HOPS complex and the 
second appears to be in the biogenesis 
of the AP-3 vesicles that transport cargo 
such as ALP from the Golgi to the vacuole 
(341, 394, 400, 401). Due to the speci c 
involvement of Vps41p in the biogenesis 
of the AP-3 vesicles and the localization 
of Vps41p/Vps39p to vacuolar membranes 
these two proteins are thought to be 
preferentially involved in the ALP pathway 
possibly by stabilizing the interaction 
between the vacuolar t-SNARE Vam3p 
and an ALP pathway-speci c v-SNARE 
(263, 347). Within all of the known 
class B and C mutants no synaptobrevin-
like molecules are found. One potential 
protein, Nyv1p, is required for fusion of 
transport intermediates containing ALP in 
vam3 mutant cells and is transported to the 
vacuole through the ALP pathway, where 
it works as a specific v-SNARE (392, 
402). A null mutant of vps41 typically has 
phenotypes similar to class B/C mutants 
with fragmented vacuoles, defects in CPY 
maturation and ALP processing (347, 
403). Many of these defects are thought to 
be an indirect effect of blocking the ALP 
pathway, since incubation of vps41-ts 
mutant cells at the restrictive temperature 
lead to a rapid block in ALP processing, 
while maturation of both CPY and CPS 
remained unaffected, as well as vacuole 
morphology. The long-term effect of the 
vps41 null mutation could be explained 
taking into count that the vacuolar 
t-SNARE Vam3p, which is required for 
the fusion of transport intermediates of the 
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CPY pathway to the vacuole, is delivered 
to the vacuole through the ALP pathway 
(347, 403). When the ALP pathway is 
blocked, newly synthesized Vam3p is no 
longer delivered to the vacuole and as 
soon as the free/active Vam3p present on 
the vacuole membrane is consumed the 
fusion of transport intermediates from 
the CPY pathway starts to be defective, 
and culminates with the appearance of 
fragmented vacuoles.
4.3.3 The CORVET complex mediates 
intra-endosomal tethering
The class C proteins that constitute the 
previously mentioned HOPS complex 
that functions at the vacuolar membrane 
interface are also present on endosomal 
membranes (337, 387). Here they form a 
novel-tethering complex referred as the 
class C core vacuole/endosome tethering 
(CORVET) complex (335). The CORVET 
complex is composed of the class C 
subunits Vps11p (Pep5p), Vps16p, Vps18p 
(Pep3p) and Vps33p together with the 
class D subunits Vps8p and Vps3p (325, 
335, 404). CORVET and HOPS complex 
thus share a great degree of similarities. 
Both of these complexes have the class 
C core proteins as a common platform 
and both are composed of six subunits 
with approximately the same size. 
The differences appear concerning the 
remaining two components. In the HOPS 
complex Vps41p/Vam6p functions as an 
effector of the Rab Ypt7p (393, 395, 399), 
while in the CORVET complex Vps8p/
Vps3p functions as an effector of the Rab 
GTPase Vps21p (yeast Rab5 homologue) 
(333, 335). Vps3p is very similar to 
hVam6p with exception of the n-terminus. 
Additionally, Vps3p can bind to Vps21p-
GDP and promote nucleotide exchange in 
a GEF-like function similar to the role of 
Vam6p in promoting nucleotide exchange 
on Ypt7-GDP (335, 395). Thus it appears 
that the HOPS and CORVET complex are 
structurally organized into three parts: the 
class C core, a GEF (Vam6p or Vps3p) and 
an effector protein (Vps41p or Vps8p). 
Since the HOPS complex is present at 
the vacuole interface and the CORVET 
complex at the endosomal interface, 
endosomal-vacuolar biogenesis might 
be regulated by which tethering agents 
is recruited. From elegant studies carried 
out on the dynamics and presence of these 
complexes at each step of the endosomal 
vacuolar pathway (335), it was possible to 
perceive that these complexes interchange 
according to their respective site of action 
and that a intermediate complexes exist. 
The  rst step in the conversion of these 
complexes appears to be the exchange of 
the putative GEF subunit, which binds to 
the class C subunit Vps33p (335, 395). 
Both Vps3p and Vam6p compete for 
binding to the effector subunit Vps41p at 
this stage. The next step is the exchange 
of the potential Rab effector. When the 
intermediate complex Vps3p-Vps41p-
Class C core is formed Vps8p can replace 
Vps41p and the CORVET complex is 
formed. One important observation in the 
inter-conversion of these complexes is 
that Vps41p can replace Vps8p; but Vps8p 
cannot displace Vps41p without first 
Vps3p being brought to the system (335). 
The order of conversion is especially 
interesting since the GEF would recruit 
the next Rab, which would bind to the 
next effector, and in this way ensure 
appropriate membrane fusion events. In 
summary there appears to be a direct role 
of the tethering complexes in the way 
the endosomal/vacuolar organization 
is regulated possibly by controlling the 
RabGTPase switching and stability (335). 
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4.4 Proteins are sorted from each other 
along the endosomal/ vacuolar pathway
Multiple pathways emerge from the late-
Golgi, which transport proteins and lipids 
to the vacuole. In addition to this pathway, 
membranes and proteins are continuously 
internalized through endocytosis. These 
two pathways intersect at the level of the 
early/late endosome. The late endosome 
is morphologically characterized by 
the presence of membrane-bound inner 
membranes or vesicles, and for this 
reason is also known as the multivesicular 
body (MVB). At the late endosome/
MVB, proteins are sorted to their correct 
destination through the presence of 
sorting signals similar to what occurred 
at the trans-Golgi. At this stage certain 
proteins such as transmembrane receptors 
and proteins that occasionally enter these 
transport intermediates and endocytic 
vesicles need to be correctly returned 
to their right place of function in order 
to maintain the appropriate trafficking 
dynamics in the cell. In the following 
sections we will address brie y how the 
cell recycles cargo back to the plasma 
membrane and how proteins are recycled 
back for further cycles of protein sorting.
4.4.1 Protein sorting at the late 
endosome / MVB.
Once proteins arrive at the MVB, they are 
once again sorted from each other (405). 
It appears that one of sorting signals for 
transport to the vacuole is the addition 
of ubiquitin (406). For example addition 
of monoubiquitin to the G-protein-
coupled pheromone receptors, Ste2p and 
Ste3p present at the cell surface, acts 
as a signal for internalization, and also 
functions as a sorting determinant at the 
late endosome/MVB (308, 407, 408). 
Other proteins travel from the late Golgi 
to the vacuole and are ubiquitinated either 
at the late Golgi or at the late endosome/
MVB. The addition of monoubiquitin to 
certain proteins allows them to interact 
with the ubiquitin-binding domain of 
the GGA proteins that mediate sorting 
at the late-Golgi to the MVB (356). For 
the addition of ubiquitin to the respective 
substrates the cell relies on Rsp5p, an 
ubiquitin ligase of the Nedd4 family that 
is localized to diverse sites such as the 
plasma membrane, Golgi and endosomes 
(409, 410). Rsp5p is responsible for the 
ubiquitination of proteins at the surface 
prior to internalization, and is involved in 
the ubiquitination of biosynthetic cargo 
destined to the vacuole, a step required 
for cargo to enter the CPY pathway. 
(352, 409, 411-413). The broad range of 
action of Rsp5p in the cell appears to be 
accomplished by speci c domains within 
Rsp5p, since different mutations in Rsp5p 
affect different cargos (414). For example 
the C2 domain is responsible for the binding 
of Rsp5p to phosphoinositides and may be 
the key feature required for recruitment 
of Rsp5p to Golgi/endosomal membranes 
(415). When the C2 domain of Rsp5p is 
deleted, ubiquitination of biosynthetic 
cargo such as carboxypeptidase S is 
affected, while the ubiquitination and 
internalization of Ste2p at the plasma 
membrane is unaffected (409, 412, 415). 
4.4.1.1 The ESCRT complexes mediate 
sorting of ubiquitinated cargo at the late 
endosome / MVB
The class E vps mutants are characterized 
by the presence of a large and aberrant 
late endosome/MVB, where proteins that 
follow the CPY pathway and endocytic 
pathway accumulate (416). The class E 
VPS family is composed of 18 genes, 
17 of which encode soluble proteins 
form membrane-associated complexes 
with each other on the MVB membrane. 
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Biochemical and genetic analyze have 
revealed the formation of four endosomal 
sorting complexes required for transport, 
commonly referred as ESCRT complexes: 
ESCRT-0 (Vps27p and Hse1p); ESCRT-I 
(Vps23p, Vps28p and Vps37p); ESCRT-II 
(Vps22p, Vps25p and Vps36p) and  nally 
ESCRT-III (Vps2p, Vps20p, Vps24p and 
Vps32p) (407, 417-421). Vps44p/Nhx1p is 
the only member of the class E VPS genes 
that encodes a transmembrane protein, 
namely a sodium/proton exchanger 
localized to the MVB membrane (422). 
Although its precise function still remains 
unclear, it appears that its ion exchange 
activity is essential for late endosome/
MVB sorting, possibly by regulating the 
lumenal MVB ionic/pH environment. 
This in turn could affect the recruitment 
of ESCRT or ESCRT-associated proteins 
to the membrane and consequently affect 
protein sorting (263, 423).
The ESCRT-0 complex provides the 
sorting receptor for ubiquitinated cargo 
into lumenal vesicles at the late endosome/
MVB. This feature is provided by the 
presence of ubiquitin interacting motifs 
(UIMs) in both Vps27p and Hse1p (419, 
424). The ESCRT-0 complex is recruited 
to the membranes through the interaction 
of the FYVE domain of Vps27p with 
phosphatidyl inositol 3-phosphate 
(PI3P) (425). This recruitment is further 
enhanced by the interaction of Vps27p 
with the ENTH domain proteins Ent3p 
and Ent5p (426). These proteins also bind 
phosphatidyl inositol-3,5-bisphosphate, 
and are required for correct sorting of 
proteins to the lumenal membranes (426). 
When the ESCRT-0 complex is correctly 
positioned, it may recruit the ESCRT-I 
complex through the interactions between 
the PTAP-like motifs present on the 
C-terminal region of Vps27p and Vps23p 
(425, 427). In addition to recruiting 
ESCRT-I to the MVB membranes, 
it is possible that it also recruits the 
ubiquitin ligase Rsp5p, thus allowing the 
ubiquitination of cargo that would then be 
closely positioned to ESCRT-0 complex 
for MVB sorting (263, 420). ESCRT-I is 
also capable of binding to ubiquitinated 
cargo, but this interaction is provided 
by the ubiquitin E2 variant (UEV) 
domain (407). After ESCRT-I is correctly 
positioned, ESCRT-II and ESCRT-III 
are recruited to the late-endosome/MVB 
membrane (417, 418, 420). ESCRT-
II associates with both ESCRT-I and 
with ESCRT-III and thus helps increase 
the membrane-binding/recruitment of 
ESCRT-IIII (428). Additionally, ESCRT-
II appears to have the ability to bind to 
ubiquitinated cargo, since point mutations 
in the NZF-ubiquitin-binding domain 
of Vps36p abolish the correct sorting of 
GFP-CPS at the late endosome/MVB 
(429). ESCRT-III complex is made itself 
from two subcomplexes composed of 
Vps2p/Vps24p and Vps20p/Vps32p 
(417). ESCRT-III is recruited to the late 
endosome membranes through interactions 
between Vps20p subunit and ESCRT-I and 
–II (420). At this stage ESCRT-III recruits 
accessory proteins such as Vps4p, Vps31p/
Bro1p, Vps46p, Vps60p and Vta1p (263, 
420, 430). Bro1p in turn recruits the 
deubiquitinating enzyme Doa4p to the 
ESCRT-III complex through interactions 
of Vps31p/Bro1p with Vps32p (420, 431, 
432). Doa4p removes ubiquitin from the 
cargo molecules prior to their incorporation 
into the budding lumenal vesicles and is 
essential for proper maintenance of the 
normal intracellular ubiquitin levels (433). 
Vps4p is an AAA-ATPase that is required 
for membrane dissociation of the ESCRT 
complexes thus allowing recycling of the 
ESCRT complexes for further cycles of late 
endosome/MVB sorting (407, 434, 435). 
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In summary, the ESCRT complexes 
mediate sorting into the lumenal vesicles 
through the following steps: ESCRT-0 is 
recruited to the MVB membrane via PI3P-
binding that is generated by the Vps34p/
Vps15p complex. Rsp5p is recruited to 
the membrane by ESCRT-0 and may 
ubiquitinate cargo. ESCRT-0 recruits 
ESCRT-I and ESCRT-II, and ubiquitinated 
cargo binds to these complexes in this 
order (429). In turn, ESCRT-III is recruited 
through interactions with ESCRT-I and 
–II, and ESCRT-III-associated proteins 
are recruited leading to deubiquitination 
of cargo to be incorporated into the 
lumenal vesicle through the action of Do -
a4p. ATP hydrolysis by Vps4p leads to 
disassociation of the ESCRT complexes 
from the membrane and cargo is sorted 
into the inward budding vesicle. (234)
4.4.1.2 The Retromer mediates recycling 
of late-Golgi proteins
The transport of vacuolar proteins from 
the late-Golgi to the PVC requires the 
efficient recycling of many late-Golgi 
membrane proteins that cycle between 
these two organelles and have to return to 
the Golgi. Such proteins include the acid 
hydrolase receptor Vps10p, the enzymes 
Kex2p and Ste13p and the SNAREs 
Snc1p and Tlg1p. This is accomplished 
by the presence of critical aromatic 
amino acids in the cytosolic tail of these 
transmembrane proteins that function as 
sorting signals for their retrieval from a 
post-Golgi compartment (274, 275, 278, 
279). The mechanism of signal recognition 
and retrieval is still not well understood 
but involves a number of genes, including 
VPS35, VPS29, VPS26, VPS5 and VPS17, 
which are thought to encode components 
of the recycling machinery namely the 
Retromer complex (273, 436-439). 
Two subcomplexes constitute the 
retromer complex, the Vps35p–Vps29p–
Vps26p subcomplex that has a role in 
cargo selection, and the Vps5p–Vps17p 
subcomplex that has a structural role 
namely in membrane recruitment and 
vesicle formation. With exception of 
the Vps17p subunit, which seems to be 
specific to fungi, retromer subunits are 
conserved in all eukaryotes. Vps35p 
appears to be the platform onto which the 
remaining components of the retromer 
associate. This observation came from 
studies that revealed that Vps35p could 
interact directly with cargo proteins such 
as Vps10p (273, 440, 441). Membrane 
binding of Vps35p to the late endosome 
membrane/MVB is further promoted 
by Vps26p, which also mediates the 
interaction with the Vps5p-Vps17p 
dimer, thus linking cargo selection and 
self-assembly (442). Association of the 
retromer to endosomal membranes appears 
to result from a direct interaction of the 
retromer with lipids of the endosomal 
membrane. Vps5p and Vps17p are both 
members of the sorting nexin (SNX) 
family, which are characterized by the 
presence of a conserved Phox homology 
(PX) domain, a BAR (Bin, amphiphysin, 
Rvs) domain and a function in the sorting 
of membrane proteins namely by avoiding 
that the protein reaches the vacuole (443, 
444). The PX domain is responsible 
for the ability to bind to the endosomal 
lipid phosphatidylinositol 3-phosphate 
(PtdIns3P) (445). Since in yeast there is 
only one phosphatidylinositol 3-kinase, 
the product of the VPS34 gene, this 
protein regulates the action of the retromer 
by regulating the level of PtdIns3P (446, 
447). Thus, Vps34p together with an 
adaptor complex composed of Vps30p/
Vps38p, which is required for stimulation 
of kinase activity, regulates the production 
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of PtdIns3P, which in turn is required for 
proper localization of Vps5p-Vps17p and 
the remaining components of the retromer 
complex (446, 447). The function of the 
retromer is to associate to endosomal 
membranes and selectively sort cargo 
proteins into the transport vesicle. But 
does the retromer function as a vesicle 
coat? Two characteristics de ne a vesicle 
coat, the ability to select cargo and the 
ability to self-assemble thus driving 
vesicle formation that selectively encloses 
cargo within. The retromer appears to 
ful ll these characteristics, since Vps35p 
provides the cargo selection function, 
while the self-assembly function is 
provided by the BAR domains of Vps5p/
Vps17p, which dimerize and bind to 
highly curved membranes (448, 449). If 
the retromer can be classi ed as a typical 
vesicle coat, like clathrin or adaptor 
coats is still not fully clear. However it 
appears that the transport intermediate 
that emerges from endosomes, and closely 
positioned to the observed retromer site of 
action, may indeed be tubules rather than 
vesicles (449-451). The retromer has not 
been shown to form electron dense coats 
as the classical vesicles coats do, and the 
mechanism of sorting cargo appears to be 
distinct from that of classical membrane 
coats (147, 452). A recycling pathway 
between the endosome and the Golgi also 
exits in yeast. This pathway is involved in 
the speci c retrieval of the endocytosed 
exocytic SNARE Snc1p, and is mediated 
by another set of sorting nexins, namely 
SNX4, SNX41 and SNX42 (453). These 
sorting nexins might constitute another 
sorting complex that is involved in 
retrograde transport.
The nature and properties of the 
transport carriers that mediate the 
retrograde transport of cargo to the late-
Golgi is still unknown. Nevertheless 
for fusion to occur with the late-Golgi, 
tethering factors have to be recruited 
from the cytosol. These tethering factors 
facilitate the assembly of SNARE 
complexes between the v-SNAREs on 
the retrograde carriers and the t-SNAREs 
on the late-Golgi. One such tethering 
factor implicated in endosome-to-late 
Golgi transport is the hetero-oligomeric 
complex GARP/VFT (Golgi-associated 
retrograde transport / Vps  fty three). The 
GARP/VFT complex is constituted by 
four subunits Vps51p, Vps52p, Vps53p 
and Vps54p and is recruited to the late-
Golgi membranes through interaction 
with the Rab-GTPase Ypt6p. Vps51p 
interacts with the t-SNARE Tlg1p, thus 
it may coordinate tethering events with 
membrane fusion (454-456). The GARP/
VFT complex is involved in tethering 
of transport carriers that originate from 
both the early and late endosome (454-
457). Interestingly two other hetero-
oligomeric complexes, where recently 
reported to be involved in tethering of 
retrograde transport carriers (458). These 
are the COG complex and the TRAPP-II 
complex. The COG complex is composed 
of eight subunits Cog1p to Cog8p, 
organized in two domains and is recruited 
to the late-Golgi by the Rab-GTPase 
Ypt1p, and interacts with the t-SNARE 
Sed5p (459-461). The main function of 
the COG complex appears to be in intra-
Golgi membrane fusion events. However 
mutations in individual COG subunits, 
revealed impaired retrograde transport 
from both early and late endosomes to 
the Golgi (459, 460).  The other hetero-
oligomeric complex is the transport 
protein particle  (TRAPP) complex 
(181). This complex is present in the cell 
in two forms, TRAPP-I and TRAPP-II 
(462). While TRAPP-I acts at the ER-
Golgi interface and mediates tethering of 
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COPII to the cis-Golgi membrane face, 
TRAPP-II acts at the intra-Golgi level and 
mediates the tethering of COPI vesicles 
(462-465). These two TRAPP forms share 
seven subunits, whereas three subunits 
are specific to TRAPP-II (Trs130p, 
Trs120p and Trs65p) (462). Mutations 
in Trs130p disrupt Golgi traffic, while 
mutations in Trs120p interrupt recycling 
of proteins from the early endosomes to 
the late-Golgi (463). Taking into count, 
that Trs120p colocalizes with the late-
Golgi marker Sec7p and Trs120p mutants 
reveal a defect in the recruitment of COPI 
subunits to the early endosome, it appears 
that Trs120p and the TRAPP-II complex 
are required for tethering of vesicles that 
traf c from the early endosome to the late-
Golgi (463). 
5. Transport to the plasma 
membrane, the last step of the 
exocytic pathway
In the previous sections we addressed how 
proteins destined to the secretory pathway 
enter the ER and are transported through 
the Golgi apparatus. During these transport 
events little differences are observed 
between exocytic cargo and proteins that 
have an intracellular function such as the 
carboxypeptidase Y receptor Vps10p. 
At the late-Golgi proteins intended for 
delivery to the plasma membrane, to 
be incorporated into the cell wall, or 
secreted to the medium, are sorted from 
proteins destined to remain intracellular. 
Meanwhile, proteins intended for delivery 
to the endosomal membrane system are 
sorted into a separate pathway. In some 
but not all cases, the N- or O-glycans 
added to the newly synthesized proteins 
provide sorting information. Proteins to be 
exocytosed are delivered to the cell surface 
in a speci c set of vesicular carriers, which 
enclose a unique set of proteins in their 
membrane, although the coat proteins 
that participate in the formation of these 
carriers have not yet been fully identi ed 
(2, 258, 260, 466). In the following 
sections we will address how exocytic 
cargo is targeted to the plasma membrane 
and the fusion machinery involved in the 
regulation, fusion and delivery of these 
transport intermediates to the plasma 
membrane.
5.1 Different vesicles transport distinct 
proteins
In the majority of the eukaryotic cells, 
exocytic cargo can reach the cell surface 
by multiple pathways (256, 257). For 
example in polarized epithelial cells 
distinct vesicles with speci c subsets of 
cargo are targeted preferentially to the 
apical or basolateral membranes (467-
470). This suggests a unique sorting 
mechanism for the different classes of 
cargos. This idea is further supported by 
the fact that when apical and basolateral 
proteins are expressed in  broblasts (i.e., 
nonpolarized cells), the sorting machinery 
of the cell segregates these cargos into 
different populations of vesicles using 
the same sorting signals as in polarized 
cells (471, 472). Similar to their higher 
eukaryotic partners, the yeast S. cerevisiae 
also has the ability of packaging exocytic 
cargo into two classes of secretory 
vesicles, which differ in their cargo 
(258-260, 473).  These two populations 
of vesicles were first identified using 
an isolation procedure that allowed the 
speci c enrichment of secretory vesicles, 
followed by further separation according 
to their densities (258, 474). Thus, the 
vesicles classes were designated as LDSV 
(light density secretory vesicle) and the 
HDSV (heavy density secretory vesicle). 
The LDSV class carries the cell wall 
component Bgl2p (endo--1,3-glucanase), 
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Pma1p (the major plasma membrane 
ATPase) and Gas1p (GPI anchored -1,3-
glucanosyltransferase) (258). On the other 
hand, invertase (a periplasmic secreted 
sucrose hydrolyzing enzyme) and acid 
phosphatase (PHO11/PHO12/PHO5) 
are found in the HDSV class of vesicles 
(258).  These two classes of vesicles also 
differ in their transit times through the 
secretory pathway. While the LDSV cargo 
is secreted in 30 minutes, the HDSV cargo 
is transported in only 5 minutes (4, 258, 
475, 476). The asynchrony between the 
different cargos develops before the  nal 
exocytic step. One possible explanation 
suggested for this difference in secretion 
kinetics is transported through different 
compartments (4, 258). Indeed, cargo 
found in the HDSV class of vesicles is 
dependent on a functional endosomal 
pathway, and hence thought to transit 
through an intermediate endosomal 
compartment (259, 260). In mutants 
de cient in the endocytic pathway such 
as vps1, vps4 and clathrin mutants, 
the biogenesis of HDSV is abolished 
and HDSV cargo is now found in LDSV 
(259, 260). Meanwhile, the biogenesis 
and sorting of cargo into LDSV appears 
unaffected in these mutants. Thus, it 
appears that LDSV are generated directly 
at the late-Golgi membrane, while HDSV 
are generated at endosomal membranes 
(258-260, 477, 478). 
Although the best-known mechanism 
of transport from the early endosomes 
to the plasma membrane is the recycling 
of the transferrin receptor and synaptic 
receptors, newly synthesized proteins are 
also capable of entering this pathway (479-
481). This is illustrated by the traf cking 
of newly synthesized transferrin receptor, 
asialoglycoprotein receptor H1 and the 
major histocompatibility complex class 
II molecules (482-485). It appears that in 
yeast, an endosomal to plasma membrane 
pathway is also functional. Mutant plasma 
membrane ATPase, pma1-7p, is normally 
delivered to the vacuole for degradation, 
however when delivery to the vacuole is 
blocked pma1-7p is rerouted to the plasma 
membrane (357, 358). Vps mutant cells 
are characterized by the missorting of 
the vacuolar protein carboxypeptidase 
Y to the cell surface (371). This feature 
can be observed by the packaging and 
accumulation of CPY into LDSV in vps1
sec6-4 cells, since this mutant appears 
to lack dense secretory vesicles due to 
the block of all traf cking events to the 
vacuole (260). However, in vps10 sec6-4 
mutant cells, where traf c to the vacuole 
is normal, but the receptor for CPY is 
lacking, CPY is found in the HDSV class 
of vesicles (259, 260). The reason for 
two divergent pathways for delivery of 
proteins to the plasma membrane is not 
fully understood. Perhaps certain proteins 
may need special processing requirements 
or alternatively need to be regulated 
differentially. 
Another difference between the 
LDSV and the HDSV is the nature of 
their cargo. While the LDSV transports 
cargo involved in cell surface expansion, 
the HDSV transports newly synthesized 
soluble exocytic proteins that appear to 
be required under certain physiological 
conditions (260).  The cargo transported 
in the HDSV is under transcriptional 
regulation, e.g. invertase and acid 
phosphatase. Packaging these proteins 
separately from constitutively expressed 
ones that are required for cell surface 
expansion, may add one layer of regulation 
at a post-translational level.  One such 
example is the approach yeast uses to 
regulate the levels of active general amino 
acid permease, Gap1p, whose localization 
to the plasma membrane is regulated by 
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the available nitrogen source (350, 486, 
487). Gap1p is capable of transporting 
all the naturally occurring amino acids 
into the yeast cell. Under poor nitrogen 
conditions, Gap1p is transported to the 
plasma membrane to increase amino acid 
uptake. On the other hand, under nitrogen-
rich conditions, the presence of Gap1p on 
the membrane is downregulated through 
the action of Rsp5p ubiquitin ligase, 
which targets Gap1p for degradation in 
the vacuole (355). 
The rapid relocation of Gap1p to the 
plasma membrane appears to involve a 
novel complex called the GSE complex 
(GTPase-containing complex required 
for Gap1p sorting in the endosome) that 
recognizes Gap1p in the endosomes 
(354). The GSE complex is composed 
of two small GTPases (Gtr1p and Gtr2p) 
and three additional components (Gse1p, 
Gse2p and Ltv1p). The Gtr2p subunit 
provides the Gap1p recognition by binding 
to a di-aromatic motif (Trp-Tyr) exposed 
on the cytosolic domain of Gap1p (354). 
Whether the GSE complex is indeed a coat 
complex, which mediates the sorting of 
proteins into vesicles for transport to the 
plasma membrane, still remains to be fully 
addressed. The GSE complex is capable of 
binding cargo but the second feature of a 
coat complex, the ability to oligomerize and 
remodel the membrane thus driving vesicle 
budding, still remains to be elucidated. 
The GSE complex appears to form a 
complex with an Mr of approximately 
600K, though its components have a 
total Mr of approximately 170K. Thus, 
the GSE complex could possibly mediate 
its self-assembly, or then associate with 
an accessory protein that would mediate 
the oligomerization and remodeling of 
the membrane. One such candidate is 
Mvp1p, which is capable of interacting 
with Gse1p (488). Mvp1p is a member of 
the sorting nexin family of proteins, which 
are characterized by the presence of a p40 
Phox homology (PX) domain that allows 
the binding to phosphatidyl-inositol-
3-phosphate present in the endosomal 
membranes (445, 489). The ability of 
sorting nexins to bind to membrane lipids, 
together with the feature that many sorting 
nexins contain BAR (Bin/Amphiphysin/
Rvs) domains that may mediate tubulation, 
raises the possibility that the GSE complex 
may fulfill the role of coat complexes 
(444, 448, 489). 
From the previous example we can 
see that the existence of a parallel pathway 
to the cell surface with an additional level 
of regulation, would be especially useful 
in adjusting the levels of external proteins 
that are required only under certain 
physiological conditions, or for soluble 
proteins, which cannot be efficiently 
retrieved (258, 260). Due to the complexity 
of the late secretory pathway, it has been 
dif cult to characterize the transport routes 
involved and the machinery responsible 
for sorting and packaging cargo into these 
vesicles. Nevertheless, these two classes 
of vesicles do reveal some distinct features 
that may allow, better understanding of 
how these parallel pathways work and are 
regulated. 
5.2 Polarized delivery of secretory 
cargo to the plasma membrane
The major mechanism for delivery of new 
membrane components to the cell surface 
involves the delivery, docking and fusion 
of secretory vesicles with the plasma 
membrane. This process is essential since 
it allows the cell to transport proteins 
to the cell surface that will permit it to 
interact with the surrounding environment. 
Polarized growth is a phenomenon that 
occurs in almost all of the cells, from 
prokaryotic to specialized eukaryotic 
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tissues and plays an important role in 
diverse cellular events such as organism 
development and cell movement. In the 
majority of eukaryotic cells this process 
occurs at discrete sites of the cell surface 
and is tightly coordinated with the 
overall polarity of the cell. For example, 
in epithelial cells, polarized delivery of 
basolateral and apical proteins to the 
correct membranes has to be spatially 
regulated to allow correct morphology and 
physiology (468, 469). Yeast cells display 
a high degree of polarized traf c during 
their life cycle, where the sites of active 
vesicle fusion to the plasma membrane 
change during the progression through 
the life cycle. This is accomplished by a 
shift in the protein machinery involved 
in cell polarity and exocytosis to discrete 
sites of the plasma membrane (490, 491). 
During vegetative growth yeast cells 
undergo polarized growth by budding. 
When a haploid cell is at the end of the G1 
phase of the cell cycle, secretory vesicles 
are directed to the emerging bud tip. As 
the bud grows in the G2 phase, vesicle 
fusion becomes transiently isotropic 
(unpolarized) within the bud. During 
cytokinesis the machinery is relocated to 
the mother-bud neck until cell separation 
occurs. In yeast cells the budding pattern 
depends on their mating type. In haploid 
cells, the next round of budding occurs 
in an axial fashion, where the bud forms 
at the pole adjacent to the previous bud 
site. Diploid cells show a bipolar budding 
pattern, where daughter cells bud opposite 
to the previous budding event (490). In 
yeast, the polarized delivery of secretory 
vesicles to the site of active membrane 
growth involves three steps: 1) polarized 
delivery of vesicles along actin cables 
towards sites of polarized growth; 2) 
Docking of secretory vesicles with the 
plasma membrane, and 3) Fusion of 
secretory vesicles at sites of polarized 
growth. In the following sections we will 
address these issues separately.
5.2.1 Motor molecules, actin 
cytoskeleton and spatial landmarks
During the different cell cycle stages, the 
yeast S. cerevisiae spatially and temporally 
regulates exocytosis by directing surface 
growth and secretion to distinct sites 
on the plasma membrane. The accurate 
delivery of secretory vesicles to the sites 
of active membrane expansion involves 
both an actin-dependent vesicle transport, 
and actin-independent establishment of 
the machinery involved in receiving the 
vesicle at the cell surface (for reviews see 
(492-494)). In animal cells, transport of 
secretory vesicles to the cell surface relies 
primarily on microtubule-based transport, 
which is accomplished by kinesin-
dependent transport along microtubules, 
followed by actomyosin-dependent 
transport (495, 496). 
Actin  laments are dynamic polymers 
whose ATP-driven assembly in the cell 
cytoplasm drives shape changes, cell 
locomotion and chemotactic migration. 
Actin is the most abundant protein in the 
eukaryotic cell, accounting for about 15% 
in some cell types.  The protein is highly 
conserved, and forms a huge variety of 
structures in cells in concert with a huge 
number of actin-binding proteins. The yeast 
actin cytoskeleton is organized into at least 
four biochemically and morphologically 
distinct structures: cortical patches, actin 
cables, the cytokinetic ring and the cap 
(494). Actin cables are highly dynamic 
structures containing actin (Act1p), 
fimbrin (Sac6p), and tropomyosin 
(Tpm1p, Tpm2p). The actin present in the 
actin cables is capable of rapid turnover 
(497). The dynamics of the actin cables 
appear to result from equilibrium between 
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protection/stabilization through the action 
of tropomyosin and disassembly by the 
cofilin (Cof1p)-Aip1p complex (498, 
499). The polarization of the actin cable 
arrays is intimately linked to a group of 
proteins called the “polarity cap” (490, 
493, 494). This term refers to a group of 
interacting cellular factors, shaped into a 
cap-like structure that localize during the 
bud emergence and apical growth and 
have a role in the regulation of the overall 
cytoskeleton polarity thus directing cell 
growth (Figure 14). The polarity cap is 
thought to function as a nucleation/anchor 
site for actin cables and is composed of 
proteins such as Cdc42p, Cdc24p, Bem1p, 
Ste20p, Cla4p, formins and the polarisome 
(490, 493, 500). One of the most crucial 
elements required for the polarization of 
the actin cytoskeleton is the small GTPase 
Cdc42p of the Rho/Rac subfamily of Ras-
GTPases, and its GEF Cdc24p (501-504). 
A key event in the polarization function 
of Cdc42p is its recruitment to the plasma 
membrane, where it can locally activate 
its downstream effectors that signal to 
the actin cytoskeleton (505, 506). The 
association to the membrane is mediated 
by a geranylgeranyl anchor, which is 
transferred to Cdc42p through the action 
of Cdc43p, a type I geranylgeranyl 
transferase (507). The local cycles of 
hydrolysis and relocalization are facilitated 
by the activating effects of the GAPs 
(Bem3p, Rga1p and Rga2p) as well as by 
the action of the GDI Rdi1p (508-511). On 
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polarization of Cdc42p/Cdc24p to the sites 
of active membrane expansion is strongly 
affected by Bem1p, which plays a crucial 
role in maintaining a polarized cell, since 
it links the Cdc42p/Cdc24p complex to the 
polarity determinants involved in shmoo- 
and bud-site selection (515-517). For 
example during early bud emergence pre-
existing cortical cues mark the proper site 
to initiate bud emergence. These cues are 
left by the previous budding events, which 
resulted from a set of actions controlled by 
the BUD gene products. These cues lead 
to the local activation of the Ras-related 
protein Bud1p/Rsr1p GTPase by its GAP 
Bud2p and GEF Bud5p (518, 519). At 
this stage Bud1p is capable of binding 
to Cdc24p and to Bem1p, which in turn 
recruits Cdc42p to a discrete region of the 
plasma membrane where the nascent bud 
the plasma membrane Cdc24p and Cdc42p 
form complexes with a subset of different 
effectors, forming putative scaffolds that 
function as clusters transmitting signals 
to the cell and orientating the actin 
cytoskeleton (493). Two such effector 
molecules essential in the Cdc42p-actin 
signaling and are involved in all stages of 
growth (bud emergence, bud growth and 
cytokinesis), are the two p21-activated 
kinases (PAKs) Ste20p and Cla4p (512, 
513). Cdc42p in the GTP-loaded form 
binds to the CRIB domain of the PAKs, 
that functions as an N-terminal PAK 
inhibitory domain, preventing the PAK 
from entering into the auto-inhibited 
conformation and thus activates these 
kinases that then mediate further 
signaling that control actin organization 
and polarized growth (514). The initial 
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Figure 14. Spatial landmarks for polarized delivery of secretory vesicles.
A. Polarization of the actin cytoskeleton. Establishment of spatial landmarks. Actin cable 
assembly is regulated by the action of the polarity cap components, which are localized to the 
bud tip. The polarity cap may be further linked to the plasma membrane via components that 
directly associate with phospholipids. Nucleation of the actin  laments is provided by the formin 
Bni1, which uses pro lin- and Bud6-bound actin subunits as substrates. Bni1 is typically associ-
ated with the fast-growing (barbed) end of the actin  lament it nucleates, facilitating insertional 
growth while protecting ends from the capping protein (Cap1/2). Cables are stabilized along their 
sides by tropomyosin, which competes with co lin for binding F-actin. Whereas individual actin 
cables are connected to each other by cross-linking proteins such as Sac6 and Abp140. Actin ca-
bles are disassembled, by the action of co lin and Aip1. Transport of secretory vesicles and other 
cargo along actin cables is provided by the action of the barbed-end-directed type V myosins. 
Reprinted, with permission, from the Microbiology and Molecular Biology Reviews, Volume 70 
(c) 2006 by American Society for Microbiology.
B. Genetic interactions between exocyst components. Solid lines depict physical interactions 
between each of the exocyst subunits that have been shown to occur either by co-immunopre-
cipitation or by two hybrid screens Dashed lines reveal possible interactions hypothesized by 
their loss when the respective interacting partner is mutated. C. The tethering function of the 
exocyst. After the vesicle has been properly marked by the active form of the RabGTPase Sec4 
and transported to the sites of active membrane fusion, Sec15p interacts with Sec4-GTP. The 
remaining components of the exocyst arrive to these sites either due to the polarization of the 
secretory pathway or are individually localized due to their interaction with the polarization ma-
chinery.  The exocyst subunits assemble into the multisubunit complex at the interface between 
the secretory vesicle and the plasma membrane, helping to bridge a distance where the SNAREs 
cannot yet interact. At this stage the exocyst appears to be in a star sh shape. As the exocyst 
subunits start to assemble and pack there coiled coil regions against each other, they bring the 
vesicle closer to the plasma membrane where SNAREs on opposing membranes may interact. 
The exocyst in the closed form shows a T-shape. 
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site will be marked and bud emergence will 
begin (520). One additional set of proteins 
required for maintaining the polarized 
state of the cell, is the polarisome, which 
is a complex formed by Spa2p, Pea2p, 
Bud6p and the additional proteins Sph1p 
and Bni1p (521). In polarisome mutants 
shmoo growth is affected and the mother-
daughter necks are enlarged, suggesting 
that initial bud emergence is not focused 
(522). Taking into count that Cdc42p/
Cdc24p remains clustered during apical 
growth and the polarisome proteins are 
required for apical actin organization, the 
polarisome proteins may function as apical 
scaffolds that help maintain a tight cluster 
of Cdc42p/Cdc24p during the elongation 
of bud (493). The polarisome appears to 
play a central role in the integration of 
the different signals inside the cells that 
help regulate polarization. Such signals 
are mediated by a family of Rho GTPases 
such as Cdc42p, and additional family 
members such as Rho1p, Rho3p and 
Rho4p, which in the activated state bind 
to the central element of the polarisome, 
Bni1p, and link Rho GTPase signaling to 
actin  lament assembly (523-526). Actin 
assembly is further promoted by the ability 
of Bni1p to bind to pro lin (Pfy1p), which 
stimulates actin polymerization, and to the 
actin bundling proteins Tef1p/Tef2p (527, 
528). Proper localization of the polarisome 
to the growth sites is provided by Spa2p, 
Sph1p and Pea2p that provide the docking 
site for Bni1p and Bud6p (521, 523, 529-
533).
Regulation of the overall polarity state 
in S. cerevisiae is under the coordinated 
control of Rho GTPases and cyclin-
dependent protein kinases. The Rho 
family GTPases, including Rho and Rac 
GTPases, are small monomeric GTPases 
primarily involved in polarization, control 
of cell division, and reorganization of 
cytoskeletal elements (534). Yeast has 
six Rho family members RHO1-5 and 
CDC42. Rho1p and Rho2p are partially 
redundant GTPases that are involved in 
a variety of roles within the cell (535, 
536). In particular, they are key proteins in 
maintaining cell integrity by stimulating 
directly two -1,3-glucan synthases 
(Fks1p and Fks2p) which participate in 
the construction of the cell wall at the 
sites of polarized growth (537). Since 
some rho1 alleles cause depolarization of 
actin cytoskeleton it is thought that Rho1p 
activity promotes polarity (538). This 
role is accomplished by signaling through 
the Pkc1p and Mpk1p MAPK cascade, 
but the precise mechanism of signaling 
remains unclear (539). The Rho GTPases 
Rho3p and Rho4p play an important 
role in growth polarization by acting on 
the cytoskeletal polarity (493). Genetic 
evidence suggest that Rho3p/Rho4p 
and Cdc42p share a common polarizing 
function, although Rho3p/Rho4p appear 
to be involved after initiation of the bud 
formation and are required to maintain 
cell polarity during the maturation of the 
daughter cells (540). 
5.2.1.1 Targeting secretory vesicles for 
transport along actin cables 
Besides the role in actin polarization, 
Rho3p appears to have a function in 
targeting of secretory vesicles to the 
sites of active plasma membrane fusion 
by positively regulating actin cable-
based vesicular transport (541, 542). 
This function can be subdivided into two 
steps: the transport of exocytic vesicles 
from the mother cell to the bud, and in a 
second step docking and fusion of vesicles 
with the plasma membrane. In the first 
stage, Rho3p directly interacts with the 
unconventional Myo2p motor. Myo2p is 
an myosin V heavy chain and constitutes 
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a type V myosin motor, which is involved 
in actin-based transport of cargos (543). 
Class V myosins are characterized by 
a particular domain architecture and 
distinct modes of regulation. Myo2p has 
a N-terminal actin-binding motor domain, 
a neck region that contains six IQ motifs 
that can bind calmodulin, and a globular 
C-terminal tail domain separated by a 
coiled-coil dimerization domain (544, 
545). The globular C-terminal domain 
mediates the association to the vesicle 
to be transported and the C-terminal tail 
appears to be required for bud localization 
(546, 547). Rho3p regulation of Myo2p is 
mediated by its direct association with the 
coiled-coil region of Myo2p (542). Myo2p 
is additionally regulated by, and physically 
associated to the myosin light chain 1, 
Mlc1p (548). Mlc1p belongs to a branch of 
the calmodulin superfamily and is essential 
for vesicle delivery at the mother-bud neck 
during cytokinesis due to is ability to bind 
to the IQ motifs of the class V myosin 
Myo2p (549). Although Mlc1p belongs to 
the calmodulin superfamily, it is unable to 
bind calcium and the precise mechanism 
of its interaction with target motifs is not 
clear. Myosin motors polarize transport of 
secretory vesicles by translocating them 
along actin cables in direction of the cap. 
Unidirectional transport is ensured by the 
fact that class V myosins are processive, 
barbed end-directed motors, and by the 
fact that the  laments in the cables appear 
to be of uniform polarity with their barbed 
ends directed towards the cap (550, 551). 
Myo2p-driven transport of secretory 
vesicles along actin cables is very rapid, 
which results in the accumulation of these 
vesicles in the cap (552). Under conditions 
where actin cables are lost, such as in 
tropomyosin mutants, or in cases where 
the motor activity of Myo2p is lost, 
vesicles are no longer delivered to the cap 
and cell growth becomes depolarized, the 
cells enlarge isotropically (552-554). 
The formation of a functional complex 
between Myo2p and the vesicle appears 
to require three proteins, Smy1p, Sec2p 
and Sec4p. Defects in these proteins are 
synthetically lethal, which suggested that 
their functions are interrelated (547, 552, 
555). This is further supported by the fact 
that Rho3p, which is directly associated 
with Myo2p, also interacts genetically 
with SEC4 and TPM1(542, 556). Smy1p is 
a non-essential kinesin-related heavy chain 
homologue that is capable of interacting 
directly with the C-terminal tail of Myo2p 
and is polarized to the cap by the motor 
activity of myosin (557). Although Smy1p 
is non-essential, overproduction of this 
protein enhances polarization of Myo2p to 
sites of polarized growth and can partially 
compensate for defects in the myo2-
66 mutant (555). Although Smy1p is a 
kinesin-related protein, it appears that its 
function does not rely on microtubules or 
on the kinesin motor activity but rather is 
associated to an activity in promoting the 
assembly of the transport complex (493, 
558).
Sec4p is a Rab GTPase that controls 
the final stage of the exocytic pathway 
in the yeast S. cerevisiae (559-561). 
Like above, activation of Sec4p involves 
exchange of GDP for GTP in a reaction 
mediated by its guanine nucleotide 
exchange factor (GEF) Sec2p (562, 563). 
Sec4p and Sec2p are found on the surface 
of secretory vesicles and escort the vesicle 
to the sites of active membrane fusion 
(562). The proper recruitment of Sec4p to 
the vesicle membrane appears to involve 
a Rab cascade where Sec2p is both a GEF 
for one Rab and an effector for the Rab 
that acts upstream (564). The  rst step of 
this cascade is the recruitment of Sec2p to 
the vesicle in a reaction catalyzed by the 
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Rab GTPases Ypt31p/Ypt32p, which is 
homologous to the mammalian Rab11 that 
regulates export from the Golgi apparatus 
(565, 566). When Sec2p is on the vesicle 
membrane it recruits the downstream Rab 
GTPase Sec4p (567). The ability of Sec2p 
to interact with these two Rab GTPases 
in a step-wise process is provided by the 
structural organization of Sec2p. The 
C-terminal region (amino acids 450-
508), designated the localization domain, 
is required for Sec2p to associate to the 
vesicle; the exchange activity for Sec4p is 
localized in the N-terminus region  (amino 
acids 1-160), and the Rab GTPase Ypt32p 
binds to a region localized within these 
two (567, 568). 
Sec15p is a component of the exocyst 
complex that provides the tethering force 
required to bring two membranes into 
close proximity prior to fusion (see next 
section for further details) (569, 570). 
The exocyst is an effector of Sec4p and 
the direct effector of this interaction is 
mediated by the subunit Sec15p (571-573). 
Interestingly, Sec2p also binds to Sec15p, 
which means that Sec2p binds to the Rab 
GTPase and to the effector of the GTPase 
they activate (568). This interaction 
occurs on secretory vesicles and couples 
nucleotide exchange on Sec4p to the 
recruitment of the downstream Sec4p 
effector. These interactions are particularly 
useful to increase signaling specificity 
or to establish a positive-feedback loop 
that maintains a localized domain of 
activated GTPase that would in turn help 
maintain a polarized cell (564). It appears 
that the Sec15p and Ypt32p binding sites 
on Sec2p overlap to some extent (amino 
acids 161-258) and these two proteins 
compete with each other for the binding 
to Sec2p (567, 568). Thus it appears that 
the following sequence of events takes 
place to correctly deliver the vesicle to the 
plasma membrane: Ypt32p-GTP recruits 
Sec2p to the vesicle; the exchange activity 
domain of Sec2p activates Sec4p by 
exchanging the bound nucleotide. Taking 
into count that Sec4p is polarized to the 
cap in a Myo2p-dependent manner and 
that Sec2p is required for the delivery of 
vesicles along actin cables, it appears that 
one of these proteins promotes binding 
of Myo2p-Smy1p to the vesicle, which 
in turn, carries the vesicle along the actin 
cables to the sites of polarized growth 
(547, 562) (Figure 14). Overexpression 
of Ypt32p in a constitutively activated 
form stimulates the interaction between 
Mlc1p and Myo2p (549). As the vesicle 
approaches the site of active membrane 
fusion, Sec15p, which has a higher 
af nity for Sec2p than Ypt32p, displaces 
Ypt32p (568). The interaction between 
the Rab GTPase and its effector Sec15p 
helps establish and maintain a domain 
of highly activated Sec4p on the vesicle, 
which then triggers downstream events. 
After the vesicle is tethered at the plasma 
membrane, the localization domain of 
Sec2p falls back and helps displace bound 
Sec15p, which releases Sec2p for further 
rounds of vesicle transport (574). Sec4p 
in turn relies on two accessory proteins to 
ensure its proper recycling (575). These 
are Gdi1p (GDP dissociation inhibitor) and 
Dss4p (dominant suppressor of the sec4-8 
temperature-sensitive mutation). Gdi1p 
slows down the dissociation rate of GDP 
from Sec4p after hydrolysis has occurred 
on the membrane, and releases the GDP-
bound form from the yeast membranes, 
thus ensuring a soluble pool of Sec4p 
(576). Dss4p in turn is a nucleotide release 
factor that assists the dissociation of GDP 
from Sec4p thus stimulating the activation 
of Sec4p by Sec2p (563, 577).
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5.3 The Exocyst provides the tethering 
force at the plasma membrane
The exocyst complex is an evolutionarily 
conserved multiprotein complex composed 
of eight components, Sec3p, Sec5p, 
Sec6p, Sec8p, Sec10p, Sec15p, Exo70p 
and Exo84p (5, 570, 578, 579). Although 
the yeast and mammalian exocyst 
components share a limited sequence 
homology (17-24%), both complexes 
contain eight subunits and are of similar 
molecular weights (569).  Morphological 
characterization of exocyst mutants 
indicate that this complex functions at 
a step after vesicles have been delivered 
to the site of active membrane fusion, 
but prior to the formation of SNARE 
complexes (570, 571, 580, 581). Exocyst 
mutants typically accumulate a pool of 
secretory vesicles at exocytic sites, which 
supports the notion that the vesicles 
are correctly targeted to the plasma 
membrane, but fail to successfully fuse 
with it. The yeast exocyst is concentrated 
in sub-regions of the plasma membrane 
that correspond to sites of active vesicle 
fusion (581, 582). 
5.3.1 Spatial regulation of the exocyst 
complex
During progress through the cell cycle, the 
exocyst complex changes its localization 
and is found speci cally in the bud tip or 
in the mother/daughter connection, which 
represent regions of active membrane 
growth. Thus, the exocyst complex must 
be capable of integrating itself into the cell 
cycle and re-localizing to the appropriate 
sites on the plasma membrane. One such 
component proposed to function as a 
spatial landmark allowing the proper 
positioning of the exocyst is Sec3p. 
Sec3p appears to be the component of 
the exocyst that is most proximal to the 
plasma membrane and was suggested 
to localize to the plasma membrane 
independently of an ongoing secretory 
pathway and of mutations in the remaining 
exocyst complex (582, 583). However, 
Sec3p many not be the only landmark for 
exocytosis. For example, deletion of SEC3 
yields viable cells at 24oC, so additional 
factors must ensure that the exocyst is 
correctly localized (584, 585). 
One component that has been 
suggested to be responsible for the Sec3p-
independent exocyst localization is Exo70p 
(583, 586). Both Sec3p and Exo70p are 
capable of responding to signals coming 
from the Rho family of small GTP-binding 
proteins, which are master regulators of 
a wide range of cellular processes (569, 
587). Sec3p appears to use a vesicle-
independent mechanism, which appears 
to be dependent on the ability of Sec3p 
to interact with the polarity-establishing 
protein Cdc42p and Rho1p in the activated 
GTP form (582, 586, 588, 589). Both 
Rho1p-GTP and Cdc42p-GTP interact with 
the N-terminus of Sec3p and truncation of 
this binding domain (sec3N), leads to its 
depolarized localization within the cell 
(586, 588). The N-terminus of the exocyst 
component Sec3 also has the ability to 
directly interact with phosphatidylinositol 
4,5-bisphosphate (589). The interaction of 
Sec3p with Cdc42p, which is essential for 
establishment of yeast polarity, and with 
Rho1p, which is important for maintenance 
of polarized growth, may help restrict 
the exocyst and hence exocytosis to the 
sites of polarized cell growth, where 
new plasma membrane components are 
intended to be delivered. The additional 
component that appears to help localize 
the exocyst is Exo70p. Exo70p relies on 
both a vesicle-dependent and on a vesicle-
independent mechanism to be correctly 
placed and is capable of interacting with 
Rho3p (542, 583, 590). The binding region 
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of Rho3p has been mapped to the domain 
C of Exo70p (590), however recent studies 
suggest that the polarized localization of 
the exocyst is not controlled by Rho3p 
(591), and this is further supported by the 
fact that a mutant form of Exo70p that 
does not have the ability to bind to Rho3p, 
exo70-1521, did not display any growth 
defects and neither did the double mutant 
exo70-1521/sec3N (592). The domain 
D, localized in the C-terminus of Exo70p, 
was crucial for its ability to associate to the 
plasma membrane (592). This association 
seems to be mediated between a positively 
charged surface patch of domain D and 
the phosphatidylinositol 4,5-bisphosphate 
[PI(4,5)P2] in the plasma membrane. 
Despite the low sequence homology 
between mammalian and yeast exocyst 
subunits, this C terminal region of Exo70p 
is the most conserved and fulfills the 
same function in mammalian cells (593). 
It appears that Exo70p and Sec3p work 
together to correctly place the exocyst at 
the vesicle/plasma membrane interface. 
Defects in either of these subunits are 
insuf cient to affect membrane targeting 
of the exocyst, and do not give rise to any 
severe growth or secretion defects. But 
when these two are combined, the exocyst 
can no longer be anchored to the plasma 
membrane, resulting in severe growth and 
secretion defects and inviability (592). In 
order to describe the mechanism of vesicle 
tethering we need to understand how 
the exocyst components themselves are 
targeted to the plasma membrane. 
U s i n g  t e c h n i q u e s  s u c h  a s 
FRAP (fluorescence recovery after 
photobleaching), GFP-tagged proteins and 
immunoelectron microscopy, it was shown 
that the yeast exocyst subunits Sec5p, 
Sec6p, Sec8p, Sec10p, Sec15p and Exo84p 
travel to exocytic sites by association 
with exocytic vesicles, transport which is 
dependent on actin cables (571, 582, 583). 
Meanwhile a portion of Exo70p and Sec3p 
become localized to the exocytic regions 
of the plasma membrane by associating 
themselves to patches of activated 
Cdc42p-GTP and Rho3p-GTP (591). The 
association of Rho3p to Exo70p may 
induce structural changes that expose the 
surface patch involved in phospholipids 
binding and thus promote anchoring to 
the plasma membrane (592, 593). At this 
stage the activated patch of Rhop/Cdc42p 
proteins would work as allosteric regulators 
on the initially unpolarized late secretory 
machinery targeting an initial fraction of 
these vesicles to this region of the plasma 
membrane. Since many components of the 
docking and fusion machinery, as well as 
Cdc42p and Rho1p, are associated with the 
secretory vesicles, this would result in the 
reinforcement of allosteric regulation by 
depositing an increased amount of exocyst 
components. The increased docking 
and fusion rates at these sites would be 
expected to lead to the polarization of the 
secretory pathway by an positive feedback 
mechanism (591). This proposed model is 
called the localized activation / allosteric 
model. It suggests that the polarization of 
the secretory pathway is the consequence, 
rather than the cause of ongoing polarized 
delivery of secretory vesicles to the plasma 
membrane. This model suggests that the 
exocyst is locally activated rather than 
sequestered, and functioning as a spatial 
landmark as proposed by the landmark / 
recruitment model (591, 594). 
5.3.2 Function of the exocyst complex
The exocyst complex is essential for the 
ability of secretory vesicles to interact 
with the plasma membrane, in a process 
that is called tethering. This process 
occurs through a physical interaction, at 
some distance, between the vesicle and 
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the target membrane. Tethering events 
occur at a stage after vesicles have been 
delivered by cytoskeletal motors, but 
prior to the engagement of SNARES on 
opposing membranes. This is supported by 
the fact that upon loss of exocyst function, 
secretory vesicles are still delivered to 
exocytic site but SNARE complexes do 
not form and hence fusion is blocked (466, 
562). The working model for assembly of 
the exocyst is that this complex is only 
fully assembled once the vesicles arrive 
at the sites marked by Sec3p and Exo70p 
(583). The component of the exocyst 
that links the complex to the vesicle is 
Sec15p (571). Not only is Sec15p an 
effector of the Rab GTPase Sec4p but it 
also interacts with Bem1p, a downstream 
effector of the Cdc42p-mediated polarity 
establishment pathway, which plays an 
essential role in the initial localization 
of Sec15p to the early bud (571, 595, 
596). Although the yeast exocyst and 
the mammalian exocyst interact with a 
somewhat different set of proteins, the 
primary mechanism and function appears 
to be the same (579, 597). An insight into 
the mechanism of how the exocyst may 
function is provided by availability of the 
structures of some of the exocyst subunit 
domains, namely the C-terminal domains 
of Sec15p, Sec6p and Exo84p, as well as 
nearly full length Exo70p (590, 598-600). 
Despite the very low sequence similarity 
between the different subunits, all of them 
share a similar motif – a tandem repeat of 
helical-bundle units, arranged in a mixed 
antiparallel-parallel right-handed bundle, 
which appear to be packed together in an 
end-on manner, forming elongated rod-
like structures (599, 601). Taking into 
count that the interaction of Exo70p with 
Sec8p and Sec10p are distributed along the 
length of the structure of Exo70p, some of 
the exocyst subunits may pack together 
in an elongated side-to-side fashion 
(590, 601). Images of the mammalian 
exocyst complex have been obtained 
by quickfreeze/Deep-etch EM, under 
conditions where the sample was either 
un xed or pre xed in glutaraldehyde (602). 
In the un xed state, the complex appears 
in different conformations usually as a set 
of 4-6 arms that radiate outwards from a 
central point in an arrangement similar 
to an open  ower (Figure 14). The arms 
are about 4-6 nm in width and 10-30 nm 
in length. For comparison, the elongated 
Exo70p structure is 3 nm by 16 nm (598). 
After  xation, the exocyst adopts a less 
variable structure that assembles the letter 
T or Y, which is composed by an elongated 
body (13 nm wide and 30 nm long) and 
two arms (15 nm and 6 nm) that spread 
outwards and appear to be connected to 
the body by an  exible hinge region (602). 
The change of exocyst structure from 
“open flower” to the “T-Y” shape may 
re ect the normal function of the exocyst. 
In the open conformation the exocyst may 
initially tether the vesicle at long distances, 
but as the subunits pack together in an 
elongated side-to-side fashion, the vesicle 
is drawn closer to the plasma membrane 
where it may promote SNARE complex 
formation and membrane fusion. The 
precise functioning of the exocyst still 
remains to be fully described (601, 602).
In addition to the association of the exocyst 
with the plasma membrane, the exocyst 
is capable of interacting with earlier 
compartments of the secretory pathway. 
Such interactions include for example the 
association of the exocyst with Seb1p, a 
component of the ER translocon (584, 603-
605). In yeast, overexpression of SEB1 
suppressed mutant alleles of the exocyst 
components (604). Overexpression of 
certain exocyst subunits increased overall 
protein synthesis (603). The interaction 
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between exocyst and ER is further 
supported by the fact that a prominent 
patch of Sec61p-GFP is observed at the 
bud tip when Sec3p is overexpressed, 
whereas sec3 cells show a defect in 
inheritance of the cortical ER into the bud 
(584, 606). This association might ensure 
the optimal function of the secretory 
pathway by balancing protein synthesis 
and secretory capacity. In this scenario the 
translocation machinery would modulate 
vesicular transport, and the downstream 
tethering proteins would themselves in 
turn regulate upstream protein synthesis 
by a feedback loop mechanism (605).
5.3.2.1 The exocyst in higher eukaryotes
Although the yeast exocyst and the 
mammalian exocyst interact with a 
somewhat different set of proteins, the 
primary mechanism and function appears 
to be the same, although some notable 
differences should be mentioned (579, 
597). For example in polarized epithelial 
cells the exocyst is required for delivery 
of secretory cargo to the basolateral 
membrane, but apparently not to the 
apical membrane (607).  In neurons, the 
exocyst has been shown to be required for 
neurite branching and syntaptogenesis. 
However, it is not required for synaptic 
vesicle release at mature synapses (608-
610). Additionally the exocyst has also 
been associated to the endocytic-recycling 
pathway that operates between endosomes 
and the plasma membrane and is used 
to return internalized receptors to the 
cell surface (600, 611, 612). Therefore 
it appears that in higher eukaryotes, 
depending on which cell type and in which 
developmental phase they are, the exocyst 
responds to a number of different signaling 
pathways and determines where and when 
vesicles may fuse to the plasma membrane. 
In support of this idea, in animal cells the 
exocyst interacts with a subset of different 
GTPases. For example, Sec15p interacts 
with Rab11p, a Rab GTPase involved in 
the regulation of the recycling pathway 
(600, 613), and Sec10p interacts with 
Arf6p, a small GTP-binding protein of 
the ADP-ribosylation factor family that 
regulates membrane recycling to the 
plasma membrane through the endocytic 
pathway (611); Sec5p and Exo84p both 
interact with the RalA GTPase, which is 
required for regulated exocytosis and for 
neurite branching (610, 614, 615). Exo70p 
is recruited by the G protein TC10 to the 
plasma membrane after insulin activation, 
and this interaction is required for targeting 
of the glucose transporter GLUT4 from the 
adipocytes to the cell surface (616-618).
5.4 SNAREs and the fusion regulation 
machinery 
The yeast exocytic SNARE complex that 
forms at the plasma membrane is composed 
of one molecule each of the Sso1/2p 
t-SNAREs (Qa type), Sec9p t-SNARE 
(Qbc type) and Snc1/2p v-SNAREs (R 
type), which form a fusion complex 
that is conserved throughout evolution. 
Besides the interaction of the exocyst 
with polarity establishment proteins and 
phospholipids of the plasma membrane, 
certain exocyst subunits are also capable 
of interacting either with SNAREs or with 
SNARE regulators. This suggests that the 
exocyst might promote SNARE complex 
assembly, or possibly assist in the process 
of SNARE-mediated membrane fusion 
(564, 619, 620). The  rst observations of 
the exocyst possibly linking tethering and 
fusion events at the plasma membrane 
came from data showing that Sec6p in the 
dimer form is capable of interacting with 
the t-SNARE Sec9p, which in turn inhibits 
the association of the two t-SNAREs Sso1p 
and Sec9p (621). Although the interaction 
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between Sec6p and Sec9p proposes a 
negative regulator function, this is not in 
agreement with the role of the exocyst, 
which has a positive role in SNARE 
complex assembly and membrane fusion. 
The interaction studies between Sec6p and 
Sec9p were performed in the absence of 
Sec6p partners and therefore the scenario 
with the entire exocyst present may be 
different. 
The N-terminal autoinhibitory domain 
of Sso1p, which is capable of folding back 
and forming a stable complex, inhibits 
the binding to its partner t-SNARE Sec9p 
(622, 623). It is thought that this inhibition 
is one of the mechanisms the cell adopts 
to spatially and temporally regulate the 
places where membrane fusion events 
may occur. SNARE complex assembly 
can only occur after relieve of the 
regulation domain, which is thought to 
be released by a regulator/opener that 
localizes to sites of secretion. The exocyst 
complex is one the best candidates as 
regulator of SNARE complex formation. 
It is localized to the sites of active 
membrane fusion, interacts genetically 
with SNAREs and has a function prior 
to SNARE complex assembly (624-626). 
One possible mechanism explaining how 
the exocyst may function, is that upon 
vesicle arrival at the plasma membrane, 
the fully assembled exocyst would interact 
with the SNAREs. At this stage, Sec6p 
would interact with Sec9p and together 
with additional regulatory proteins would 
promote Sec9p-Sso1p assembly, which 
then would lead to the subsequent ternary 
SNARE complex formation (together with 
the v-SNARE Snc1p) and vesicle fusion 
at the plasma membrane (621). Possible 
regulator candidates of the transition from 
tethering to SNARE complex assembly 
are Sec1p, Sro7p and Mso1p (627-629).
5.4.1 Sec1/Munc18-like family: Sec1p
Sec1p is a member of the Sec1/Munc18-
like (SM) family of proteins, which are 
involved in all SNARE-mediated fusion 
events. In yeast, Sec1p is localized to 
the sites of active vesicle fusion and is 
capable of binding to the pre-assembled 
t-SNARE complexes and to the fully 
assembled SNARE complex, with higher 
af nity to the  nal one (628, 630, 631). 
The association of Sec1p with the SNARE 
complexes directly stimulates SNARE-
mediated membrane fusion. For this 
reason it is thought to be a key regulator 
in fusion events at the plasma membrane. 
The exocyst complex is composed of eight 
subunits, three of which (Sec3p. Sec5p 
and Exo70p) appear to be specifically 
involved in regulation of exocyst function, 
by integrating signals originating from 
different signaling pathways within the 
cell. Interestingly, sec3, sec5 and 
exo70 cells are viable and these proteins 
appear not to be essential for growth 
or secretion under conditions where 
the upstream Rab GTPase Sec4p or the 
downstream SNARE-binding fusion 
enhancer protein Sec1p are overexpressed 
(619). Overexpression of Sec1p in these 
cells resulted in an increased level of 
assembled SNARE complexes over the 
wild type levels, suggesting a possible 
mechanism by which the defect in exocyst 
assembly can be compensated (619). Since 
a fraction of Sec1p could be coprecipitated 
with the exocyst (619), and the normally 
polarized distribution of Sec1p is lost 
when the exocyst function is lost (466, 
628), the interaction between exocyst and 
Sec1p may serve to localize and possibly 
activate Sec1p at exocytic sites where it 
can promote the transition from tethering 
to SNARE-mediated vesicle docking and 
fusion.
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5.4.2 Lethal giant larvae family: Sro7p/
Sro77p
A screen for suppressors of the growth 
defect observed in cells with loss of Rho3 
GTPase function identi ed two proteins, 
Sro7p and Sro77p (632). They are yeast 
homologs of the lethal giant larvae (Lgl) 
family of proteins identified as tumor 
suppressors in Drosophila melanogaster 
and implicated in cell polarity in animal 
epithelial cells (633). The  rst functional 
evidence that revealed a direct role of Lgl 
in exocytosis was provided by the ability 
of Sro7p and Sro77p to interact with 
the plasma membrane t-SNARE Sec9p 
(634). This  nding was further supported 
by the fact that Sro7p is found in the 
cell periphery associated to Sec9p, and 
is also associated to the ternary SNARE 
complex formed by Sec9/Sso/Snc (634). 
The fact that sro7/sro77 cells have 
a severe exocytic defect at restrictive 
temperature and act downstream of 
Rho3 GTPase, suggests that members 
of the lethal giant larvae/tomosyn/Sro7 
family play an important role in polarized 
exocytosis by regulating SNARE function 
at the plasma membrane (634). Structural 
analysis of Sro7/Lgl proteins revealed the 
presence of two seven-bladed WD40 -
propellers followed by a 60-residue-long 
‘tail’, which is bound to the surface of 
the amino-terminal propeller, and turned 
out to be a conserved SNARE regulatory 
domain (635-637). The binding site for the 
‘tail’ on Sro7 is largely hydrophilic, which 
suggests that the tail serves a regulatory 
rather than a structural role. Studies on 
the interaction between Sro7p and Sec9 
suggest that Sro7p may exist in two 
conformational states, one where Sro7p 
binds preferentially to the Qbc-SNARE 
domain of Sec9p, and another where this 
domain of Sec9p is displaced by the Sro7p 
tail (636). The decision between which 
state is preferred may be affected by 
factors involved in Sro7p regulation. 
Taking into count the structural 
arrangement of Sro7p, the regulation 
appears to occur by an allosteric 
mechanism, where interactions with 
bound ligands lead to rearrangements 
in the -propeller domain interface, 
which are then propagated to the tail 
(636). One such potential regulator is 
Sec4p, which can directly interact with 
Sro7p. This interaction is dependent of 
the nucleotide state of the Rab GTPase 
(629). Furthermore, a ternary complex is 
formed between Sec4p-GTP, Sro7p and 
the t-SNARE Sec9p, which suggests that 
Sro7p is an effector of the Rab GTPase 
Sec4p and may act in parallel to the 
exocyst to promote SNARE complex 
formation or SNARE-mediated fusion 
in response to Sec4-GTP (629). In yeast, 
Sro7p and Sro77p are also capable of 
interacting with the exocyst subunit 
Exo84p, and this interaction may promote 
SNARE-mediated membrane fusion at 
speci c regions of the plasma membrane 
(638).  Genetic data collected on Sro7p 
suggest that this member of the Lgl family 
has many of the properties required of a 
key downstream effector in transmitting 
Rab GTPase function onto the SNARE 
assembly process (629, 634, 638). Thus it 
appears that Sec4p, Sro7p and Sec1p work 
in concert with the exocyst to ensure that 
the vesicle fuses correctly with the plasma 
membrane. This regulatory mechanism 
is further supported by the finding that 
overexpression of Sec4p, Sro7p and 
Sec1p, which enhance SNARE-mediated 
function, can overcome the partially 
defective exocyst complex in sec3 and 
exo70 cells (619, 629, 638). Suppression 
by Sec4p, however, requires that its 
downstream effector Sro7p/Sro77p is 
fully functional. Meanwhile Sec1p, which 
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works downstream or independently of 
Sro7p, does not require Sro7p (629).
5.4.3 The multicopy suppressor of Sec1p 
Mso1p
Mso1p was found in a screen for 
suppressors of the temperature-sensitive 
mutation sec1-1, and was found to directly 
interact with Sec1p (639). Deletion of 
MSO1 yielded viable haploid cells with 
no obvious growth phenotypes except a 
mild accumulation of secretory vesicles 
in the small bud tip (639, 640). Deletion 
of MSO1 in diploid cells resulted in 
sporulation defects, namely in formation 
of the prospore membrane, which is the 
precursor of the spore membrane, forming 
on the cytoplasmic side of the spindle 
pole bodies (641-643).  In addition to the 
association of Mso1p to Sec1p, Mso1p is 
capable of interacting with the SNARE 
complex, Sec15p and it appears to 
functionally interact with Sec4p GTPase 
and its exchange factor Sec2p (642). 
Although the precise function of Mso1p is 
not fully understood, the set of interacting 
partners of Mso1p places it in the interface 
between the exocyst complex and the 
exocytic SNARE machinery (Figure 
14), where it may bridge the connection 
between Rab GTPase and Sec1p function 
facilitating the binding of Sec1p to the 
SNARE complex prior to membrane 
fusion (627, 642). On the other hand, 
overexpression of MSO1 inhibited growth 
of sec4-8, sec8-9 and sec15-2 mutants 
even at permissive and semirestrictive 
temperature, which suggest that Mso1p 
may have a second role in attenuating Sec4p 
function (627). One model for the function 
of Mso1p in secretory vesicle membrane 
fusion would be that it coordinates the 
recruitment and subsequent removal of 
Sec1p in response to the GTPase cycle 
of Sec4p (627). According to this model, 
the pair Mso1p-Sec1p is recruited by 
activated Sec4-GTP to the assembling 
v-SNARE and t-SNARE complexes, 
formed between membranes tethered by 
the exocyst complex. GTP hydrolysis 
on Sec4p would trigger dissociation of 
Mso1p and Sec1p from the preassembled 
trans-SNARE complex, leading to full 
SNARE assembly and membrane fusion. 
In support of the regulatory function 
of Mso1p, local sequence alignments 
revealed that the C-terminus of Mso1p is 
highly homologous to the Munc13/Mint 
family members of SNARE regulators, 
and that this region is required for proper 
localization of Mso1p to the plasma 
membrane (627, 642). Both Mso1p and 
Munc-13 members are connected with 
exocytosis, interact with Sec1p/Munc18p 
and with the SNARE complex (15, 644). 
Furthermore, in Caenorhabditis elegans 
and in Drosophila melanogaster UNC13/
Munc13 displaces Unc18/Munc18 from 
the SNARE complex prior to exocytosis 
(644-646). Therefore, the role of Munc13 
and Munc18 proteins in SNARE-mediated 
fusion corresponds well with the binding 
of Mso1p and Sec1p to yeast SNAREs 
and the proposed regulatory mechanism.
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AIMS OF THE STUDY
The aims of the present study was to elucidate whether Hsp150 is capable of entering 
parallel or alternative post-ER routes in the yeast secretory pathway. 
First the role of the COPII coat member Sec24p and its two homologues Sfb2p 
and Sfb3p in ER exit of Hsp150 was elucidated. Second, the dependence of Hsp150 
secretion in post-Golgi secretory mutants was studied as well as the structural signatures 
that guided Hsp150 to these alternative pathway. In addition we also wanted to further 
clarify the role of the exocyst components and accessory regulatory proteins.
While searching for the signature that guided Hsp150 exit in the yeast secretory 
pathway, we found that Hsp150 was capable of working as a carrier, allowing the fused 
protein to proper fold and be secreted. Therefore we explored the potential of using 
Hsp150 as a carrier for the expression of recombinant heterologous proteins in both S. 
cerevisiae and P. pastoris. The same technology was to be used in the development of a 
staining procedure to be used to visualize secretory organelles at the electron microscopy 
level.
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MATERIALS AND METHODS
A summary of the experimental methods used in this study, together with the references 
to the respective publications in which they are described can be found in Table 1. The 
yeast strains used in this study are listed in Table 2, together with the publications in 
which they are described. Table 3 highlights the relevant features of the yeast mutants 
used. A schematic representation of the recombinant proteins used throughout this study 
can be found in Figure 15. 
Method Publication
-lactamase activity assay II, III
Calco uor staining of bud scars I
Fermentationof yeast cells III
Immunoprecipitation I, II
Invertase activity assay II
Invertase activity staining in non-denaturing gels I, II
Metabolic labeling of proteins I, II
Nucleotide sequencing I, II
Plasmid constructions I, II, III
HRP staining method developed for yeast electron microscopy I, II
Scanning electron microscopy I
SDS-PAGE I, II, III
Secretory vesicle analysis by density gradients II
Subcellular fractionation II
TCA precipitation of secretory proteins II
Transmission electron microscopy I, II
Western blot analysis I, II, III
Yeast mating and tetrad dissection I, II
Yeast strain construction I, II, III
Yeast transformation I, II, III
Table 1. Experimental methods used in this study
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Table 2. Yeast strains used in this study
Strain Relevant mutant genotype Used in Publication Source/reference
Control cells
H1 None I R.Schekman
H245 None I, II K. Kuchler & J. Thorner
H247 None I, II K. Kuchler & J. Thorner
H335 URA3::Hsp150-lactamse II Simonen et al., 1994
H1718 LEU2::Hsp150HRP II This study
H306 hsp150 II This study
H2260 sec15-1 SEC15 II This study
ER to Golgi transport
H1101 sec24-1 I C. Kaiser
H1735 sec24-1 LEU2::Hsp150-HRP II This study
H1866 sec24::kanMX4/SEC24 I Euroscarf
H1914 sec24-1/SEC24 sfb3/SFB3 sfb2/SFB2 I Karhinen et al., 2005
H1895 sec24-1 sfb3 I Karhinen et al., 2005
H1930 sec24-1 sfb3 sfb2 I Karhinen et al., 2005
H1927
sec24 URA::SEC24-HIS6 LEU2::PCM244 
CEN
I Karhinen et al., 2005
H1996
sec24 URA::SEC24-HIS6 LEU2::PCM244 
CEN sfb3
I Karhinen et al., 2005
H2025
sec24 URA::SEC24-HIS6 LEU2::PCM244 
CEN sfb2
I Karhinen et al., 2005
H2023
sec24 URA::SEC24-HIS6 LEU2::PCM244 
CEN sfb3 sfb2
I Karhinen et al., 2005
H1141 sec24b (sfb2) I J.P. Paccaud
H1142 sec24c (sfb3) I J.P. Paccaud
H2006 sfb3sfb2 I Karhinen et al., 2005
H4 sec18-1 II R.Schekman
H1735 sec18-1 LEU2::Hsp150-HRP II This study
Intra-Golgi transport and trans-Golgi sorting
H3 sec7-1 II R.Schekman
H1732 sec7-1 LEU2::Hsp150-HRP II This study
H10 sec7-1 II R.Schekman
H1734 sec7-1 LEU2::Hsp150-HRP II This study
H206 sec14-3 II This study
H1720 sec14-3 LEU2::Hsp150-HRP II This study
H815 vps10::HIS3 II Scott Emr
H2335 vps10::LEU2 II This study
Endosomal / Vacuolar pathway
H2079 vps1::LEU2 II A. Chang
H2077 vps8::LEU2 II A. Chang
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Tethering of Secretory vesicles / Exocyst regulation
H211 sec2-56 II R.Schekman
H213 sec4-2 II R.Schekman
H212 sec3-1 II R.Schekman
H214 sec5-24 II R.Schekman
H216 sec8-6 II R.Schekman
H2129 sec10-2 II P. Novick
H2074 sec6-4 II P. Novick
H2253 sec6-4 LEU2::Hsp150-lactamase II This study
H2255 sec6-4 LEU2::Hsp150HRP II This study
H2409 sec6-4 vps1::LEU2 II This study
H2075 sec15-1 II P. Novick
H2087 sec15-1 LEU2::Hsp150-lactamase II This study
H2257 sec15-1 LEU2::Hsp150HRP II This study
H2182 sec15-1 mso1::URA3 II This study
H2319 sec15-1 mso1::URA3 LEU2::Hsp150HRP II This study
H2188 sec15-1 mso1::LEU2 II This study
H2336 sec15-1 vps10::LEU2 II This study
H2328 sec15-1 vps1::LEU2 II This study
H2356 sec15-1 vps8::LEU2 II This study
Fusion of secretory vesicles with the plasma membrane
H2 sec1-1 II R.Schekman
H217 sec9-4 II R.Schekman
H2181 mso1::URA3 II This study
H2316 mso1::URA3  LEU2::Hsp150HRP II This study
H2187 mso1::LEU2 II This study
Actin cytoskeleton
H2311 tpm1::LEU2 II A. Bretsher
H2312 srv2::HIS3 II D.G. Drublin
Pichia pastoris strains
P714 Control III Invitrogen
P1405 Hsp150-Kex2p--Lactamase III This study
P1407 MF-Kex2p--Lactamase III This study
P1402 Hsp150-ST3Ne III This study
P1403 MF-ST3Ne III This study
P1476 Hsp150-Kex2p--NGFR III This study
P1477 MF-Kex2p--NGFR III This study
P1478 Hsp150-Kex2p--TRAP III This study
P1479 MF-Kex2p--TRAP III This study
Table 2 continuing
Materials and Methods
74
Mutation Description of gene product Phenotype Reference
sec24-1 Component of the COPII coat. Role in cargo 
selection. Required for recruitment of the 
Sec13/31 complex to ER membranes
Defect in formation of 
COPII coat leading to ER 
accumulation
Hicke et 
al.,1992
sec24b/
sfb2/lss1
SEC24 family member. Mutant phenotype 
found only in combination with other 
mutants. 
Altered ER to Golgi 
transport when in 
combination with other 
mutants
Peng et al., 
2000
sec24c/
sfb3/lst1
SEC24 family member. Secretion defect 
observed at elevated temperatures.
Growth and Pma1p 
secretion defects observed 
at elevated temperature
Roberg et 
al., 1999
sec18-1 ATPase required for the release of Sec17p 
during the priming step of vesicle fusion. 
Vesicles cannot fuse to 
their target membane. ER 
accumulation
Kaiser & 
Schekman, 
1990
sec7-1 GEF for ADP ribosylation factores. Required 
for ER to Golgi and Intra-Golgi transport
Protein accumulation in ER 
and Golgi. Formation of 
Berkley bodies
Franzusoff & 
Schekman, 
1989
sec14-3 PI/PC transfer protein involved in 
phospholipid metabolism. Regulates Golgi 
to PM transport
Protein transport from the 
trans-golgi is inhibited
Hama et 
al.,1999
vps10 Transmembrane sorting receptor. Required 
for proper targeting of CPY to the vacuole
CPY is not targetted to the 
vacuole. Secretion of CPY 
to the medium
Marcusson 
et al., 1994
vps1 Dynamin-like GTPase. Required for protein 
targeting from the Golgi to the vacuole
Golgi to endsome traf c is 
blocked. Proteins normally 
targetted to the vacuole via 
endosome are secreted
Vater et al., 
1992
vps8 Membrane protein that interacts with the 
small GTPase Vps21p.  Required for 
protein transport from the late endosome to 
vacuole
Endosome to vacuole 
traf c is blocked
Chen et al., 
1996
sec2-56 Sec4 GEF. Essential for post-Golgi 
secretory vesicle transport
Unpolarized secretory 
vesicle accumulation
Walch-
Solimena et 
al., 1997
sec4-2 Secretory vesicle associated RabGTPase. 
Required for proper delivery of the vesicle 
to the sites of membrane fusion
Unpolarized secretory 
vesicle accumulation
Goud et al., 
1988
sec3-1
sec5-24   
sec6-4
sec8-6   
sec10-2 
sec15-1   
Exocyst subunits. Required for tethering 
of secretory vesicles to the sites of active 
membrane fusion on the plasma membrane
Accumulation of secretory 
vesicles at the sites of 
active membrane fusion
Novick et 
al., 1980
sec1-1
Binds to assembled SNARE complexes. 
Required for docking and fusion of exocytic 
vesicles. 
Secretory vesicle 
accumulation
Novick & 
Schekman, 
1979
sec9-4 PM t-SNARE. Important for fusion of secretory vesicles
Secretory vesicle 
accumulation
Brenwald et 
al., 1994
mso1
Possible component required for vesicle 
docking. Interacts with Sec1p and SNAREs. 
Required for prospore membrane formation
Secretory vesicle 
accumulation in the 
small bud. Required for 
sporulation
Aalto et al., 
1997
tpm1 Binds and stabilizes actin cables and  laments Loss of actin cables
Liu et al., 
1992
Table 3. Relevant defects of the mutants used in this study
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Figure 15. Hsp150 and Mating factor  constructs used in this study. 
Materials and Methods
76
RESULTS AND DISCUSSION
1. Role of the family members of 
the COPII coat component Sec24p 
in ER exit of Hsp150 (I)
The HSP150 gene and its products, were 
first identified and characterized in our 
laboratory in 1992 (647). Hsp150 is a 
secretory glycoprotein expressed in several 
yeast strains, like S. cerevisiae, P. pastoris 
(647-653). It consists of a cleavable signal 
peptide of 18 amino acids, subunit I and 
subunit II (Figure 15). The two subunits 
are separated by a Kex2p recognition 
site, which is presumably cleaved in 
the late-Golgi, yielding two subunits, 
(SUI of 54 amino acids and SUII of 341 
amino acids) that remain noncovalently 
attached to each other. Subunit II contains 
a repetitive region of 11 tandem repeats 
of mostly 19 amino acid peptides, and 
a unique C-terminal region containing 
four cysteine residues, which form at 
least one disul de bond (647-649, 651). 
Hsp150 lacks any N-glycosylation sites 
but is extensively O-glycosylated (647). 
The HSP150 gene is constitutively 
expressed, however the promoter of the 
HSP150 gene includes heat-inducible 
elements (heat shock elements, HSE) and 
accordingly, the expression of HSP150 
is upregulated by shift of the cells from 
physiological temperature 25oC to heat 
shock temperature 37oC (647, 648). 
Hsp150 was found to be secreted to the 
culture medium with a half-time of about 
2 minutes in wild type S. cerevisiae 
(647, 649).  We have previously found 
that normal function of Sec13p was not 
required for ER exit of the Hsp150 (654). 
Sec13p is a functional component of the 
COPII coat and is thought to be required 
for vesicle formation at the ER membrane 
and therefore essential for protein transport 
from the ER to the Golgi. Sec13p function 
is linked to Sec31p where together they 
can self-assemble into a cytosolic cage 
and possibly function as an scaffold agent 
recruiting the Sec23p/24p-cargo to the 
emerging vesicle. We also found that the 
C-terminal domain of Hsp150 harbors an 
active mediator of Sec13p-independent 
secretion, and when fused to invertase was 
capable of recruiting invertase out of the 
ER (654). Since Sec24p functions as the 
cargo selection subunit of the COPII coat, 
we were interested in exploring the role of 
Sec24p and its two homologues Sfb2p and 
Sfb3p, in the exit of proteins from the ER.
1.1 Hsp150 is secreted in the absence of 
functional Sec24p family proteins
Sec24p is an integral component of the 
COPII coat, which has thought to be 
essential in the formation of functional 
COPII-coated vesicles that emerge at 
the ER membrane, and transport cargo 
to the next compartment of the secretory 
pathway, the Golgi. Incubation of the 
temperature sensitive strain S. cerevisiae 
sec24-1 at 37oC turns this component of 
the COPII dysfunctional, and ER exit of 
CPY and invertase is blocked under these 
conditions (655). To verify the block in 
ER exit, CPY pulse chase experiments 
with [35S]-methionine/cystein were carried 
out under the permissive temperature 
(24oC) and restrictive conditions (37oC), 
whereafter cell lysates were analyzed by 
immunoprecipitation with CPY antiserum 
(655). At 24oC the vast majority of CPY 
was detected in the mature form as soon 
as 10 minutes after chase. At 37oC, CPY 
remained in the ER-specific p1 form 
even after chase periods up to 120 min. 
In order to follow invertase, the sec24-1 
cells were shifted to low glucose medium 
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to derepress the synthesis of invertase, 
followed by incubation either at 240C or 
370C (655). Under permissive conditions, 
invertase was secreted to the periplasmic 
space, because it was detected by non-
denaturating gel electrophoresis in the 
periplasmic space in the mature form, i.e. 
with similar mobility as control cells. In 
contrast, at the restrictive temperature, 
invertase remained intracellular and in 
the ER-speci c form co-migrating with 
invertase blocked in the ER at 370C in 
sec18-1 cells. When the experiment was 
repeated at 370C in sec24-1 cells Hsp150 
exited the ER and was ef ciently secreted 
(655). After immunoprecipitation of cell 
lysates and culture medium samples using 
Hsp150 antiserum, the majority of the 
signal was found to reside in the culture 
medium and due to the mature form of 
Hsp150 (655). Therefore, while CPY and 
invertase accumulated in the ER under 
conditions where the Sec24p function 
was impaired, Hsp150 was selectively 
exported to the medium.
1.1.1 Hsp150 is secreted in sec24-1 
sfb2 and sec24-1 sfb3 mutants
In this previous study, the roles of Sfb2p 
and Sfb3p, the two homologues of Sec24p 
in ER exit of Hsp150, was not addressed. 
Cells lacking either of these genes or 
both of them, are viable and have no 
observable phenotype. However there is a 
possibility that in the absence of Sec24p, 
Sfb2p or/and Sfb3p may contribute to the 
formation of the COPII coat, and therefore 
be functionally redundant. Indeed in 
vitro, both of these members are capable 
of forming COPII vesicles when Sec24p 
was missing, but the size of the vesicles 
and the nature of the cargo selectively 
incorporated into them appeared to differ 
from Sec24p COPII-coated vesicle (151, 
152). To verify if Sfb3p was responsible 
for the exit of Hsp150 in the absence of 
functional Sec24p, the double mutants 
sec24-1 sfb2p and sec24-1 sfb3p were 
constructed, and secretion of Hsp150 was 
followed by pulse-chase experiments. 
Immunoprecipitation experiments with 
Hsp150 antiserum revealed that Hsp150 
was efficiently secreted in the double 
mutants, and with kinetics similar to the 
sec24-1 strain (I, Figure 2A and Fig 7 
of (655)). During the chase period, the 
apparent molecular weight of the ER 
form of Hsp150 increased from 86 to 105 
kDa. This was due to O-glycan extension, 
carried out in the ER by Golgi mannosyl-
transferases that normally recycle between 
the Golgi and the ER, but became trapped 
in the ER in COPII mutants (656). Thus, 
it appears that Sfb2p and Sfb3p are 
dispensable for ER exit of Hsp150 in the 
absence of functional Sec24p. 
To verify that ER exit of Hsp150 
was the result of active and specific 
recruitment rather than to bulk flow, 
the fate of two other reporter proteins 
known to be dependent of Sec24p was 
followed. Pulse-chase analysis of cell 
lysates using CPY antiserum showed that 
after approximately two hours, CPY still 
persisted in the ER p1 form (67 kDa) in 
the double mutants sec24-1 sfb3 and 
sec24-1 sfb3, and in the parental sec24-
1 cells, and failed to evolve to the p2 
Golgi form (69 kDa) or mature form (62 
kDa) (I, Figure 3B). The overall intensity 
of the CPY ER-speci c form decreased 
with chase time, and this coincided with 
the appearance of an unreported 59 kDa 
form, which was not detected in sec18-
1 cells which accumulate CPY in COPII 
vesicles due to the incapacity of fusing 
to the Golgi membrane. We suspect that 
the faster migrating molecules represent a 
partially degraded form of CPY. 
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Next we followed the maturation 
of Gas1p under the same conditions 
described previously. Gas1p is a 
glycolipid-anchored plasma membrane 
protein whose exit from the ER is slowed 
down in cells lacking Sfb3p (153, 657, 
658). Immunoprecipitation experiments 
using Gas1p antiserum revealed that 
Gas1p was translocated into the ER 
(86 kDa) and acquired glycans in both 
the parental sec24-1 strain as in the 
double mutant sec24-1 sfb3 but failed 
to achieve the mature form (92 kDa) 
detected under permissive temperature 
(I, Figure 3A). To further study whether 
Hsp150 was the only protein secreted to 
the culture medium in sec24-1, sec24-1 
sfb2 and sec24-1 sfb3 under restrictive 
conditions, TCA precipitates of culture 
medium samples of 35S-labelled cells were 
analyzed by SDS-PAGE. One protein, 
of 150 kDa corresponding to the mature 
form of Hsp150, was detected in the 
culture medium (unpublished data). This 
suggests that no other proteins, detected 
under our experimental conditions, were 
secreted in these cells. We therefore 
concluded that neither Sfb2p nor Sfb3p 
compensated for the nonfunctional 
Sec24p in ER exit of Hsp150. Under these 
conditions, functional transport vesicles 
were still generated at the ER membrane 
and delivered, at least Hsp150 cargo, to 
the next compartment of the secretory 
pathway.
1.1.2 Hsp150 is secreted under 
conditions where all Sec24p family 
proteins are absent
Since deletion of SFB2 or SFB3 had no 
severe effect on the secretion of Hsp150 
in the sec24-1 background, and to ensure 
that the possible third member of the 
family was not compensating in the 
double mutants, we set out to construct 
the triple mutant sec24-1 sfb2 sfb3. 
The strain was viable but had a very long 
generation time (6,5 h) when compared 
to the parental sec24-1 (3 h) and to the 
double mutants sec24-1 sfb2 and sec24-
1 sfb3 (4 h). Immunoprecipitation of 
Hsp150 from lysates and culture medium 
samples of the triple mutant revealed that 
Hsp150 was capable of exiting the ER 
even in the absence of all three family 
members, albeit slowly. Under these 
conditions proteins corresponding to the 
mature form of Hsp150 could be observed 
in the culture medium as early as after 15 
min of chase. After 2 hours, approximately 
45% of Hsp150 had been exported from 
the ER (I, Figure 5). Therefore it appears 
that Sfb3p and Sfb2p are not required 
for ER exit of Hsp150 in the sec24-1 
background. In the above experiments we 
used sec24-1, where the last 35 C-terminal 
amino acids of Sec24p(ATLRLWASST
LVEDKILNNESYREFLQIMKARISK) 
are replaced by an unrelated 8 amino acid 
peptide (VNAKTMGF). Therefore, it 
could be possible that the mutated Sec24 
protein still allowed the formation of 
semi-functional COPII-coated vesicles 
that could eventually allow the ER exit of 
Hsp150. To address this issue we decided 
to construct a strain that lacked the SEC24 
gene. To overcome the fact that deletion 
of SEC24 is lethal, a mutant strain lacking 
the original SEC24 gene but carrying 
SEC24 under a controllable tetracycline-
regulated dual system promoter was used. 
In the absence of tetracycline, the tetO 
promoter expresses SEC24, however 
when cells are grown in the presence of 
tetracycline (or its derivative doxycycline), 
tetracycline-activable repressor elements 
bind to the promoter and expression of 
SEC24 is turned off (659). To follow the 
expression of SEC24 and find out the 
optimal time period where no Sec24p is 
Results and Discussion
79
present, but protein synthesis goes on, 
an epitope-tagged version of Sec24p was 
used. Results collected from the assays of 
depletion of Sec24p-HA versus protein 
synthesis revealed that after 24 hours of 
addition of doxycycline, Sec24p-HA had 
been completely depleted as tested by 
Western blot assay using anti-HA antibody 
(I, Figure 6). Under these conditions, 
Hsp150 was still ef ciently synthesized as 
could be veri ed by immunoprecipitation 
35S- Hsp150 (I, Figure 7).
To analyze the in uence of complete 
absence of Sec24p on ER exit of Hsp150, 
the sec24 cells were incubated for 
24 hours in the presence or absence of 
doxycycline to turn off expression of 
SEC24-HA. At this stage cells were shifted 
to 37oC and labeled with [35S]-methionine-
cystein. The pulse chase experiment 
revealed that secretion of Hsp150 to the 
medium in the absence of the antibiotic 
was very ef cient (I, Figure 7A). In the 
presence of the antibiotic, Hsp150 could 
be secreted to the culture medium (I, 
Figure 7C). After 15 min of chase a small 
amount of Hsp150 was detected in the 
culture medium, and after 1 hour, about 
40% was detected. The secretion kinetics 
of Hsp150 in the absence of Sec24p were 
slightly slower than in sec24-1 cells. But 
the experimental conditions were also 
different, so no direct relationship between 
these two independent experiments could 
be done. To verify that secretion of 
Hsp150 was speci c, CPY and invertase 
were studied. Under the same conditions 
as above, in the presence of doxycycline, 
CPY remained in the ER after 2 hours 
chase (I, Figure 8A). Similarly, after 
incubation of cells in the presence of 
doxycycline for 24 hours and shift to low 
glucose conditions, invertase remained 
quantitatively in the ER (I, Figure 8B). 
Thus it appears that Hsp150 was secreted 
to the culture medium in cells lacking 
Sec24p, while two other exocytic proteins, 
invertase and CPY, remained trapped in 
the ER. 
After establishing the conditions in 
which Sec24p was absent, we set out to 
investigate the role of its two homologues 
Sfb2p and Sfb3p. For this purpose we 
constructed strains lacking either or 
both of the homologues in the sec24 
background. Secretion analysis was 
carried out as previously and the same 
controls were used. Secretion of Hsp150 
in sec24 sfb2p and sec24 sfb3p cells 
was similar to that in the parental sec24 
strain (data not shown). In sec24 sfb2p
sfb3p cells, a small fraction of Hsp150 
was secreted to the culture medium, as 
early as 15 min, and this fraction increased 
up to 30% after 2 hours of chase (I, 
Figure 7E). Taking into count that under 
the same experimental conditions CPY 
and invertase remained trapped in the 
ER (I, Figure 8) it appears that all Sec24 
family proteins are dispensable for ER 
exit of Hsp150. The decrease in Hsp150 
secretion kinetics in the sec24 and 
sec24psfb2psfb3p mutants may be 
the result of a diminished Golgi complex 
as a result of the continuous Golgi-to-
ER traf c mediated by COPI retrograde 
traffic, which gradually depletes the 
Golgi membranes and hence the secretion 
capacity of Hsp150.
1.2 Deletion of all SEC24 family genes 
results in morphological changes 
within the cell
Due to the proposed role of the Sec24p 
family members in ER exit of secretory 
cargo we set out to study the subcellular 
morphology of the mutants. Deletion of 
SFB2 or SFB3 individually in the sec24-
1 background yielded viable cells with 
a slightly prolonged generation time. 
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Deletion of both SFB2 and SFB3 from 
sec24-1 cells also gave viable cells, but 
with a very long generation time. First we 
analyzed the overall shape of the mutants 
by scanning electron microscopy (SEM) 
at the permissive temperature 24oC. 
Structural abnormalities were observed 
in sec24-1 sfb3 cells, as compared to 
parental strain sec24-1 (I, Figure 1A). The 
double mutant was irregularly shaped with 
small depressions in the cell surface. Bud 
scars appeared to be localized on opposite 
sides, whereas in the parental strain they 
were adjacent to each other. Calcofluor 
staining and confocal image analysis 
revealed that in the double mutant, bud 
scars were randomly distributed around the 
cell surface (I, Figure 1B). Furthermore, 
the triple mutant sec24-1 sfb2p sfb3p 
revealed an even more severe phenotype 
(I, Figure 4A and B). These cells displayed 
an irregular shape; the cell wall appeared 
collapsed and had even more severe 
depressions. A signi cant number of cells 
had undetached daughter cells. These 
cells also displayed a random budding 
pattern (I, Figure 4B). Interestingly, 
deletion of SFB3, SFB2, or even both, in 
a cell carrying a normal copy of SEC24 
yielded no defects in the budding pattern. 
Therefore, it appears that the combination 
of sec24-1 with either sfb3p or sfb2p 
sfb3p, but neither deletion alone, resulted 
in a random budding pattern observed.  
Next, the cells were incubated 
for 1 hour at the permissive (24oC) or 
restrictive (37oC) temperature prior to 
fixing and processing for transmission 
electron microscopy (TEM) (II). The 
parental sec24-1 strain at both 24oC and 
at 37oC displayed no severe ultrastructural 
abnormalities (I, Figure 1C-1 and C-
2). At both temperatures, structures 
corresponding to what appears to be a 
cluster of vesicles surrounded by a coat 
were detected. In sec24-1 sfb3 mutants 
incubated at the permissive temperature 
displayed some proliferated ER (I, Figure 
1C-3). Incubation of these cells at 37oC 
further increased this phenotype, and ring-
like structures that appear to be composed 
of 1 to 3 layers of membranes juxtaposed 
to each other were also detected (I, Figure 
1C-4). None of these structures were 
observed in the parental sec24-1 cells. 
Analysis of the triple mutant sec24-1 sfb2 
sfb3 revealed severe morphological 
defects that supported the observations 
collected from the SEM analysis (I, 
Figure 4C). At the permissive temperature 
segments of cell wall projecting into the 
cytosol, indicative of abortive daughter 
cell budding were detected. This was 
further supported by the finding of 
multiple or fragmented nuclei within the 
same cell. Alternatively, the abnormal cell 
shape may cause unusual shapes of the 
nuclei, which in thin sections appear as a 
fragmented nucleus. In addition, the cell 
wall depressions detected previously by 
SEM were detected as donut shape cells 
(data not shown). 
The triple mutant sec24-1 sfb2 
sfb3 ,  had already at  24oC ER 
proliferations, similar to the double mutant 
sec24-1 sfb3 and this phenotype was 
further exacerbated after shift of the cells 
to the restrictive temperature (I, Figure 
4C). Extensive ER accumulation was 
observed throughout the cell and multiple 
ER membranes (4 to 8) were detected 
closely to each other, positioned in a 
stack-like manner (I, Figure 4C-3). They 
appeared to extend throughout the cell and 
make connections with cortical ER. This 
suggests that the Sec24p family members 
are involved in ER-to-Golgi traf c, and 
have overlapping functions in export of 
secretory cargo from the ER.
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One additional observation that 
deserves to be mentioned is that the 
depressions observed in the SEM samples 
of sec24-1 sfb3 and sec24-1 sfb2 
sfb3 cells, in cells in early logarithmic 
growth phase, were also observed in 
control cells grown to late stationary 
phase and therefore were in senescence. 
Interestingly, aged cells also appear to 
have fragmented nucleolus, display a 
symmetrical cell division and increased 
generation time and cell size (660, 661). 
All of these aging symptoms were also 
observed in sec24-1 sfb3 and sec24-
1 sfb2 sfb3 cells at the permissive 
temperature in early logarithmic phase. 
How exactly the Sec24 proteins in uence 
the aging of yeast cells is unknown. It is 
known that deletion of SFB2 and SFB3 
reduces the cargo repertoire selected into 
the COPII-coated vesicles. Hence proteins 
such as the plasma membrane ATPase 
(Pma1p), the GPI-anchored protein Gas1p, 
invertase, CPY and alkaline phosphatase 
(ALP) are blocked or display show delay 
in ER exit (151, 153-155). Therefore one 
possibility for the early aging phenotype 
may be that the Sec24 proteins and 
perhaps other proteins not yet identi ed, 
may play an important role in the normal 
yeast life cycle by affecting either the cell 
wall stability or intracellular regulatory 
mechanisms.
1.3 Hsp150 secretion and formation 
of the carrier in the absence of Sec24p 
family members
In summary we have shown that the 
soluble secretory glycoprotein Hsp150, is 
secreted under conditions in which other 
secretory cargo proteins remain trapped 
in the ER. This suggests that sorting of 
Hsp150 is selective rather due to bulk 
 ow. Since Hsp150 is a soluble protein, 
and the coat components are cytosolic 
proteins, it has to interact with a putative 
transmembrane receptor, for ER exit to 
occur. The sorting signal responsible for 
the selective ER exit of Hsp150 in the 
absence of Sec24p family members was 
mapped to the C-terminal domain of 
Hsp150 (Figure 15, amino acids 299-413). 
The same region of Hsp150 has also been 
shown to mediate Sec13p-independent 
ER exit (654). This transmembrane 
adaptor protein may possibly have on 
its cytosolic side, ER exit motifs, which 
ensure its active packaging into COPII-
coated vesicles, similar to what is found 
for Emp24p. Emp24 together with Erv25p 
forms a heteromeric transmembrane 
protein complex, and mediates the active 
incorporation of Gas1p into COPII vesicles 
(662, 663). Emp24p/Erv25p heteromeric 
complex cycles between the ER and the 
Golgi, where it is capable of binding to 
both coat proteins and cargo molecules, 
thus mediating their active incorporation 
into the COP vesicles. Emp24p and 
Erv25p have a di-aromatic motif on their 
cytoplasmic sequences that bind to COPII 
coat subunits and promote their export 
from the ER. The Erv25p tail sequence, 
which binds to COPI coat subunits, is 
responsible for returning this complex to 
the ER (662). Since Hsp150 contains one 
signature for ER exit in COPII mutants 
and another for ER exit in COPI mutants, 
perhaps more than one cargo receptor 
exist for Hsp150. In ongoing work in 
our laboratory, candidates for an Hsp150 
receptor are being searched for.
In vitro, the minimal components 
required to drive the formation of the 
COPII coated vesicle are Sar1p, Sec23p/
24p complex and Sec13p/Sec31p complex 
(127, 161). Sec24p is thought to act as the 
cargo sorting subunit of the COPII coat 
(145). However, Sec24p is not absolutely 
indispensable, since vesicles can still be 
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generated in the mutant sec24 strain. 
Under these conditions the homologues 
Sfb2p and Sfb3p compensate. But 
these vesicles only contain a subset 
of the cargo proteins packaged into 
Sec24p containing vesicles (151-155). 
Furthermore, Sfb3p generated vesicles are 
not capable of packaging SNARE proteins 
and can therefore not fuse with the 
Golgi membrane. In normal cells, these 
homologues may co-exist with Sec24p 
in the formation COPII-coated vesicles, 
and thus extend the repertoire of the cargo 
sorting machinery. So how can an ER-
derived carrier vesicle be formed in the 
absence of all Sec24p family members? 
Perhaps in vivo, unusual transport vesicles 
are formed in such conditions, which 
are still capable of recruiting Hsp150, 
but do not recruit other secretory cargo. 
We would however like to suggest some 
possible mechanisms for how ER export 
may possibly be mediated in the absence 
of Sec24p family proteins. In the first 
model, an incomplete COPII coat might 
be formed, where the Sec23p binding 
partner, Sec24p would be missing. This 
coat could possibly be temporarily 
stabilized by Sec16p, which is capable of 
interacting with Sec23p and with Sec31p, 
for sufficient time to allow budding of 
the vesicle (138, 139, 142). Alternatively, 
since Sec23p and Sec24p are structurally 
related to each other (133, 141, 144, 
162), it may be possible that the COPII 
coat formed in the absence of Sec24p, 
includes two copies of Sec23p. This 
could possibly provide some structural 
stabilization to the deforming membrane. 
However, these two models have two 
major problems. How exactly would the 
incomplete COPII coat recruit secretory 
cargo and SNAREs in the absence of the 
cargo sorting Sec24p family members. 
A novel uncharacterized component X 
may possibly interact with Sec23p and 
form a complex, thus supporting COPII 
formation, by providing coat stabilization 
and recruiting cargo, such as Hsp150 and 
SNAREs. Alternatively, if the putative 
transmembrane receptor is long enough, 
it may recruit Hsp150 and allow local 
deformation of the ER membrane, by 
enrichment of this receptor in a speci c 
sub-region of the ER membrane. The 
remaining COPII coats may then provide 
some additional stabilization. Alternatively 
Hsp150 may use an ER exit route that is 
completely independent of COPII, where a 
novel set of proteins would recruit Hsp150 
and the necessary SNAREs into the 
budding membrane. However, successful 
ER exit of Hsp150 required functional 
Sec12p, Sec23p and Sec31p, thus making 
the last model unlikely. 
Future work will be required to address 
all this unanswered issues. For instance, 
the identification of the putative 
transmembrane receptor for Hsp150, 
may allow the subsequent identi cation 
of interacting proteins, which may give 
some insight into the ER exit mechanism. 
Additionally through a detailed TEM 
analysis, it may be possible to elucidate if 
indeed COPII vesicles are formed in cells 
lacking all Sec24 family members, and if 
Hsp150 incorporated into them.
2. The yeast secretory glycoprotein 
Hsp150 is selectively secreted in 
a subset of post-Golgi secretory 
mutants (II)
Our previous results suggested that 
Hsp150 is selectively secreted to the 
culture medium in cells with a de cient 
COPII subunit Sec13p (654), and in the 
absence of all Sec24p family members 
(655, 664), or in cells with a deficient 
COPI component Sec21p (665, 666). 
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Therefore we wanted to explore if Hsp150 
was capable of bypassing additional post-
Golgi secretory mutants. To investigate 
this possibility a subset of different post-
Golgi temperature sensitive mutants (see 
Table 2 for details) were shifted to the 
restrictive temperature and metabolically 
labeled. After 60 minutes of incubation, 
TCA precipitation of culture medium 
samples was performed (II, Figure 2A and 
B). Under these conditions no proteins 
were detected in the cases of mutants 
such as sec4-2 (RabGTPase) or sec2-41 
(Sec4p GEF) that work prior to vesicle 
docking, and neither in mutants that affect 
SNARE-mediated membrane fusion such 
as sec1-1 (SM family member) or sec9-
4 (t-SNARE).  Interestingly, we found 
that one specific and significant band 
with similar electrophoretic mobility as 
mature Hsp150 was detected in the culture 
medium of sec15-1 exocyst subunit mutant 
cells (lane 8). Meanwhile, in the other 
exocyst mutants sec5-24, sec6-4, sec8-
6 and sec10-2 secretion of all proteins 
was severely or completely blocked.  It 
thus appeared that Hsp150 bypassed the 
sec15-1 mutation. To further validate 
this, a pulse-chase experiment was 
performed. 35S-labelled cells were chased 
in the presence of cycloheximide for 60 
minutes at the restrictive temperature, and 
cell lysates and culture medium samples 
were analyzed by immunoprecipitation 
with Hsp150 antiserum. In wild type cells 
approximately 80% of Hsp150 was found 
in the culture medium, meanwhile, in 
sec18-1 cells Hsp150 was detected solely 
in the intracellular fraction and in the ER 
form. Analysis of the remaining post-
Golgi temperature-sensitive secretory 
mutants revealed that Hsp150 appeared 
to be significantly secreted (>50%) 
only in sec15-1 mutant cells. In all the 
mutants screened, secretion of proteins 
appeared to be blocked with exception of 
the sec3-1 mutant, where a small amount 
of Hsp150 (approximately 20%) was 
secreted. Taking into count that deletion 
of SEC3 yielded viable cells (584) it 
appears that under certain conditions, 
additional spatial landmarks such as 
Exo70p may compensate absence of 
Sec3p in the exocyst complex (583, 619). 
In view of the fact that Hsp150 appears to 
be secreted in sec15-1 cells while other 
proteins fail to be secreted, we decided to 
further investigate the role of the exocyst 
in secretion of Hsp150.
2.1 Hsp150 is secreted in the absence of 
functional Sec15p 
Sec15p is the exocyst subunit that 
interacts with the approaching secretory 
vesicle, marked by the RabGTPase 
Sec4p, and bridges the vesicle to the 
plasma membrane through the action 
of the tethering exocyst complex (569, 
571, 573). Besides the interaction of 
Sec15p with the secretory vesicle and 
with the remaining exocyst complex 
subunit, Sec10p, Sec15p is also capable 
of interacting physically with Bem1p 
(595). The polarity establishment protein 
Bem1p is considered to be required for 
proper localization of several proteins 
involved in polarity including Cdc42p and 
its exchange factor Cdc24p (596, 667). 
The interaction of Sec15p with Bem1p 
may provide an additional link that helps 
coordinate the polarity machinery and 
the secretory pathway components (595). 
The interaction of Sec15p with Bem1p is 
thought to occur though the C-terminus 
of Sec15p, and this interaction is required 
for proper localization of Sec15p, even 
under conditions where actin is disrupted 
(595). Interestingly, in the case of the 
temperature-sensitive mutant form of 
Sec15p in the sec15-1 mutant, the last 76 
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C-terminal amino acids are missing due 
to premature termination. This shorter 
version of Sec15p fails to interact with 
Bem1p (595). This truncation did not 
affect the binding of Sec15p with Sec10p. 
This interaction has been shown to be due 
to the  rst 82 amino acids localized in the 
N-terminus of Sec15p (595). 
To address the functional importance 
of the C-terminal region of Sec15p, wild 
type Sec15p and the truncated form were 
tagged with GFP and compared with an 
other exocyst component Sec8p-GFP 
(595). Here they showed that wild type 
cells show a bright and proper localization 
of both Sec15-GFP and Sec8-GFP to sites 
of active membrane expansion at both 
permissive and restrictive temperature. In 
contrast, truncated sec15-GFP and Sec8-
GFP localization was faint and appeared 
to be cytoplasmic even at permissive 
temperature. Shift to the restrictive 
temperature lead to the appearance of 
disorganized punctate-staining over 
both mother and daughter cells. From 
these studies it was concluded that the 
C-terminal region of Sec15p, which is 
lacking in sec15-1 cells, is important for 
proper localization of both Sec15p and 
the remaining exocyst components. In 
support to these observations, the exocyst 
complex was found to be disrupted in 
lysates of sec15-1 cells (580, 581, 595, 
668). Furthermore, the level of exocyst 
assembly is reduced significantly in 
the sec15-1 strain even at permissive 
temperature. When sec15-1 cells were 
shifted for 30 minutes to the restrictive 
temperature, the isolated complex was 
dramatically reduced to almost non-
detectable levels (581). In addition to 
the instability of the exocyst complex in 
the sec15-1 strain, Sec4p appeared to be 
unable to associate to Sec15 and to the 
remaining exocyst complex (668). Taking 
together, the data collected on the sec15-
1 mutant, it appears that at the restrictive 
temperature the sec15-1 mutation severely 
affects the overall stability and integrity 
of the exocyst complex, and consequently 
fusion of secretory vesicle to the plasma 
membrane. Therefore, the sec15-1 
mutation seems to be a viable platform to 
carry out secretory studies to understand 
the possible mechanism by which Hsp150 
appears to be selectively secreted.  
2.1.1 Hsp150 is secreted in sec15-1 cells
To verify if indeed sec15-1 is a tight 
temperature-sensitive secretory mutant, 
growth at permissive and restrictive 
temperature was studied and compared 
with that of known secretory mutants (II, 
Figure 2 E and Supplementary Figure 
S1). Cells were grown overnight to early 
logarithmic phase in either rich medium 
(YEPD) or synthetic complete medium 
(SC). Samples from each strain were 
taken and standardized to Od600=0,2 
and incubated either at permissive or 
at restrictive temperature. Samples 
were collected hourly and cell density 
measured. Growth of the sec15-1 strain 
at the permissive temperature (24oC) 
was indistinguishable from control cells 
or from the remaining temperature-
sensitive mutant strains addressed (II, 
Supplementary Figure S1). However at 
the restrictive temperature (37oC) these 
cells failed to grow. Similar results were 
observed for sec18-1 and sec6-4 mutant 
cells. In contrast, control cells incubated at 
the restrictive temperature divided steadily 
Next aliquots of 104 cells and 4 tenfold 
dilutions were carried out for each strain 
and spotted onto YEPD or SC plates. The 
samples were then incubated at 24oC or 
37oC for 2 to 3 days. All temperature-
sensitive post-Golgi secretory mutants 
analyzed failed to grow at the restrictive 
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temperature re ecting the importance of 
the respective proteins in the late stages 
of the secretory pathway. In conclusion 
sec15-1 is a non-leaking temperature-
sensitive mutant and the resulting Sec15p 
is nonfunctional at 37oC. 
To analyze the secretion kinetics 
of Hsp150 in the sec15-1 mutant, cells 
were preincubated at the restrictive 
temperature and pulse-chase experiments 
were performed. 35S-labelled cells were 
chased in the presence of cycloheximide 
for up to 60 minutes. We have previously 
reported that a small fraction of secreted 
Hsp150 remains cell wall-associated in 
normal cells in a non-covalent fashion, 
and can thus be released by SDS treatment 
(654, 669). Covalently bound cell wall 
proteins can be released by mild-alkaline 
treatment. Using this technology we 
investigated if the cell-associated pool of 
Hsp150 was extracellular or intracellular. 
These cell wall samples together with the 
intracellular and culture medium samples 
were immunoprecipitated with Hsp150 
antiserum and subjected to SDS-PAGE 
analysis. After a preincubation period 
of 15 minutes at restrictive temperature, 
the secretion kinetics of Hsp150 was 
very rapid and some Hsp150 could be 
detected in the culture medium already 
after a 5 minute chase (II, Figure 3Ba). 
After 60 minutes chase, 60% of Hsp150 
was found in the medium, 16% was 
associated to the cell wall and only 22% 
remained intracellular. For comparison, 
in control cells, after 60 minutes of chase 
79% of Hsp150 was in the medium, 
10% remained associated to the cell wall 
and a very low amount was detected 
intracellular (II, Figure 3Aa). In contrast, 
when using another exocyst subunit 
mutant, sec6-4, Hsp150 was found solely 
as an intracellular form and no Hsp150 
was secreted to the cell exterior (II, 
Figure 3C). Similar results were obtained 
for the exocyst mutants sec5-24, sec8-
6 and sec10-2 (data not shown). It has 
been reported that incubation of sec15-1 
cells, for 30 minutes at the restrictive 
temperature damages the integrity of the 
exocyst complex and its ability to interact 
with the RabGTPase Sec4p (581, 668). To 
ensure that the preincubation period was 
suf cient to render sec15-1 defective, we 
extended it to 30 and 60 minutes. When 
cells were preincubated for 30 minutes, 
48% of the labeled Hsp150 was found 
in the culture medium, 22% was cell 
associated and 30% remained intracellular 
(II, Figure 3Bb). After 60 minutes of 
preincubation at 37oC lead to the following 
distribution of Hsp150, 28% in the culture 
medium, 37% in the cell wall and 35% 
intracellular (II, Figure 3Bc). 
Increase of the preincubation period 
appeared to increase the relative amount 
of covalently cell wall-attached Hsp150, 
relative to secreted and noncovalently 
attached. The faster migrating Hsp150 
bands detected in the lanes subjected to 
alkaline treatment (II, Figure 3 lanes 3, 7, 
11, 15 and 19) are the result of  release of 
O-glycans by -elimination (669). Also in 
control cells increase of the preincubation 
period lead to a greater fraction of Hsp150 
(approximately 29%) being covalently 
attached to the cell wall (II, Figure 
3AB). In summary, in control cells 90% 
and 85% of Hsp150 was secreted to the 
cell exterior when cells where either 
preincubated at 37oC for 15 or 60 minutes, 
respectively. Meanwhile sec15-1 cells 
externalized 78%, 70% and 65%, when 
the preincubation periods lasted 15, 30 
and 60 minutes, respectively. In other 
exocyst mutants such as sec6-4, sec5-24, 
sec8-6 and sec10-2, Hsp150 remained 
quantitatively intracellular. 
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TCA precipitation of culture medium 
samples of sec15-1 cells revealed that 
Hsp150 was the only labeled protein 
detected. To verify if indeed the ability 
to be secreted in sec15-1 was unique 
to Hsp150, secretion of other reporter 
proteins was assed in the same set of 
secretory mutants. Invertase, a periplasmic 
secreted glycoprotein, is often used as a 
reporter to measure secretory defects in 
S. cerevisiae. To derepress the synthesis 
of invertase, cells were shifted to pre-
warmed low glucose growth medium and 
incubated at the restrictive temperature 
for up to 120 minutes, followed by 
quanti cation of intra- and extracellular 
activity (II, Fig 5). In control cells over 
80% of invertase activity was external, 
meanwhile in sec18-1 and sec6-4 cells the 
activity remained intracellular. In sec15-1 
cells an initial secretion of invertase 
(<20%) to the extracellular space was 
detected in the  rst 30 minutes, followed 
by no increase during the following 90 
minutes. Incubation of these strains at 
permissive temperature yielded a similar 
distribution as the control cells. To 
further analyze invertase traf c in these 
strains, samples were collected at 90 
minutes and intracellular and periplasmic 
samples were subjected to native gel 
electrophoresis, followed by invertase 
activity staining (II, Fig 5). Under these 
conditions we found invertase in the 
fully mature form in control, sec6-4 and 
sec15-1 cells, meanwhile in sec18-1 cells, 
invertase remained trapped in the ER and 
failed to extend its N-glycans. In control 
cells the vast majority of invertase was 
in the periplasmic space. In contrast, 
in sec6-4 and sec18-1 cells the entire 
detected amount of invertase was trapped 
intracellular. In sec15-1 cells a small 
amount of Hsp150 was also found in 
the periplasmic space, thus verifying the 
results obtained for invertase above. 
Next we addressed the secretion of 
Bgl2p, Gas1p and Pma1p in the same 
secretory mutants. Secretion analysis 
revealed that these proteins completely 
failed to be secreted in sec18-1, sec6-4 
and sec8-6 cells, as well as in the sec15-1 
mutant (data not shown).
Thus it appears that secretion in 
sec15-1 cells at the restrictive temperature 
is a unique feature of Hsp150. However, 
a small fraction of invertase was also 
secreted in these cells. One possibility for 
the differences of secretion ratios observed 
between these proteins may reside in 
the different kinetics in translation/
processing/transport through the secretory 
pathway.  To address this issue we carried 
out a comparative secretion kinetics 
assay on invertase and Hsp150 in control 
cells, in a subset of exocyst mutants 
and in the post-Golgi secretory mutant 
sec14-1 (II, supplementary figure S2). 
At permissive temperature, invertase 
secretion to the periplasmic space was 
similar in all the mutants observed where 
extracellularly invertase activity could 
already be detected, as early as 5 minutes 
after shift to low glucose conditions. 
At the restrictive temperature secretion 
of invertase was completely blocked in 
sec14-1, sec5-24, sec6-4 and sec8-6 cells. 
However in sec3-1, sec10-1 and sec15-1 
cells a small amount of activity (typically 
below 20%) was detected extracellular. 
This partial secretion occured in the  rst 
30 minutes of incubation and failed to 
increase after that. For comparison, wild 
type cells incubated at the restrictive 
temperature ef ciently secreted invertase 
and in average more than 80% was found 
in the exterior of the cell. In parallel with 
the above experiments a pulse-chase 
experiment was performed to address 
the secretion kinetics of Hsp150. Similar 
to invertase, secretion of Hsp150 to the 
culture medium was completely blocked 
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in sec5-24, sec6-4 and sec8-6 cells. In 
addition, in sec3-1 and sec10-1 mutants 
the same low secretion ratio and kinetics 
for Hsp150 and invertase was observed, 
where approximately 20% of the labeled 
Hsp150 was secreted to the culture 
medium in the  rst 30 minutes. However 
in the case of sec14-1 and sec15-1 mutants, 
an increased ratio of Hsp150 secretion was 
observed in comparison to the amount of 
invertase secreted. In the case of Hsp150, 
a total of approximately 50-60% of 
Hsp150 was secreted. TCA precipitation 
of culture medium samples revealed only 
one protein that migrated in SDS-PAGE 
like mature Hsp150. Thus it appears 
that Hsp150 is specifically and more 
ef ciently secreted in sec15-1 and sec14-1 
mutants than invertase. The secretion 
kinetics of invertase was also addressed 
by Harsay et al., (1995). They concluded 
that invertase was rapidly secreted after 5 
minutes of derepression (258). We have 
also shown that Hsp150 can be found in 
the culture medium as soon as 5 minutes 
after pulse (649). Therefore it appears that 
both these proteins are secreted with the 
same kinetics in control and in a subset of 
exocytic mutants other than sec15-1. The 
differences between invertase and Hsp150 
in sec15-1 cells possibly re ect a selective 
secretion pathway for Hsp150, instead of 
a difference in the kinetics of progression 
of Hsp150 and invertase through the 
secretory pathway.  
2.1.2 The sorting signal for bypass of 
the sec15-1 mutation resides in the N-
terminal/RR region of Hsp150
As previously referenced, Hsp150 is 
selectively secreted to the culture medium 
in cells that have a deficient COPII 
subunit Sec13p (654), and in the absence 
of all Sec24 family members (655, 664), 
and even in cells with a de cient COPI 
component Sec21p (665, 666). We 
have previously found that ER exit of 
Hsp150 in COPII-de cient mutant cells 
is dependent on a molecular signature that 
resides in the unique C-terminal domain 
of Hsp150 (Figure 15) (654, 655), and in 
the case of  COPI-independent ER exit, 
to the repetitive region of SUII (666). In 
search of the molecular signature guiding 
secretion of Hsp150 in sec15-1 cells, 
variants of Hsp150 lacking either the 
C-terminal domain (Hsp150) or having 
a shorter version of the repeat domain of 
SUII (Hsp1504R) were to -lactamase 
and expressed in sec15-1 cells (Figure 
15). The -lactamase portion originating 
from E. coli folds in the yeast ER to a 
bioactive conformation and in normal 
conditions the fusion protein is ef ciently 
secreted to the medium (650, 651). A 
pulse chase experiment of the variant 
lacking the unique C-terminal fragment 
was  rst carried out to see if this region 
was required for bypass of Sec15p. Cells 
were preincubated at the restrictive 
temperature, labeled, and chased for 60 
minutes in the presence of cycloheximide. 
After cell fractionation, Hsp150-
lactamase was immunoprecipitated 
with -lactamase antiserum. In sec15-1 
cells, after a 5 minutes chase, we could 
already detect Hsp150--lactamase 
in the culture medium and after 1 hour 
of chase, 50% was found in the culture 
medium, 16% was non-covalently 
attached to the cell wall and 7% was 
covalently cell wall-bound, while only 
30% remained intracellular (II, Figure 
4C). In control cells similar secretion 
results were obtained for Hsp150-
lactamase (II, Figure 4A). In sec6-4 
cells Hsp150-lactamase failed to be 
secreted and accumulated intracellularly. 
At the permissive temperature the fusion 
protein is ef ciently secreted to the culture 
medium. 
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To further elucidate the sorting 
determinant we analyzed the secretion of 
Hsp1504R-lactamase (Figure 15). 
Pulse-chase experiments revealed that 
analogous to Hsp150-lactamase (II, 
Figure 4), this shorter version of the fusion 
protein was efficiently secreted in wild 
type cells and in sec15-1 cells, but failed 
to be secreted in sec6-4 cells incubated at 
restrictive temperature (data not shown). 
From these results it is apparent that 
the molecular signature that mediates 
Hsp150 secretion in sec15-1 mutant cells 
does not reside in the unique C-terminal 
fragment and neither in the full repetitive 
region of Hsp150, but rather appears to 
reside in either subunit I or in the  rst 4 
repeats of SUII (Figure 15). Alternatively, 
since Hsp150 is heavily O-glycosylated 
in both SUI and SUII (651, 666), the 
molecular signature may reside in the 
oligosaccharides (670). However, deletion 
of the protein O-mannosyltransferase 
gene PMT4, which is responsible for the 
transfer of mannose residues from the 
dolichylphosphate-D-mannose to serine 
or threonine residues on the target protein 
(90, 91, 93) yielded no secretory defects 
in these cells (unpublished data).
2.2 Hsp150 is selectively packaged into 
a subset of secretory vesicles
Secretory cargo destined to the exterior 
of the cells is packaged into secretory 
vesicles, which selectively concentrate 
cargo and transport them to the plasma 
membrane. Two pools of post-Golgi 
vesicles, which differ in respect to their 
cargo, have been identi ed by isodensity 
gradient centrifugation (258, 260, 474). 
The vesicles detected in the lighter region 
of the gradient were classi ed as LDSV 
(low density secretory vesicle) and contain 
proteins such as the endo--1,3-glucanase 
Bgl2p, the plasma membrane ATPase 
Pma1p and the GPI-anchored -1,3-
glucanosyltransferase Gas1p. Meanwhile, 
the vesicles detected in the heavier region 
of the gradient HDSV (heavy density 
secretory vesicles) contained proteins such 
as invertase, exo--1,3-glucanase Exg1p 
and alkaline phosphatase ALP. Both 
vesicle populations transport cell wall-
modifying enzymes such as glucanases, 
which are thought to be involved in the 
softening of the yeast cell wall in order to 
allow its expansion and insertion of new 
wall materials. Since Hsp150 is secreted 
to the culture medium in wild type and 
sec15-1 cells, we set out to investigate 
in which population of secretory vesicles 
was Hsp150 transported.   
2.2.1 Hsp150 is packaged into a novel 
class of secretory vesicles
To address into which population of 
secretory vesicles Hsp150 was guided, 
cells were grown to early logarithmic 
phase and shifted to restrictive temperature 
for 2 hours to allow accumulation of 
secretory vesicles. The cells were then 
lyzed, and after differential centrifugation 
steps, the secretory vesicles were 
isolated as an individual pellet (for a 
detailed description see II, Methods and 
materials). This pellet was then loaded 
on the bottom of an Optiprep density 
gradient and centrifuged for 19 hours at 
100.000 x g, which allowed the vesicles to 
migrate to their corresponding densities. 
Subsequently aliquots were sequentially 
removed and analyzed for the presence 
of different proteins by either activity 
measurements or by SDS-PAGE analysis. 
Unlike previous reports (258-260), which 
used Nycodenz to construct the density 
gradients, we used Optiprep for the 
following reasons. Similar to Nycodenz/
Iohexol, Optiprep is a nonionic derivate 
of metrizoic acid which is constituted by 
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Iodixanol, essentially a dimer of iohexol. 
The main differences between Nycodenz 
and Optiprep is that Nycodenz gradients 
are hyperosmotic at densities above 1,16g/
mL even when inverse gradients are used 
to balance the osmolarity. In contrast 
Optiprep is capable of forming isoosmotic 
solutions at all densities (671, 672). Also a 
better performance/resolution by Optiprep 
versus Nycodenz has been observed in the 
separation/puri cation of organelles that 
fractionate close to this density limit (671, 
672). Thus, in an attempt to preserve the 
structural properties and identity of the 
vesicles we used Optiprep in this study. 
We isolated vesicles from sec15-1, sec6-4 
and control cells at both permissive and 
restrictive temperatures and loaded them 
on the bottom of a 12-30% Optiprep 
gradient constructed in 0.8 M Sorbitol 
/ TEA. Control cells and temperature-
sensitive mutant cells, incubated at the 
permissive temperature accumulated very 
little secretory vesicles, as confirmed 
by transmission electron microscopy. 
Therefore, detection of proteins by SDS-
PAGE analysis was dif cult under these 
conditions. For this reason vesicle analysis 
was carried out in the temperature-
sensitive sec6-4 and sec15-1 mutants 
which accumulate a significant number 
of secretory vesicles (258). The aliquots 
collected from the gradient were subjected 
to SDS-PAGE analysis and probed by 
western blotting for the presence of a 
subset of different marker proteins. To 
verify the purity of the isolated secretory 
vesicles and to address the integrity of 
both experimental sets we  rst followed 
the ER marker Kar2p/BIP. In both sec6-4 
and sec15-1 cells Kar2p/BIP was found on 
the top of the gradient together with the 
syntaxin Pep12p, which is commonly used 
as a late endosomal marker (II, Figure 6 A 
and B). When probing for proteins such 
as Bgl2p, Gas1p and Pma1p, which are 
found in the LDSV population, we found 
that these proteins were detected in the 
same fractions (1-7) in both sec6-4 and 
sec15-1 cells (II, Figure 6, A and B). The 
accumulation of Gas1p, Pma1p and Bgl2p 
in the LDSV population was similar in 
sec6-4 and sec15-1 cells (II, Figure 6E).
When the samples were assayed for 
invertase activity, we found that the 
distribution profile was different. 
Invertase could be detected in fractions 5-
15 (HDSV, see next section) and at a very 
high density (fractions 24-28) (II, Figure 
6 C and D). The total amount of invertase 
activity in the gradient was in the case of 
sec15-1 cells about 20% lower than in 
sec6-4 cells (II, Figure 6 E). 
In the case of sec6-4 cells, invertase 
and Hsp150 were detected in the same 
fractions (II, Figure 6C), this is in the 
HDSV  (C3-17) as well as in the very 
heavy density fractions (C23-27). In 
contrast, in the case of sec15-1 cells (II, 
Figure 6D), Hsp150 was found in the 
HDSV population only (D3-15). Less than 
50% of Hsp150 was found throughout the 
gradient in the sec15-1 strain as compared 
to sec6-4 cells (II, Figure 6 E)
Previous studies carried out on the 
identity of the secretory vesicles using 
Nycodenz, placed the LDSV at a density 
equal to 1.14 g/mL and the HDSV at a 
density of 1.16 g/mL (258, 260). In our 
experimental conditions using Optiprep we 
found LDSV at a density approximately 
of 1.11 g/mL and the HDSV at 1.13 g/
mL. This difference in density between 
Optiprep and Nycodenz has previously 
been reported, and appears to be due to 
the different ability of these two media in 
forming isoosmotic solutions (672). In this 
study they found that for example that the 
endoplasmic reticulum, mitochondria and 
lysosomes sediment at signi cantly lower 
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densities in Optiprep when compared to 
Nycodenz. This may be the reason why 
vesicles detected in the very heavy density 
fractions (with a density of 1.198 g/mL) 
were not detected in the previous studies, 
which had a maximum density range 
of 1.195 g/mL. This also explains the 
differences observed between the densities 
found for LDSV and HDSV in our versus 
previous studies. 
In summary, we have detected 
Hsp150 together with invertase in the 
HDSV population of secretory vesicles, 
and in a novel population of vesicles, 
which sedimented in the very heavy 
density fractions of the gradient. In the 
sec15-1 strain, where much of Hsp150 is 
secreted, its amount within the secretory 
vesicles, accumulated during restrictive 
temperature, was much lower than in 
sec6-4 cells, where Hsp150 was found 
only in the HDSV population. Invertase, 
however, was found in sec6-4 and sec15-1 
mutants, in both the HDSV population and 
in the novel very heavy density fractions. 
Proteins carried in LDSV accumulate to 
similar levels internally in both sec6-4 and 
sec15-1 cells. Conclusion: a novel type of 
vesicles was identi ed, in which part of 
the Hsp150 is transported.
2.2.2 Mutations affecting the 
Endosomal/vacuolar pathway do not 
affect Hsp150 secretion
Previous reports have documented that 
mutants that disturb the endosomal/
vacuolar pathway also disturb the 
formation of the HDSV population 
of vesicles (259, 260). Under these 
conditions, cargo typically found in the 
HDSV is rerouted to the LDSV population 
(260). In addition, when the pathway that 
targets CPY from the Golgi to the vacuole 
is blocked, like in vps1 and vps10 mutants, 
CPY is targeted to the plasma membrane 
through the LDSV population of vesicles. 
Thus, to further elucidate the pathway 
through which Hsp150 is secreted in 
sec15-1 cells, we set out to investigate the 
role of the endosomal/vacuolar pathway 
in exocytosis of Hsp150.
To address this issue we crossed 
vps10, vps1 and vps8 mutants with 
either sec15-1 or sec6-4 cells. Spores were 
dissected and scored for the appropriate 
genotype (see Table 2 for details). 
Crossing of the different vps mutants with 
either sec15-1 or sec6-4 yielded viable 
cells with no severe effects on growth (II, 
Supplementary Figure S4.1-S4.3 C). Next 
secretion of Hsp150 and invertase was 
followed in the single and double mutants 
by pulse chase experiments and invertase 
activity assays (II, Supplementary Figure 
S4.1 to S4.3). Under these conditions no 
secretion defects were observed for either 
protein in vps10, vps1 or vps8 strains. 
Furthermore, in the double mutants no 
effects on secretion could be observed 
when compared to the parental strains 
sec15-1 and sec6-4. To verify that the 
endosomal/vacuolar delivery pathway 
was indeed affected in these mutants, 
maturation of CPY was followed. In the 
case of the vps deletants, CPY was found 
intracellularly in the P2-Golgi form and 
failed to acquire the mature form, which 
occurs by protease cleavage in the vacuole. 
Therefore it appears that the combination 
of mutations that block traf c through the 
endosomal/vacuolar pathway with sec15-1 
had no effect on the secretion of Hsp150. 
Vps mutants have been shown to 
abolish the formation of the HDSV 
population of secretory vesicles while 
the formation of the LDSV remains intact 
(260). For this reason we decided to isolate 
the different population of secretory 
vesicles that accumulate in sec6-4 vps1, 
sec15-1 vps1, sec15-1 vps10 and 
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sec15-1 vps8 mutants, and investigate 
the effect these double mutations have on 
the biogenesis of the different population 
of vesicles. Cell growth, isolation and 
isodensity centrifugation of the secretory 
vesicles was conducted as previously with 
the exception that the gradient covered 
a broader region (10-35%) in an attempt 
to increase the resolution. Similar to the 
previous fractionations carried out, the 
distribution of the ER marker Kar2p/BiP 
throughout the gradient was similar in all 
of the mutants, as well as the total amount 
of protein detected (II, Figure 9 and 
Supplementary Figure S5). In addition, 
fractionation of the congenic sec6-4 and 
sec15-1 cells yielded comparable results to 
those obtained previously, thus re ecting 
the reproducibility of the fractionation and 
density gradient analysis. 
When post-Golgi secretory mutants 
are combined with endosomal mutants 
that block the delivery of CPY to the 
vacuole, CPY is no longer delivered to 
the vacuole and since fusion to the plasma 
membrane is blocked, CPY accumulates 
intracellularly (260) (II, Supplementary 
Figure S5 I). Combination of sec15-1 or 
sec6-4 with the absence of the dynamin-
like GTPase Vps1p lead to relocalization 
of cargo normally transported by the 
HDSV into the LDSV population of 
secretory vesicles, as previously mentioned 
by Harsay et al., 2002 and blocks traf c 
through the endosomal pathway (260, 358, 
362)(see Figure 16). This relocalization 
can be detected by a shift in the peak 
of invertase activity, which runs in the 
HDSV region in the case of the sec15-1 
and sec6-4 cells, to the LDSV region in 
the case of the sec15-1 vps1 and sec6-4 
vps1 mutants (II, Figure 9B and D). In 
addition the majority of the unprocessed 
P2-Golgi form of CPY cofractionated 
with the LDSV population of secretory 
vesicles. On the other hand, invertase 
activity detected in the very heavy density 
fractions remained unaffected by the 
absence of the dynamin-like GTPase 
Vps1p. Interestingly, packaging of Hsp150 
into the LDSV population did not abolish 
its secretion capacity in sec15-1 vps1 
cells, since approximately 50% of the total 
amount of Hsp150 was secreted in this 
strain. Meanwhile, other proteins such as 
Pma1p, Gas1p and to a signi cant degree 
invertase, remained intracellular (II, 
Supplementary Figure S5 I). In contrast, 
in the single and double sec6-4 mutant 
strains Hsp150 failed to be secreted and 
accumulated intracellularly. In conclusion, 
disturbing the endosomal pathway did not 
block the secretion of Hsp150 in sec15-1 
cells, neither did it block the formation 
of the novel pool of vesicles detected in 
the very heavy density fractions of the 
gradient.
Next, we analyzed the secretory 
vesicles that could be found in the sec15-1 
vps10 mutant strain. Since Vps10p is the 
sorting receptor for carboxypeptidase Y, 
we expect that its absence would not affect 
the biogenesis of the HDSV population, 
while CPY would still be missorted 
into the secretory vesicles (Figure 16). 
Indeed we found that formation of HDSV 
prevailed and CPY accumulated within 
the HDSV population (II, Figure 9E). The 
unprocessed p2-Golgi form of CPY was 
found together with invertase and Hsp150 
in HDSV. In addition a signi cant amount 
of p2 CPY was found in the very heavy 
density region of the gradient together 
with invertase. Hsp150 was efficiently 
secreted in the double mutant sec15-1 
vps10, and was not detected in the very 
heavy density fractions of the gradient. 
Externalization of Gas1p or Pma1p was 
not observed during the time course of 
the experiment. In conclusion absence of 
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VPS10, lead to speci c packaging of CPY 
into the HDSV. Results collected from 
the vps1 mutant suggest that HDSV are 
formed from endosomal membranes. This 
raises the questions where indeed does the 
CPY receptor function. Is it at the trans-
Golgi, or does it sort CPY for transport 
from early to late endosome (Figure 16). 
We expected that vps10 deletion would 
lead to the packaging of CPY into LDSV, 
since vps10p is proposed to function at 
the trans-Golgi. However this was not 
the case, since CPY was detected together 
with HDSV cargo. Thus either Vps10p 
functions in early to late endosome traf c 
or alternatively HDSV may originate 
directly from late-Golgi membranes.
Next we studied the secretory 
vesicles that could be detected when the 
CORVET component Vps8p was missing. 
The CORVET complex is responsible 
for intra-endosomal tethering and when 
VPS8 is deleted, delivery of proteins form 
the early endosome to the late endosome 
is blocked (334, 335, 358).  Biogenesis 
of the HDSV and LDSV population 
prevailed in sec15-1 vps8 mutants, since 
Gas1p and Pma1p pro les were distinct 
from that of Hsp150 (II, Figure 9I). In 
addition, CPY coincided in the sec15-1 
vps8 with the HDSV population, with 
the majority of CPY being found in the 
mature M form (II, Figure 9I). The mature 
CPY is thought to be due to processing of 
CPY in a pre-vacuolar compartment, due 
to accumulation of CPY and proteases in 
the same compartment. In the case of the 
double mutant sec15-1 vps8, invertase 
was found in the gradient fractions 
containing the very heavy density vesicles, 
with only a small amount occurring in the 
HDSV region. In contrast, Hsp150 was 
not detected in the heavy density vesicles. 
Thus Hsp150 was selectively secreted 
in sec15-1 vps8, while other proteins 
analyzed were trapped intracellularly. 
Invertase was detected in the novel very 
heavy density vesicles when traf c from 
early- to late-endosome was blocked. This 
suggests that the HDSV population may 
preferentially be formed on the membranes 
of late-endosomes, while the novel very 
heavy density vesicles are formed on the 
early-endosomal membranes (Figure 16).
In summary, we found that blocking 
the endosomal/vacuolar pathway had no 
inhibitory effect on secretion of Hsp150 
in the sec15-1 background. Our results 
support previous studies (260), which 
suggest that the biogenesis of HDSV 
population of vesicles takes place on the 
membranes of a post-Golgi compartment, 
most probably of endosomal nature 
(Figure 16). When the endosomal/
vacuolar pathway was blocked (for 
example vps1 cells), formation of the 
HDSV population was inhibited, and 
when traffic from an early endosomal 
compartment to the vacuole was disturbed 
(such as in vps8 cells), proteins intended 
for delivery to the vacuole were packaged 
into HDSV. In vps10 sec15-1 cells CPY 
was selectively packaged into the HDSV 
population and into the novel very heavy 
density vesicles, but remained absent 
from the LDSV population, which is 
puzzling. The CPY receptor Vps10p 
selectively exports CPY from the late-
Golgi (270, 275). According to this 
traditional perception CPY should be 
found in the LDSV population of vesicles 
in the vps10 sec15-1 cells.  However, the 
detection of CPY in the HDSV class of 
vesicles in the absence of Vps10p suggests 
that CPY may have a Vps10p-independent 
step. Thus, an alternative view is that 
CPY may undergo two sorting steps, one 
at the Golgi (Vps10p-independent) and a 
second at the early endosomes (Vps10p-
dependent) (260).
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Both invertase and CPY appear to 
be transported to the early endosomes, 
but once there, proteins intended to the 
vacuole have to be separated from proteins 
intended for delivery to the exterior of the 
cell. The active involvement of Vps10p 
at the early endosomal membranes would 
help ensure that only the appropriate 
cargos are selected, and thus explain 
Figure 16. Post-Golgi sorting pathways. From the Golgi a multitude of different pathways 
emerge, each transporting proteins and membranes to diverse targets. There are two pathways 
for targeting proteins and membranes to the vacuole. One of these, the CPY pathway transits 
through the endosomes prior to reaching the vacuole, meanwhile the ALP pathway appears to be 
mediated in one unique direct step. Similarly there appears to be at least two pathways for target-
ing proteins to the cell surface. One is targeted directly from the Golgi to the PM (demonstrated 
by the LDSV), and a second transits through an endosomal compartment, prior to be targeted to 
the cell surface (demonstrated by the HDSV). It is possible to block speci c transport events in 
these pathways and analyze how cargo is incorporated into the different populations of secretory 
vesicles. See text for further details.
why in its absence, CPY is packaged into 
HDSV. Thus, the function of Vps10p 
may be similar to that of the mannose 
6-phosphate receptor, which is involved 
mainly in trans-Golgi to early endosome 
sorting, but has also been suggested to be 
required for early to late endosome sorting 
prior to recycling back to the late-Golgi 
(673-675). 
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2.2.3 Morphological characterization 
of the different secretory vesicles: 
development of a novel HRP staining 
procedure for TEM
The results collected so far suggest that 
Hsp150 is selectively secreted in sec15-
1 cells at restrictive temperature. Next, a 
morphological approach was developed. 
We took advantage of the fact that the 
molecular signature that guides Hsp150 
to bypass the sec15-1 block does not 
reside in the unique C-terminal fragment 
of Hsp150, and that the repetitive region 
of Hsp150 (Hsp150, see Figure 15) 
promotes correct folding of heterologous 
proteins fused to its C-terminus (see 
further sections). We decided to test 
whether the Hsp150 carrier would 
assist proper folding in the yeast ER of 
Horseradish peroxidase (HRP). HRP is 
commonly used in morphological studies, 
due to its ability to react with the substrate 
diaminobenzidine (DAB) when in the 
presence of hydrogen peroxide. This 
reaction yields an insoluble precipitate in 
the lumen of the intracellular compartment 
where HRP is located. This precipitate 
becomes electron dense upon subsequent 
reaction with reduced osmium tetroxide, 
and is visible in TEM as a dark staining 
pattern (II, Material and methods). This 
method that we have adapted now for 
yeast, was previously developed for 
mammalian cells (676). 
The  rst step in the development of 
this method was the construction of the 
fusion protein Hsp150-HRP, where the 
unique C-terminus of Hsp150 was replaced 
by HRP (Figure 15). This construct was 
then expressed in wild type S. cerevisiae 
cells to verify that indeed Hsp150 was 
able to confer secretion competence to the 
fused HRP protein. Immunoprecipitation 
experiments with either Hsp150 or HRP 
antiserum veri ed that the fusion protein 
was efficiently secreted to the culture 
medium with kinetics similar to those 
of wild type Hsp150. Next, we took 
advantage of the fact that the C-terminal 
fragment of Hsp150 is required for the 
Hsp150 secretion in sec24-1 and sec7-
1 cells, and therefore in these mutants 
Hsp150-HRP should remain trapped 
in the ER and Golgi, respectively (655). 
In addition, we used control cells and 
sec18-1 for comparison. This allowed 
the development and optimization of 
the conditions for application of this 
staining procedure for yeast. Incubation 
of these cells at the restrictive temperature 
resulted in different morphologies that 
were characteristic to each block of the 
secretory pathway in the different mutants 
(Figure 17). In control cells no signi cant 
staining was observed due to the fact 
that the protein is efficiently secreted. 
Since Hsp150-HRP is not capable of 
exiting the ER in sec24-1 and in sec18-1 
cells, in these cells a membrane-staining 
characteristic of typical ER structures was 
observed (Figure 17). In the sec7-1 cells 
a different staining pattern was observed 
suggestive of Golgi-stacks. Thus when 
all the morphological data collected from 
the different sec mutants was assembled; 
a framework of the staining pattern 
expected along the secretory pathway was 
constructed. 
Using this staining procedure we set 
out to analyze whether any morphological 
differences could be observed within 
the secretory vesicles that accumulate 
in sec6-4 and sec15-1 cells. To be able 
to distinguish secretory vesicles that 
transported Hsp150 we constructed 
sec6-4 and sec15-1 cells expressing a 
fusion protein where the C-terminal 
fragment of Hsp150 was replaced by 
horseradish peroxidase (HRP). These 
mutants, accumulate secretory vesicles, 
Results and Discussion
95
Figure 17. Development of a novel HRP staining method for TEM. Taking advantage of 
the dark precipitate formed by HRP when H2O2 is added, we developed a novel HRP staining 
procedure. To assist the proper folding and transport of HRP through the secretory pathway we 
exploited the carrier ability of the Hsp150 fragment. When the H2O2 treatment is omitted, no 
precipitate is observed as can be observed in the control panels. However when H2O2 is added, a 
precipitate visible under the TEM can be observed in the secretory compartments where the fu-
sion protein Hsp150HRP is localized.
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therefore we reasoned that Hsp150-
HRP containing vesicles should have 
electron dense material within them upon 
DAB and H2O2 treatment (II, Figure 7B). 
Since in sec6-4 cells Hsp150 accumulates 
intracellularly, a difference at the level of 
quanti able HRP-positive vesicles should 
be obvious as compared to sec15-1, 
which ef ciently secretes Hsp150. Thus, 
Hsp150-HRP was expressed in sec15-
1 and sec6-4 cells, and secretion assays 
at permissive and restrictive temperature 
were carried out. Immunoprecipitation 
of Hsp150-HRP using HRP antiserum 
showed that Hsp150-HRP is secreted in 
sec15-1 cells with similar kinetics to those 
of the endogenous Hsp150. In contrast, 
in sec6-4 cells, it remained quantitatively 
intracellular. Since Hsp150D-HRP 
behaved like Hsp150, the next step was 
to visualize these proteins using TEM. 
Cells were incubated for 90 minutes at 
the restrictive temperature (to accumulate 
secretory vesicles) and chased for 10 
minutes in the presence of cycloheximide 
(to enrich secretory proteins at the  nal 
stages of the secretory pathway). Vesicle 
were counted and scored for the presence 
or absence of HRP. Both sec15-1 and 
sec6-4 mutants accumulated a signi cant 
number of 100 nm secretory vesicles, 
however quanti cation showed that almost 
4-fold more HRP-stained vesicles were 
detected in sec6-4 than in sec15-1 (II, 
Table 2). Sections collected from sec6-4 
mutants, revealed that they accumulated 
a signi cant number of both stained and 
unstained vesicles, whereas sections 
collected from sec15-1 mutants, showed 
that the secretory vesicles accumulated in 
these cells were in their majority unstained 
(II, Figure 7). 
Parallel samples of these cells 
were collected and subjected to vesicle 
isolation to verify if the HRP stained 
vesicles corresponded to the region where 
Hsp150 was detected. After isodensity 
centrifugation and  xation, the samples 
were subjected to the HRP staining (II, 
material and methods). Analysis by TEM 
revealed a homogeneous population of 
100 nm vesicles that corresponded to 
the size of typical post-Golgi secretory 
vesicles (II, Figure 8). A positive HRP-
staining pattern was observed within the 
vesicles that were collected from fractions 
of the gradient corresponding to vesicles 
that were previously shown to transport 
Hsp150, i.e., within the HDSV region, 
as well as from the very heavy density 
regions of the gradient. In contrast, no 
signi cant staining pattern was observed 
within the LDSV region. Once again, 
much less stained vesicles were observed 
in the samples collected from the sec15-1 
cells in comparison to the number detected 
in the sec6-4 cells. In addition, no HRP-
stained very heavy density vesicles were 
detected in sec15-1 cells.
2.3 Mso1p is required for fusion of 
secretory vesicles in sec15-1 cells
Thus it appears that in sec15-1 cells, 
Hsp150 is selectively and efficiently 
transported to the cell exterior, while 
other secretory proteins are retained 
intracellularly. Sec15p is the exocyst 
subunit that responds to the activated 
state of the RabGTPase Sec4p, and is 
responsible for the connection between 
exocyst and the incoming secretory 
vesicle (571, 580, 581, 613, 668). The 
later is a crucial step for vesicle tethering 
at the plasma membrane.  So how does the 
vesicle carrying Hsp150 then fuse with 
the plasma membrane in sec15-1 cells? 
In theory two alternatives could possibly 
take place: A) fusion of these vesicles 
with the plasma membrane is completely 
independent of the exocyst function, or 
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alternatively, B) The RabGTPase Sec4p 
may recruit an alternative effector protein 
in the absence of functional of Sec15p, 
which may or may not use an alternative 
set of accessory proteins. 
Hsp150 was not secreted in the 
following exocyst subunit mutants sec3-
1, sec6-4, sec5-24, sec8-6 and sec10-1 
(II, Figure 1). Consequently it appears 
that these components are essential for 
the fusion of secretory vesicles carrying 
Hsp150. Nevertheless, it is possible that 
in the absence of sec15-1, an alternative 
route may come into play, which would 
direct the fusion of these vesicles to the 
plasma membrane without the interplay of 
the remaining exocyst subunits.  However 
due to the lethality of double temperature-
sensitive mutant strains, and a strain 
that has a combination of sec15-1 with a 
deletion of an additional exocyst subunit, 
we could not address this question to rule 
out the  rst hypothesis. 
RabGTPases are key regulators of 
intracellular events. Once in the activated 
state, they generally interact with a 
multitude of different effector proteins, 
which may either contribute to a speci c 
cellular event or may have different roles 
within the cell (11, 677-679). However, 
only one effector has been found for Sec4p, 
namely the exocyst complex, and to be 
more precise, through the interaction with 
the Sec15p subunit. Recently however, 
Sro7/77p has been suggested to function 
as a new effector of the RabGTPase Sec4p 
(629, 636). Sro7/77p appears to provide 
one additional regulatory link between the 
secretory vesicle and the fusion machinery 
by responding to activated Sec4p and 
interacting with the t-SNARE Sec9p 
(636). In a screen performed to test which 
proteins confer fusion competence to the 
secretory vesicles carrying Hsp150, one 
speci c protein, Mso1p, emerged as a key 
component. Mso1p was initially identi ed 
in a multi-copy suppressor screen for 
sec1-1 temperature-sensitive mutants 
(639) and has recently been proposed to 
play a key role in the dynamic interface 
that takes place between the RabGTPase 
Sec4p, Sec1p and the exocytic SNARE 
machinery (627, 642). 
2.3.1 Deletion of MSO1 blocked fusion 
of Hsp150 transporting vesicles in 
sec15-1 cells
Deletion of the MSO1 gene is not lethal 
in vegetatively growing cells, although 
they do show a slight reduction in growth 
rate (639). In the mso1 deletant, a slight 
accumulation of small secretory vesicles 
is detected during the early stages of bud 
expansion, which suggests a positive role 
for Mso1p in the last stages of the exocytic 
pathway, namely in the fusion of secretory 
vesicles with the plasma membrane. 
Although Mso1p appears not to be 
essential in haploid cells, it plays a crucial 
role in sporulation (641). At the end of the 
second meiotic division that occurs during 
sporulation, de novo plasma membrane is 
generated by the fusion of the prospore 
membranes to the meiotic plaque, which 
is localized on the cytoplasmic side of 
the spindle pole bodies (SPB) (680). This 
meiotic plaque functions as a recruiting 
platform for the fusion of further prospore 
membranes, culminating in the protrusion 
of this membranous structure through 
the cytoplasm. The tips of the prospore 
membrane are marked by the leading 
edge coat proteins, which advance and 
encapsulates the material required to 
form a viable haploid cell. When MSO1 
was deleted in diploid cells, the prospore 
membranes failed to fuse to the meiotic 
plaque. Instead numerous 60 to 70-
nm vesicles accumulated at the SPB. 
Consequently, no prospore formation was 
observed in these cells (641, 642). 
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Taking into count the accumulation of 
secretory vesicles in mso1 cells (639), and 
the fact that Mso1p interacts with exocytic 
SNARES, Sec1p and also with Sec15p 
(641, 642), we investigated if Mso1p 
played a role in the secretion of Hsp150 
in  sec15-1 cells. To address this issue, 
sec15-1 cells were crossed with mso1 
cells, sporulated and the resulting haploid 
cells were scored for their respective 
genotype. Deletion of the MSO1 gene in 
the sec15-1 background yielded viable 
cells that grew slightly slower than the 
parental strains (II, Supplementary Figure 
S6). We set out to analyze if any secretion 
differences could be observed between 
the double mutant and the background 
sec15-1 mutant. Pulse chase experiments 
were carried out at permissive (24oC) and 
restrictive (37oC) conditions, followed by 
immunoprecipitation of Hsp150. In mso1 
cells Hsp150 was efficiently secreted 
at both the permissive and restrictive 
temperature, with kinetics similar to 
those of wild type cells (II, Figure 10A). 
TCA precipitation of medium samples 
from mso1 cells, revealed the presence 
of the same set of proteins as in wild 
type cells. As shown before, in sec15-1 
cells, approximately 60% of Hsp150 was 
secreted after 60 minutes of chase at the 
restrictive temperature. However when 
the MSO1 gene was deleted in the sec15-1 
background, no secretion of Hsp150 to the 
medium or to the cell wall was detected 
at the restrictive temperature. TCA 
precipitation of medium samples and SDS-
PAGE analysis revealed the total absence 
of any labeled proteins in the double 
mutants. When sec15-1 mso1 cells were 
incubated at the permissive temperature, a 
wild type secretion pro le was observed. 
Next we compared the secretion of 
invertase in mso1, sec15-1 and sec15-
1 mso1 mutants (II, Figure 10B). In 
mso1 cells at permissive and restrictive 
temperature, invertase was efficiently 
externalized to the periplasmic space, with 
secretion kinetics similar to those of the 
wild type cells, which suggests that Mso1p 
is not a key factor under these conditions 
in the secretion of either invertase or 
Hsp150. Similar to previous results, in 
sec15-1 cells, secretion of invertase was 
signi cantly impaired, with only a very 
small portion (<20%) of the active protein 
being externalized. In contrast in the 
double mutant sec15-1 mso1 secretion 
of invertase was completely blocked 
and accumulated intracellularly at the 
restrictive temperature, analogous to the 
secretion block observed for Hsp150. At 
the permissive temperature, the double 
mutant mso1 sec15-1, ef ciently secreted 
invertase to the periplasmic space. In 
addition, secretion of other secretory 
cargo such as Pma1p, Bgl2p and Gas1p 
were also analyzed, and under the same 
experimental conditions no secretion of 
these proteins was detected (data not 
shown). 
Since protein secret ion was 
completely blocked in the mso1 sec15-1 
strain, we next investigated which 
secretory vesicles accumulated in this 
double mutant and compared it to the 
sec15-1, mso1 and sec6-4 mutants. Cells 
were grown to early logarithmic phase 
and shifted to restrictive temperature for 2 
hours to allow accumulation of secretory 
vesicles. The cells were then lyzed, and 
after differential centrifugation steps, 
the secretory vesicles were isolated as 
an individual pellet and loaded on to the 
gradient as previously.. 
Secretion in themso1 strain is not 
blocked at the restrictive temperature, 
therefore they accumulated a very small 
number of secretory vesicles. As a 
consequence, detection of secretory cargo 
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carried by these vesicles was hard to 
follow due to their low signal. 
Analysis of LDSV secretory cargo 
such as Gas1p, Pma1p and Bgl2p, revealed 
that they, accumulated intracellularly in 
the same relative amounts and hence failed 
to be secreted in either sec15-1, sec6-4 or 
sec15-1 mso1 cells (data not shown). As 
before, in both sec6-4 and sec15-1 mutants, 
invertase activity was found in two peaks, 
within the region corresponding to HDSV 
and in the very heavy density vesicles. 
In the case of the sec15-1 mso1 mutant 
invertase activity was also detected in the 
same regions. However, while the total 
intracellular invertase activity from sec15-
1 mutants was slightly lower than in sec6-
4 mutants, in the double mutant sec15-1 
mso1 the invertase activity levels were 
approximately equal to those  detected 
in sec6-4 mutants. This suggests, that 
invertase secretion is completely blocked 
in the double mutant and further supports 
the invertase secretion assays carried out 
previously (II, Figure 10B). 
As previously, we found that 
Hsp150 was detected in significantly 
lower levels in the sec15-1 mutant than 
in sec6-4 mutants, and that in sec15-1 
mutants it was detected only in the region 
corresponding to the HDSV (II, Figure 
10C). However when MSO1 was deleted 
in the sec15-1 background, a signi cant 
higher amount of Hsp150 was detected 
in the gradient, which supports the fact 
that Hsp150 is not secreted in sec15-1 
mso1 mutant. Furthermore, in the double 
mutant, Hsp150 was found in two regions, 
the one corresponding to the HDSV and 
now also in the region corresponding to 
the very heavy density vesicles. Both 
the distribution profile of the different 
reporter proteins, as well as the total 
amount detected in the double mutant 
sec15-1 mso1 were similar to sec6-4 
mutants, where secretion of all cargo is 
blocked. This suggests that Mso1p plays a 
key role in the ability of vesicles to fuse in 
the sec15-1 background.
In summary, deletion of MSO1 alone 
apparently had no effect on the secretion 
of Hsp150, invertase or other secretory 
cargo analyzed. But, in a sec15-1 
background, secretion of all proteins to the 
culture medium was completely blocked 
at the restrictive temperature including 
that of Hsp150 which was selectively 
secreted in sec15-1 cells. To further verify 
the secretory block imposed on Hsp150 
and other proteins in the double mutant 
sec15-1 mso1, we decided to study 
the accumulation of secretory vesicles 
using the novel staining procedure 
described above. For this end, Hsp150-
HRP was expressed in mso1, sec15-1 
and in sec15-1 mso1 cells. Cells were 
incubated at the restrictive temperature for 
90 minutes and chased in the presence of 
cycloheximide as previously. As reported 
previously, mso1 cells accumulated a 
signi cant number of secretory vesicles in 
the early bud tip, but as this bud expanded 
and grew in size, the number of vesicles 
decreases (II, Figure 11B). Similar 
to previous results, the sec15-1 sister 
cell accumulated a significant number 
of secretory vesicles, nevertheless the 
majority of them lacked HRP staining, 
because both Hsp150 and Hsp150-HRP 
were secreted. In contrast, about half of 
the secretory vesicles that accumulated 
within the sec15-1 mso1 cells at the 
restrictive temperature, were HRP stained. 
The staining pattern and distribution ratio 
observed in the double mutant sec15-1 
mso1 cells were very similar to those 
in sec6-4 cells, where secretion of all 
proteins was also completely blocked.
In conclusion we found a role 
for Mso1p in the fusion of Hsp150-
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containing secretory vesicles with the 
plasma membrane, under conditions 
where the exocyst is impaired due to the 
sec15-1 mutation. Deletion of MSO1 in 
the sec15-1 background blocked secretion 
of all proteins, including that of Hsp150. 
Furthermore under these conditions, 
where Hsp150 detected in the HDSV and 
in the very heavy density vesicles, similar 
to what was found in sec6-4 cells.
2.3.2 The role of Mso1p in the vesicle 
plasma membrane interface
Mso1p is capable of interacting directly 
with proteins , which have a key role in 
exocytosis events at the plasma membrane. 
Immunoprecipitation experiments revealed 
that Mso1p coprecipitated with the Sec1/
Munc18 family member Sec1p, with the 
exocytic SNARE complex Sso1/2p-Sec9p-
Snc1/2p and speci cally with the exocyst 
subunit Sec15p (642). Interaction with 
the remaining exocyst components like 
Sec8p was not detected in the complexes 
containing Mso1p-Sec1p. Thus, it appears 
that the role of Mso1p at the plasma 
membrane interface may be to temporally 
regulate tethering of the secretory vesicle 
with the pairing of the exocytic SNAREs, 
which subsequently leads to fusion of 
the vesicle with the plasma membrane. 
The precise mechanism that allows this 
regulatory interaction to take place is 
not fully understood. However, there are 
regions within the C-terminus of Mso1p 
that are highly homologous to a conserved 
region in the Munc13 family members 
(627) and to the common phosphotyrosine 
binding (PTB) domain in Mint proteins 
(642). These proteins are proposed to work 
as SNARE regulators in the stimulus-
coupled secretion pathway that takes place 
in higher organisms, namely at the vesicle 
“priming” stage (15, 644). Since both 
Mso1p and the Munc13 family members 
play a role in exocytosis, interact with 
Sec1/Munc18 and are components of the 
exocytic SNARE complex, it is possible 
that Mso1p may indeed represent a yeast 
ortholog of Munc13-related proteins. 
When sec15-1 cells are incubated at 
the restrictive temperature, association 
of the mutant form of Sec15p with the 
incoming secretory vesicle, as well 
as assembly of the remaining exocyst 
complex are impaired (570, 573, 580, 581, 
595). Under these conditions secretory 
vesicles fail to fuse to the plasma 
membrane due to the inef cient tethering 
function of the exocyst complex (Figure 
18). Nevertheless, secretory vesicles 
transporting Hsp150 are still capable 
of fusing to the plasma membrane and 
deliver their cargo to the culture medium, 
while other secretory cargo accumulates 
intracellularly. Thus, additional complexes 
may exist in yeast that play an important 
role in the fusion of subclasses of vesicles 
to the plasma membrane in order to 
ensure that speci c proteins are delivered 
to their final destination. Since Hsp150 
is a soluble protein, it must interact with 
a transmembrane receptor protein for 
packaging into the forming secretory 
vesicle. This putative receptor may 
recruit either directly or indirectly a set of 
alternative accessory proteins, or interact 
directly with Mso1p. This interaction 
with Mso1p at the plasma membrane may 
help stabilize the secretory vesicle at the 
plasma membrane, even if temporarily, 
until a functional SNARE fusion complex 
is formed. According to this hypothesis, 
when the MSO1 gene is deleted in the 
sec15-1 background, these secretory 
vesicles are no longer capable of being 
stabilized at the plasma membrane 
interface and fail to fuse. Consequently 
secretion is blocked. When the MSO1 
gene is deleted in a wild type background, 
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Figure 18. Tethering and SNARE assembly at the plasma membrane. A) Hypothetical 
description of how the transition from tethering to SNARE assembly occurs in wild type cells 
with some of the key protein depicted.  B) Illustration of how the shift to 37oC of sec15-1 cells 
disrupts the exocyst integrity and how possibly the cell may adapt to such changes. See discussion 
for details. 
no severe deficiencies are observed, 
since, under these conditions, the fully 
functional exocyst complex provides 
sufficient stabilization of the vesicle at 
the plasma membrane. During the early 
stages of bud tip expansion that occur 
in mso1 cells, a signi cant number of 
secretory vesicles accumulate at the tip 
region. During this early phase, a large 
amount of secretory vesicles are targeted 
to a relatively small region within the 
bud tip. This phenotype may arise due 
to the fact that in the absence of Mso1p 
function, stabilization and temporal 
regulation may be slightly impaired. As 
a consequence of this somewhat lower 
stabilization or increase in the transition 
time from tethering to fusion events, 
secretory vesicles start to accumulate due 
to the higher residence time of the vesicle 
at this interface. As the bud tip grows and 
vesicle fusion events become broader, 
the secretory vesicles are distributed to 
different regions of the plasma membrane 
and the exocyst complex becomes capable 
of handling this load ef ciently, hence the 
lower accumulation of secretory vesicles 
and almost wild type phenotype observed.
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Alternatively, in the absence of Sec15p 
function, Sec4p may recruit an alternative 
effector protein, such as a possible 
Sec15p homologue, that would partially 
compensate for the lack of functional 
Sec15p. Although an additional isoform 
of Sec15p was found in the extracts of rat 
brain (681), in yeast cells the presence of 
isoforms has not been reported.
In conclusion, isolation of mutants 
that abolish the secretion of Hsp150 in the 
sec15-1 background may help uncover the 
identity of additional proteins that possibly 
play a role at the plasma membrane/
secretory vesicle fusion interface.
2.4 Multiple pathways lead to the cell 
surface: Why the need for divergent 
pathways?
Two reported pathways for delivery of 
exocytic cargo to the plasma membrane 
exist, which use the LDSV and HDSV 
populations of secretory vesicles (258, 
260). These vesicle populations can be 
distinguished on one hand by the presence 
of specific secretory cargo, and on the 
other hand by their secretion kinetics, 
where HDSV cargo is secreted quickly. 
Expression of cargo proteins transported 
in the HDSV are typically regulated at 
the transcriptional level. Perhaps these 
proteins require specific processing. In 
agreement with this, Hsp150 has a Kex2p 
cleavage site and is transported by the 
HDSV population of secretory vesicles. 
The HDSV exocytic branch transits 
through the early-endosome, where the 
Kex2p protease is believed to function. 
Another difference between these two 
exocytic branches was observed during 
the early stages of the cell cycle of exo70 
mutant cells (682).  The exo70 mutant 
strain accumulated a signi cant amount 
of Bgl2p (LDSV-specific cargo), while 
secretion of invertase (HDSV-specific 
cargo) appeared unaffected. Furthermore, 
the combination of the vps1 mutation, 
which causes a defect in invertase vesicle 
traf cking with the exo70 mutation was 
detrimental to the cell. One additional 
difference observed between the behavior 
of these different vesicle populations 
appeared from studies carried out on 
actin cytoskeleton mutants (551, 552, 
554, 683). These cells accumulate a 
considerable number of post-Golgi 
secretory vesicles, but do not accumulate 
signi cantly invertase. Interestingly, when 
Hsp150 secretion assays were carried out 
in tpm1 or srv2 mutants, which disturb 
the actin cytoskeleton, we observed that 
these mutations had no effect at all on the 
secretion kinetics of Hsp150. Under these 
conditions more than 90% of the total 
labeled pool of Hsp150 was found in the 
culture medium after 30 minutes chase 
(II, Supplementary Figure S8).
Yeast have myriad ways to respond to 
the changing surroundings, to ensure that 
they are operating at their peak ef ciency. 
At least two parallel routes for targeting 
proteins to the cell surface have evolved 
to ensure delivery of proteins to their  nal 
destination. One of these pathways, the 
HDSV pathway may function as a rescue 
route, since proteins transported in this 
class of secretory vesicles are generally 
expressed when the cell is exposed to non-
physiological conditions. This pathway 
appears to be less susceptible to changes 
in growth conditions and unfavorable 
mutations, such as disruption of the actin 
cytoskeleton. When yeast cells are shifted 
to adverse growth conditions, growth is 
temporarily slowed down, which in turn 
leads to a delay or block in polarized 
delivery of secretory vesicles to the 
emerging bud tip of the dividing cell. 
Since the HDSV population appears to be 
less dependent on an active cytoskeleton 
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polarization for their delivery to the sites 
of active membrane fusion. This suggests 
that HDSV vesicles may fuse all around 
the cell surface. This would allow essential 
enzymes, such as Invertase and alkaline 
phosphatase, to be secreted, which in turn 
would provide the cells with the tools to 
quickly adapt to the changing environment 
and gain competence to continue the 
normal cell cycle. 
Studies carried out on the transport of 
the general amino acid permease Gap1p 
further supports the notion that proteins 
required under certain growth conditions, 
transit through the endosomal/Vacuolar 
pathway. This permease is regulated both 
transcriptionally, and posttranslationally 
by differential sorting in the late secretory 
pathway (351, 413, 487, 684). When 
cells are grown on a nitrogen-limiting 
media, such as urea, Gap1p is bound 
by a membrane coat complex, the GSE 
complex, present on the endosomal 
membranes and transports Gap1p to 
the plasma membrane (354). However, 
when cells are grown under nitrogen-rich 
conditions, for example on glutamate, 
the Rsp5p ubiquitin ligase ubiquitinates 
Gap1p, and the modified protein is 
targeted to the vacuole for destruction 
thus downregulating the levels of Gap1p 
on the cell surface (355). Thus, it appears 
that proteins that are only required 
under certain growth conditions are  rst 
transported to the early endosomes. The 
endosome as a compartment, which 
receives both exocytic and endocytic 
material, may respond to clues from the 
external environment, and alter its sorting 
properties in order to direct various 
cargoes either to the plasma membrane or 
to the vacuoles for degradation (260). 
Several different types of early 
endosomes occur in mammalian cells, 
which can be recognized by their distinct 
morphologies and functions (479, 685). 
Although yeast endosomes are clearly 
less characterized, it is emerging that 
they share a significant amount of 
similarities (686). Biogenesis of the 
HDSV population of secretory vesicles 
is proposed to occur on the membranes 
of the early endosome, since both vps1 
and vps27 mutations abolished their 
formation (260). However, a strong 
effect on invertase sorting into the HDSV 
population of vesicles has been reported 
in pep12 mutants, thought to block vesicle 
fusion with the late endosome (260). 
Therefore it is possible that invertase 
(and secretory cargo typically found in 
the HDSV population) is  rst transported 
from early to late endosomes, from which 
it is then selectively incorporated into the 
HDSV vesicles that reach the cell surface 
(Figure 16). Due to the fact that certain 
vps mutations  abolish the formation of the 
HDSV population of secretory vesicles, 
while the LDSV population appears 
rather unaffected by such disturbances 
in the endosomal/vacuolar pathway, 
lead to the proposal that invertase is  rst 
sorted into endosomes and packaged 
into HDSV vesicles for exocytosis (258-
260). However, studies carried out on 
drs2/dnf and clathrin mutants have 
suggested that the HDSV population 
of secretory vesicles may indeed arise 
directly from the trans-Golgi membranes 
(477, 478). One possible interpretation 
forwarded for the mechanism by which 
the endosomal mutants affect the traf c 
of HDSV cargo was based on the fact 
that late-Golgi resident proteins are in 
continuous movement between the late-
Golgi and the endosomes (264, 365). 
Thus when a strong endosomal block 
is on, the continuous vesicle formation 
without appropriate retrieval to the Golgi 
through the endosomes, would eventually 
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deplete the late-Golgi membranes of the 
appropriate resident proteins required 
for sorting invertase into clathrin coated 
vesicles (259, 260, 478), and hence in 
their absence formation of the HDSV 
population of vesicles is abolished. If 
indeed biogenesis of HDSV takes place on 
the late-Golgi membranes, this hypothesis 
provides some explanation for the fact 
that in sec15-1 vps10 mutant cells, CPY 
is detected in the HDSV population of 
secretory vesicles (II, Figure 9E). 
An alternative explanation forwarded 
for the observation of CPY in the HDSV 
region in sec6-4 vps10 mutants, is if CPY 
is sorted both at the late-Golgi and at the 
endosome. But only the endosomal CPY 
sorting step would be Vps10p-dependent 
(260). Several different proteins have been 
shown to cycle from endosomes back to 
the plasma membrane (354, 358, 405, 
482, 687). Therefore proteins intended 
for delivery to the vacuole have to be 
efficiently sorted from those intended 
to be recycled to the plasma membrane. 
Therefore, although Vps10p has been 
proposed to mainly function at the Golgi 
(270, 275), it may also play an important 
role in sorting cargo at early endosomes 
(Figure 16). 
A signi cant amount of data shows 
that secretory cargo transported in the 
HDSV population is rerouted to the LDSV 
vesicles upon disruption of the endosomal/
vacuolar pathway, and that a functional 
delivery pathway for newly synthesized 
proteins operates from the endosomes to 
the plasma membrane. Further work will 
need to be done to clearly define from 
which membranes the HDSV vesicles 
originate.
 To add one more layer of complexity 
to the parallel pathways found in the 
yeast secretory pathway, we found a third 
distinct population of secretory vesicles 
in sec6-4 and sec15-1 mutant cells. This 
novel population of secretory vesicles was 
found in the very heavy density fractions 
of the gradient (d=1,198±0,003 g/mL) and 
typically had diameters between 80 and 
120 nm (II, Figure 6 and 8). No Golgi or 
vacuolar/endosomal markers were found 
in these vesicles and thus we suggest that 
they indeed represent a new population 
of secretory vesicles that transport cargo 
typically found in the HDSV population 
of secretory vesicles. These novel vesicles 
appeared to display selectivity in their 
cargo selection as could be observed 
when they were HRP stained (II, Figure 
8). While the HDSV population (that 
transport both invertase and Hsp150) 
revealed a homogeneous staining pattern, 
part of the vesicles in the very heavy 
density fractions were stained and part 
was not. 
This selective packaging may be 
the key feature behind the secretion 
differences observed between Hsp150 
and invertase. In all the mutants analyzed, 
which secreted Hsp150, such as sec15-1 
cells, Hsp150 was not detected in the very 
heavy density fractions, while invertase 
which failed to be secreted was found 
in signi cant levels in these vesicles. In 
contrast when MSO1 was deleted in the 
sec15-1 mutant background, Hsp150 
failed to be secreted (as in the case of 
sec6-4 cells) and accumulated in two 
populations: in the HDSV and in the very 
heavy density vesicles. Since disturbing 
the endosomal/vacuolar pathway did 
not disturb the biogenesis of the very 
heavy density vesicles we proposed 
that these vesicles might arise from the 
trans-Golgi membranes. However when 
the biogenesis of the different secretory 
vesicles was addressed in the vps8 
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mutant, which blocks traf c from early 
to late endosome and therefore is similar 
in nature to the pep12 mutant described 
previously, we found that the majority 
of the invertase activity was in the very 
heavy density vesicles, with very little 
being detected in the HDSV (II, Figure 
9F). Thus one possibility is that these 
very heavy density vesicles may form on 
the membranes of the early endosomes, 
whereas the HDSV form on the 
membranes of the late-endosome (Figure 
16). This possibility would explain the 
preferential packaging of invertase into 
the very heavy density vesicles in vps8 
sec15-1 cells. Alternatively, in the double 
mutant vps8 sec15-1, invertase may 
just show a preferential packaging at the 
trans-Golgi into the very heavy density 
vesicles, if indeed they form at the trans-
Golgi. At this point we cannot rule out 
the possibility that both HDSV vesicles 
and very heavy density vesicles originate 
from the same compartment. Hsp150 as 
a soluble secretory cargo relies on the 
interaction with a transmembrane receptor 
(who’s nature is unknown so far) to be 
selectively packaged into the different 
secretory vesicles. This receptor may have 
the ability to recruit additional accessory 
proteins or even coat proteins, (as in the 
case of GSE complex-mediated transport 
of Gap1p to the plasma membrane) which 
could possibly ensure efficient vesicle 
formation and transport of Hsp150 to the 
cell surface. We are currently aiming to 
address the nature of the putative receptor 
and identify proteins it may interact 
with. This would allow us to get a deeper 
understanding of the partners involved, 
and possibly the key features characteristic 
of the different exocytic pathways that 
operate in yeast. 
3. Hsp150 as a carrier for secretion of 
heterologous protein in yeast (III)
3.1 Aspects of recombinant protein 
expression in yeast
Many factors have to be considered when 
designing protein production in yeast 
cells. The main objective of heterologous 
expression is the production of secretory 
proteins of mammalian origin. Therefore 
the host must be capable of providing 
eukaryotic-specific post-translational 
modifications, which are required for 
proper folding and full activity of the 
recombinant protein. In contrast to 
prokaryotes, yeast as a eukaryotic cell 
is capable of executing many, but not 
all of the required post-translational 
modi cations that take place during transit 
through their native secretory pathway. 
A second reason for using yeast as an 
expression system is that the amount of 
endogenous proteins in the yeast medium 
is relatively low (<0,5%). Thus, secretion 
of the protein product to the cell exterior 
facilitates down stream processing and 
purification (688). Other advantages of 
using yeast as a recombinant expression 
system are the well-established techniques 
for genetic engineering, large-scale protein 
production by fermentation, the capability 
of the organism to grow in inexpensive 
culture media, and the lack of ethical 
concerns. 
However, in order to achieve 
extracellular production, it’s necessary 
to fuse a functional signal peptide to the 
protein of interest to direct the protein for 
translocation across the ER membrane, 
and thus to allow the protein to access 
the yeast secretory pathway. Although 
signal peptides are recognized with 
low specificity in yeast, it is preferable 
to choose a sequence of yeast origin 
to ensure efficient translocation (689). 
The most commonly used yeast species 
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for heterologous protein expression 
are Saccharomyces cerevisiae and the 
methylotrophic yeast Pichia Pastoris. 
3.2 Hsp150 promotes the folding of 
heterologous fused proteins to active 
and secretion competent forms
Usually secretion of heterologous proteins 
in yeast requires a ‘carrier protein”, whose 
role is to guide the foreign protein to the 
ER translocation channel and to smuggle 
the protein through the ER quality control 
machinery thus facilitating ER exit and 
secretion of the protein (688). Taking 
into count the high secretion ef ciency of 
Hsp150 and its bypass of secretory blocks 
in several temperature-sensitive mutants 
under restrictive temperatures, we wanted 
to explore the possibility of using Hsp150 
as a carrier in the production of different 
heterologous proteins and to compare S. 
cerevisiae and P. pastoris as hosts (647, 
654, 655, 664, 666). The Hsp150 carrier 
fragment which was previously shown 
to confer secretion competence to E. coli 
-lactamase in S. cerevisiae contains 
the 321 N-terminal amino acids of the 
endogenous Hsp150 protein and consists 
of the signal peptide for ER targeting, 
subunit I and the repetitive region of the 
subunit II (651) (Figure 15). The carrier 
portion has 95 potential O-glycosylation 
sites, but it lacks N-glycosylation sites. 
All of the O-glycosylation sites of the  rst 
53 amino acids of the Hsp150 are used 
(666). In order to release the fused protein 
from the carrier, a Kex2p cleavage site 
can be introduced between the carrier and 
the foreign protein. Several recombinant 
proteins such as E.coli -lactamase, rat 
nerve growth factor receptor and rat 
alpha-2,3-sialyltransferase have been 
successfully expressed using the Hsp150 
– carrier system (651, 652, 690-692). For 
this reason we were interested in further 
analyzing the repertoire of heterologous 
proteins that could be expressed using the 
Hsp150 carrier method, and to compare 
the performance of the Hsp150 carrier to 
that of the mating factor (MF)  carrier 
(688, 693-695). 
The MF carrier consists of the -
factor preproprotein of the S. cerevisiae 
mating factor  and it is composed of the 
19 amino acid signal peptide followed by 
a 66 amino acid fragment (pro) with three 
consensus N-glycosylation sites, and a 
dibasic Kex2 endopeptidase-processing 
site (696) (Figure 15). Upon post-
translational translocation into the ER, the 
signal peptide is removed by the signal 
peptidase and in the late-Golgi, the Kex2p 
endoprotease removes the pro-fragment 
at the C-terminal side of the Kex2p site 
(697). For the purpose of heterologous 
expression, the foreign protein is fused to 
the C-terminus of the MF carrier, either 
with or without the Kex2p cleavage site. 
In the  rst case the protein of interest is 
released into the medium free of its carrier. 
Whereas in the second case, the fusion 
protein is secreted in the unprocessed 
form (698). 
Despite the successes of S. cerevisiae 
as a host organism the product yield 
is usually low. In general, higher 
protein yields can be obtained by the 
methylotrophic yeast Pichia pastoris. The 
simplicity and similarity of techniques 
to those used in S. cerevisiae combined 
with the higher ability to produce foreign 
proteins have made P. pastoris the 
preferred option for production of the 
recombinant protein (693, 694, 699). The 
high level of expression in P. pastoris 
results from the use of a commercially 
available expression system that is based 
on the alcohol oxidase (AOX) promoter. 
Alcohol oxidase catalyses the first step 
in methanol utilization pathway by 
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oxidation of methanol to formaldehyde 
and hydrogen peroxide (699). To avoid 
hydrogen peroxide toxicity, this  rst step 
in methanol metabolism takes place within 
a specialized organelle, the peroxisome, 
where the resulting hydrogen peroxide is 
degraded to oxygen and water by catalase. 
Alcohol oxidase has a poor affinity for 
oxygen and the methylotrophic yeasts 
appear to compensate for this de ciency 
by synthesizing large amounts of the 
enzyme in the presence of methanol. 
The regulation of the promoter of AOX1 
is similar to that of the GAL1 gene of S. 
cerevisiae, in the sense that the control 
appears to involve two mechanisms: a 
repression / derepression mechanism plus 
an induction mechanism (700). However, 
unlike GAL1 regulation, the absence of a 
repressing carbon source, such as glucose 
or glycerol in the medium, does not result 
in substantial transcription of the AOX1 
gene. The presence of methanol appears 
to be essential to induce high levels of 
transcription. One additional advantage 
of P. pastoris over S. cerevisiae is that 
it is a poor fermenter. Since it prefers 
aerobic growth, it can reach extremely 
high cell densities when the conditions are 
optimized (701). In contrast, S. cerevisiae, 
when grown to high cell densities, 
produces ethanol as fermentation product, 
which in turn at toxic levels inhibits cell 
growth and production of recombinant 
proteins. This quality of P. pastoris, is 
particularly useful, when the secreted 
protein is proportional to cell density.
Therefore the method we adopted 
for recombinant protein production was 
to insert our different fusion protein 
constructs (Figure 15) under control of the 
AOX1 promoter, induce their expression 
by methanol and collect samples at diverse 
time points for comparison.
3.2.1 Secretion ef ciency of the 
Hsp150 carrier is higher than the 
commonly used MF 
As a starting point for comparison 
of the efficiency of the Hsp150 and 
MF carriers, we used the following 
recombinant proteins, which included 
E.coli -lactamase, the ectodomain of rat 
nerve growth factor receptor (NGFRe), 
the ectodomain of rat alpha-2,3-
sialyltransferase (ST3Ne), and rat bone 
tartrate-resistant acid phosphatase type 5 
(TRAP). The constructs were inserted into 
the pPICZ vector under the control of the 
AOX1 promoter, and the resulting plasmids 
were transformed by electroporation into 
P. pastoris (for strain list see table 2). 
Strains were grown initially in BMGY 
overnight at 30ºC. On the next day the 
cell density was measured and a new 
shake  ask grow period was now started 
using BMMY as growth medium. On 
the following day recombinant protein 
production was initiated by the addition 
of methanol (0,5% V/V). Samples were 
collected daily and analyzed for the 
expression of the proteins. 
In the case of both carriers, E. coli 
-lactamase, folded correctly to an 
enzymatically active form and the fusion 
protein was efficiently secreted to the 
culture medium (III, Figure 4 and Figure 
19A). When using the Hsp150 carrier 
2,3 fold more protein was secreted in 
comparison to the MF carrier. In the case 
of the MF carrier a substantial amount of 
the protein remained intracellular. On the 
other hand, when we analyzed the activity 
of the secreted protein we only observed a 
1,6 fold increase when using the Hsp150 
carrier. The difference observed between 
the amounts of protein secreted versus 
active protein secreted may reflect that 
the secretory pathway is overloaded. For 
example if the ER protein disulphide 
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19. Production of recombinant proteins in P.pastoris. A) Medium samples corresponding to 
OD600=2 were collected from strains expressing  -Lactamase, which was fused either to the 
Hsp150 or to the MF carrier. Quanti cation of the secretion of -lactamase to the medium 
as well as activity measurements was carried out. B) Medium samples from strains expressing 
NGFRe were collected and analyzed by SDS-PAGE followed by silver staining. Endoglycosidase 
H treated cells are referenced. C) Activity measurement of ST3N fused to either carrier using a 
radioactive substrate. The donor was sialic acid (CMP[14C]NeuNAc) and the acceptor was lacto-
N-tetraose (LNT). The  nal product was [14C]NeuNAc  2,3-Gal1-4GlcNac. D) TRAP activity 
test was carried out using either the Hsp150 or the MF carrier and the distribution of the activity 
was measured. E) Electron microscopy pictures of P.pastoris expressing Hsp150--lactamase or 
Hsp150-ST3N and control were collected at diverse time points and prepared for TEM.
isomerase (PDI) is saturated, it can no 
longer form all of the disulphide bridges. 
Since correct disulphide bridges are 
essential for the activity of -lactamase, 
if PDI is saturated, we would expect a 
reduction in the total amount of active 
-lactamase secreted. Alternatively the 
protein may misfold while in the medium, 
and in turn become inactive. TEM analysis 
of P. pastoris strains expressing Hsp150-
-lactamase, showed heavily stained 
vacuoles (Figure 19E). This suggests 
that a significant amount of proteins 
are targeted for degradation, which is 
probably due to the overload placed on 
the secretory pathway.
So to further optimize the production 
of -lactamase we decided to use a 
fermentor, where the growth conditions 
can be regulated and optimized to best suit 
the expression of the protein(701). Under 
these conditions the cells reached a high 
density (OD600=400/ wet weight= 330g/L), 
and 450 mg/L of -lactamase was secreted 
to the culture medium with a peak activity 
of 200 U/mL (III, Figure 5).
Although -lactamase was secreted 
efficiently, the main interest is to 
produce proteins of mammalian origin, 
which can be used for therapeutic 
purposes. One bene t of P. pastoris over 
S. cerevisiae, is that P. pastoris does 
not hyperglycosylated proteins or add 
terminal -1,3-linked mannose residues, 
which are highly immunogenic in humans 
(702, 703). 2,3-Sialyltransferase (ST3N) 
is a type II transmembrane protein of the 
Golgi complex of mammalian cells. It 
transfers sialic acid form CMP-NeuNAc 
to terminal galactose residues of  Gal1-
3-GlcNAc or Gal1-4-GlcNAc, creating a 
-2,3 linkage. Sialylation of glycoproteins 
is particularly important since proteins 
circulating in the blood plasma that lack 
this modification are removed by the 
hepatic asialoglycoprotein receptor (687). 
Production of the soluble ectodomain of 
ST3N would allow large-scale sialylation 
of deficiently sialylated recombinant 
proteins, thus increasing their half time 
in circulation. Additionally,  the 2,3-
linked sialic acid is a component of the 
tetrasaccharide sialyl Lewis X exposed 
on lymphocytes (704). This epitope 
is recognized by selectins present on 
endothelial cells that line the blood vessel 
walls and is required for tissue invasion 
and in ammation.
In order to facilitate folding and ER 
exit the cytosolic and transmembrane 
domain of ST3N were omitted and the 
soluble catalytic ectodomain ST3Ne was 
fused to the Hsp150 and MF carriers. 
Both carriers were equally effective in 
promoting the folding of the ST3Ne 
portion to a catalytically active and 
secretion-competent conformation in the 
ER of P. pastoris.  Approximately 50% of 
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the total active protein remained attached 
to the cell wall, the other half remained 
intracellular in both cases (Figure 19C). 
The Hsp150 carrier produced 6,7 fold 
more protein than the MF carrier. TEM 
analysis of P. pastoris strains expressing 
Hsp150-ST3Ne, showed enlargement of 
the cell wall during the induction period 
(Figure 19E). This cell wall thickening 
may be caused by the increased deposit of 
Hsp150-ST3Ne.
This data suggest that the yeast strain 
carrying Hsp150ST3Ne could serve 
as a self-perpetuating and inexpensive 
source of 2,3-sialyltransferase activity. 
By immobilizing ST3Ne on the cell wall, 
substrates may diffuse through the cell 
wall and gain access to the cell wall-bound 
enzyme. After sialylation the product 
is released back into the medium and 
therefore easily puri ed afterwards (652, 
705). This straightforward method could 
potentially allow the large-scale sialylation 
of glycoproteins and oligosaccharides 
produced either in yeast or by other hosts. 
By adding these mammalian specific 
modifications, it may be possible to 
increase the circulation half-time or even 
use it for enzyme assisted synthesis of 
glycodrugs for use in anti-in ammatory 
therapy (706). Furthermore it is possible 
to co-express both -2,3-sialyltransferase 
and -1,3-fucosyltransferase VII 
ectodomains in S. cerevisiae (707). Both 
of these enzymes are actively targeted 
to the cell wall and were capable of 
producing the tetrasaccharide sialyl 
Lewis X epitope. Thus suggesting, that 
yeast cells can indeed be used as a self-
perpetuating source of glycosyltransferase 
activity.
Next, we attempted to express rat 
bone tartrate-resistant acid phosphatase 
type 5 (TRAP), which is highly expressed 
by osteoclasts, activated macrophages 
and neurons (708). TRAP is associated 
with osteoblast migration to bone 
resorption sites, and once there it initiates 
osteoblast differentiation, activation 
and proliferation by secreting TRAP 
into the bone area, where resorption 
occurs by dephosphorylation of the bone 
matrix phosphoproteins (709). TRAP is 
commonly used as a histochemical and 
biochemical marker for osteoclasts and 
bone resorption. It is also used to diagnosis 
hairy cell leukemia and signals of bone 
breakdown/destruction by cancer. TRAP 
is translated as a monomeric polypeptide, 
but the puri ed enzyme is composed by 
two disulfide-linked subunits (20 and 
16 kDa) (710, 711). The deduced amino 
acid sequence of human, rat and mouse 
TRAPs, show a high degree of similarity 
to mammalian purple acid phosphatases. 
TRAP is composed of 327 amino acids 
with a putative cleavable signal peptide 
of 21 amino acids. The mature form of 
TRAP was joined to the Hsp150 and 
MF carrier, after the Kex2p cleavage site 
(Figure 15).
In the case of the Hsp150 carrier, the 
vast majority of active TRAP produced 
was secreted to the cell exterior  (61% 
in the cell wall and 29% in the culture 
medium) and only a very small portion 
remained intracellular (<10%) (Figure 
19D). In contrast, when using the MF 
carrier, a lower amount was secreted 
(21% in the cell wall and 16% in the 
culture medium), with the majority of the 
protein accumulating intracellular (62%). 
Western blot analysis con rmed that the 
Hsp150 carrier was more skilled than it’s 
rival MF carrier, in conferring secretion 
competence to fused TRAP. The Hsp150 
carrier produced 3,6 fold more protein than 
the MF carrier. Using our experimental 
conditions we managed to secrete a total 
of 40,6 mg/L of active TRAP (15,6 mg/L 
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in the culture medium and 25mg/L in 
the cell wall), which can be classi ed as 
an ef cient secretion rate for shake  ask 
growth. For comparison, a previous study 
using the baculovirus expression system, 
obtained a maximal level of 4.3 mg/L of 
medium (712).
Producing TRAP using this relatively 
s t ra ightforward and inexpensive 
procedure, could potentially allow its use, 
for example, in tissue regeneration therapy. 
Where application of a thin layer of TRAP 
on the surface of the new biomaterials 
being discovered, may promote their use 
as arti cial bone substitutes. The intrinsic 
bone matrix remodeling activity of TRAP, 
may promote the integration of the new 
material with the pre-existing material, 
mimicking the natural process of bone 
deposition on an osteoclast resorbed bone 
surface (713, 714).
To further test the ability of the 
Hsp150 carrier to promote correct 
folding and secretion of the heterologous 
protein fused to it, we decided to choose 
a protein that would challenge the yeast 
chaperone machinery. For this purpose 
we selected the rat nerve growth factor 
receptor ectodomain (NGFRe). NGFRe 
has 41 potential O-glycosylation sites, 
one N-glycosylation site and 24 cysteine 
residues, and it is structurally arranged 
into four domains, each containing 
three disulfide bonds. (690, 692, 715). 
Furthermore, heterologous proteins with 
complex conformations or multiple 
disul de bonds are often misfolded and 
targeted for degradation in yeast (688). 
When expressing this protein in P. pastoris 
NGFRe was secreted to the culture 
medium revealing that the protein adopted 
in the ER the correct conformation (Figure 
19B). However in this case, the MF 
carrier was more ef cient in promoting 
the secretion of NGFRe (approximately 2 
fold more) than the Hsp150 carrier was. 
Our previous studies on the expression 
of NGFRe in S. cerevisiae revealed that 
NGFRe was N-glycosylated, but not O-
glycosylated (690, 692) whereas in P. 
pastoris the NGFRe portion is also O-
glycosylated. 
There is no consensus primary amino 
acid sequence for O-glycosylation. Hence 
it should not be assumed that P. pastoris 
will not glycosylate a heterologous 
protein just because that protein is not 
glycosylated by its native host, neither 
should it be assumed that the specific 
Ser and Thr residue(s) selected for O-
glycosylation by P. pastoris will be the 
same as their native host (702). 
In conclusion it appears that 
the Hsp150 carrier was efficient in 
promoting proper folding of heterologous 
proteins. The ability of Hsp150 to 
function as a good carrier appears to reside 
in the fact that it does not interfere with 
the folding of the fused protein. Structural 
analysis showed that the repetitive region 
within SUII occurs as random coil. A 
prediction that is supported by the fact 
that this regions is heavy O-Glycosylated 
(647, 666) and extensive O-glycosylation 
cause peptides to adopt extended rod-like 
con gurations due to steric interference 
(716). 
Thus it appears that the lack of 
structure in the repetitive region of 
Hsp150 allows the fused protein to adopt 
its native conformation and therefore 
bypass the quality control machinery in 
the ER, resulting in ef cient ER exit and 
secretion.
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4. Final remarks
This present study provides evidence 
that in vivo, COPII vesicles are covered 
by different compositions of the COPII 
components. By alternating Sec24p and its 
homologues Sfb2p and Sfb3p, the cargo 
repertoire that the COPII coat recognizes 
is altered. In the absence of Sec24p, Sfb2p 
or Sfb3p may replace Sec24p in the COPII 
coat. However in the absence of all Sec24 
members, we found that Hsp150 was 
speci cally recruited for ER exit, while 
other exocytic proteins remained in the 
ER. Under these conditions an aberrant 
coat was evidently formed. The signature 
guiding Hsp150 for ER exit under these 
conditions is located in the C-terminal 
domain of the protein, which suggests an 
active and speci c recruitment rather than 
bulk  ow.
In this study we also showed that 
Hsp150 was secreted under conditions 
where the exocyst component Sec15p was 
defective, meanwhile other secretory cargo 
remained intracellularly. We found that 
Hsp150 is transported in HDSV vesicles 
and in a novel class of very heavy density 
vesicles. The selective incorporation of 
Hsp150 into this novel class of vesicles 
may be responsible for its secretion in 
sec15-1 mutant cells. Moreover, we found 
that mutants that abolish the formation of 
the HDSV population of secretory vesicles 
by disturbing the endosomal/vacuolar 
pathway, did not affect the secretion of 
Hsp150. However, secretion of Hsp150 
was dependent on Mso1p, which may play 
a role in stabilization of secretory vesicles 
at the plasma membrane interface, and 
hence allow secretion of a subset of 
secretory vesicles. The signature guiding 
Hsp150 exit in sec15-1 cells did not reside 
in the C-terminal domain of Hsp150, like 
in the case of COPII independent pathway, 
but rather in subunit I or in the first 4 
repeat (Figure 15). Thus it appears that 
Hsp150 uses different putative receptors 
along the secretory pathway. This feature 
may allow its ef cient sorting and rapid 
movement through the yeast exocytic 
pathway
Although Hsp150 is not an essential 
protein, its ability to escape multiple 
secretory blocks, while other proteins 
are trapped, suggests that it may have 
an important biological function. As 
secretion of Hsp150 is rapid and the 
HSP150 gene is strongly expressed 
at 37°C, it may play a role under heat 
shock conditions. However, deletion of 
HSP150 yielded no obvious phenotype 
(647). In yeast there are three proteins 
homologous to Hsp150, PIR1/CCW6, 
PIR3/CCW8 and PIR4/CCW5, but none 
of them are upregulated at 37oC. Deletion 
of all family members is non-lethal, but 
since the quadruple mutant exhibits cell 
wall defects, it appears that one function 
of the PIR family proteins is in cell wall 
stabilization (717). Taking into count 
the ability of Hsp150 to escape multiple 
secretory blocks, Hsp150 may have a 
more sophisticated role. The Hsp150 
carrier confers secretion competence 
to fused heterologous proteins, which 
indicates a possible chaperoning role 
for Hsp150. Thus, Hsp150 might escort 
proteins through the secretory pathway 
under stress conditions. 
Unders tand ing  how para l le l 
secretory pathways are coordinated is 
a key challenge for future research and 
will allow us to understand the dynamic 
nature of the yeast secretory pathway, and 
possibly how more complex secretion 
pathways evolved in higher eukaryotes. 
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